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Abstract 
 
Anions play important roles in various chemical, biological and environmental 
processes, hence there is a significant interest in designing artificial anion receptors that 
can bind or sense anions. In this study, a range of anion receptor compounds derived 
from imidazole ureas has been synthesised using organic (triethylbenzene and 
mesitylcalixarene) and metal-organic (Ru(II), Pt(II) and Pd(II)) scaffolds and 1H NMR 
spectroscopy was used extensively to assess the anion binding and self-assembly 
properties of the receptor compounds.  
The cation and anion binding properties of the free imidazole urea ligands using 
different types of transition metals as well as anions is discussed in Chapter 2.  The 
imidazole urea compounds bind to transition metals namely Cu(II), Co(II) and Ni(II) in 
unidentate fashion and show hydrogen bonding interactions with the anions at the urea 
NH. The self-assembly properties of these imidazole urea compounds has been studied 
by gelation experiments in which silver(I) complexes of these ligands, particularly the 
silver(I) complex of an imidazole urea bearing a dodecyl terminal group can form a gel 
at 2% (w/v) due to the combination of hydrogen bonding, van der Waals and 
solvophobic interactions. 
In Chapter 4, a new series of organic-based derivatives of these ligands have also been 
prepared using triethylbenzene and mesitylcalixarene scaffolds and they were found to 
show weak interactions with halide ions in a competitive solvent, DMSO and exhibit 
acid-base reactions with basic anions such as fluoride and acetate. 
In Chapters 5 and 6, the synthesis of metal-based imidazole urea derivatives using 
ruthenium(II), platinum(II) and palladium(II) precursors is described. During the course 
of the experiments, a number of interesting, and in some cases, unexpected results were 
iii 
 
found. Tripodal ruthenium(II)-based derivative in which the ruthenium(II) centre is 
linked to three imidazole urea ligands, have also been prepared and show interaction 
only with basic anions such as fluoride, acetate and benzoate. On the other hand, Pt(II) 
and Pd(II) complexes of imidazole ureas have shown a tendency to self-aggregate 
forming oligomers and also show interactions with basic anions such as fluoride and 
acetate through deprotonation. 
Finally, although the anion binding and self-assembly properties of these receptors were 
not fully understood, it is suggested that the complex behaviour of these organic and 
metal-based derivatives could be due to the multiple intramolecular and intermolecular 
interactions of the molecule.  
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Chapter 1  
Anion receptors based on organic and metal-organic host scaffolds 
 
1.1 Introduction to Anion Recognition 
 
The past twenty years have seen increasingly rapid advances in the field of anion binding 
and sensing. The development of artificial anion receptors has received significant 
attention due to the important roles anions play in chemical, biological and 
environmental processes.1–4 For instance, anion such as fluoride2 have been shown to 
play a dual role; being considered as a pollutant anion at high concentration on one hand 
and at the same time useful in a human diet.  
Recognition of other anions such as cyanide,5 sulphate2,6 and nitrate7 also has been 
widely explored due to the harmful effects of high concentrations of these anions to the 
environment. Another toxic detrimental anion such as cyanide ion can cause poisoning 
in the environment even though at relatively low concentration. Despite its toxicity, it is 
still widely used in the production of synthetic fibres, resins and herbicides as well as 
being utilised in mining industries, and particularly in gold separation which possesses 
great risk in the contamination of drinking water.8 
Conversely, there are also anions that are essential in biological processes such as 
carboxylates.1 For instance, levels of multi-carboxylate anions such lactate and citrate in 
the human body can provide vital information on serious diseases, for example, the 
changes in citrate levels can be associated with kidney dysfunction and prostate cancer,9 
while high level of lactate can contribute to the growth and progression of cancer 
cells.10,11 
Excess concentration of phosphate ion in chronic kidney disease patients (CKD) can 
cause hyper- and hypophosphatemia that is associated with severe cardiovascular and 
kidney problems.12–14 Disregulation of chloride transport in cells can be associated with 
diseases such as Dent’s disease, osteoporosis, Bartter’s syndrome and idiopathic 
epilepsy.15    
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Despite the popularity of anion recognition, the design of synthetic anion receptors 
remains a great challenge for several reasons. First, anions are larger than isoelectronic 
cations, with a lower charge-to-radius ratio thus resulting in less effective electrostatic 
binding. Anions are also prone to bind to protic solvent making it a challenge to 
recognise them in water for instance. Additionally, some anions may be pH sensitive; 
therefore to design a particular anion receptor, the pH of the solution should also be 
taken into consideration to achieve the maximum interaction between the host and the 
guest anions. In designing a supramolecular host for both natural and artificial systems, 
a host should show high selectivity and be capable of discriminating between one guest 
and another.  
The affinity of a host for a particular receptor can be determined by its binding constant, 
K, which represents the thermodynamic equilibrium constant for the binding process, 
Host + Guest  (Host.Guest):16 
K= 
[Host .  Guest]
[Host] x [Guest]
 
The selectivity of a particular host can be determined from the ratio of binding constant 
of one guest over another: 
Selectivity =
Kguest 1
Kguest 2
 
Basic concepts such as the lock and key analogy,17 preorganisation and 
complementarity16 as well as knowledge on the interaction between host and guest can 
be exploited to manipulate the selectivity of a particular host. Another type of selectivity 
is known as kinetic selectivity, which relates to the transformation of the competing 
substances along the reaction path such as an enzymatic catalysis process. In this case, 
a system is said to be selective for the guest that transforms fastest, rather than the one 
that is bound the strongest.16   
There are two types of anion receptors that have been extensively reviewed; neutral 
receptors and positively-charged receptors. In neutral receptors which are usually based 
on amides,18,19 ureas,20–22 thioureas,20,23,24 squaramides25 and pyrroles,26 the main 
interactions normally occur via effective hydrogen bonding and in some cases through 
deprotonation of the hydrogen bonding donor. In contrast, positively charged anion 
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receptors exploiting pyridinium,22,27,28 imidazolium29,30 and ammonium31–34 units 
interact with anions mainly via electrostatic interactions. The detailed literature on the 
recognition pathways of anions by these types of host molecules are discussed in the 
following section. 
 
1.2 Types of interactions in anion recognition 
 
1.2.1 Hydrogen bonds 
 
Of all the interactions, hydrogen bonding is the most common and has been 
demonstrated in the work of many researchers.35–38 Hydrogen bonding is mainly 
exploited due to its relative strength (10-30 kJ mol-1) and it allows the possibility of 
designing receptors with specific shapes.35 A considerable amount of literature has been 
published on anion hosts that contain hydrogen bond donor units in their molecules 
such as amides,39 sulphonamides,39 ureas,40 imidazoles,29,41 pyrroles,42,43 thioureas24 and 
squaramides.25  
Chiral macrocycles 1.1-1.3 featuring amide and sulphonamide as anion-binding sites 
have been described by Ema and co-workers.39 These systems have multiple H-bonding 
sites and a fluorescent binaphthyl moiety that enables the recognition process to be 
monitored using cost effective UV/Vis and fluorescent methods. Electrospray ionization 
(ESI) mass spectrometry was employed to determine the binding of the anions to the 
receptor while the binding affinities were determined from 1H NMR titration 
experiments in DMSO-d6. NMR data proved that deprotonation occurs at the NH group 
of the nitrobenzamide and sulphonamide of 1-3.  
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Recognition of anions by receptor 1.1 has been observed from significant colour changes 
upon addition of strongly basic anions such as F¯, N3¯, AcO¯, CN¯ and H2PO4¯. Of all the 
anions tested, only CN¯ ion showed a very distinct colour change from colourless to deep 
reddish purple indicated that 1.1 could be used to selectively recognise CN¯ ion. In 
contrast, receptors 1.2 and 1.3 did not show any colour changes, but experienced 
fluorescence quenching upon addition of the respective anions. Additionally, receptors 
1.2 and 1.3 can be utilised to discriminate N3¯ ion as they showed different intensity in 
the fluorescence quenching. The recognition abilities of these receptors were then 
extended toward biologically important molecules namely AMP, ADP, ATP, CMP, GMP, 
H3PO4 (Pi) and H4P2O7 (PPi) (Figure 1.1). A sensor array using receptor 1.2 and 1.3 has 
also been developed, and can discriminate the seven respective phosphates in an 
aqueous DMSO solution with 100% classification accuracy.   
 
Figure 1.1 Molecular structures of seven respective phosphates used in the study of molecular 
recognition properties of receptors 1.1-1.3. 
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Recently, Davis and co-workers reported the synthesis of steroidal squaramide receptor, 
1.4. The presence of squaramide units contribute to a greater acidity, therefore a 
stronger hydrogen bond donor compared to that of ureas and thioureas as well as 
converging N-H groups that are suitable for anion capturing. Receptor 1.4 displayed a 
very high chloride ion affinity in chloroform with binding constant greater than 1014 M−1, 
among the highest reported for anion recognition by electroneutral synthetic 
receptors.44 In addition, 1.4 also binds bromide, iodide and nitrate anions at lower 
binding constants of 1.6 x 1013 M-1, 3.9 x 1011 M-1 and 1.5 x 1013 M-1, respectively. 
 
1.2.2 Electrostatic interaction and hydrogen bonds 
 
Effective sensors for anions can also be produced through a combination of electrostatic 
and hydrogen bond interactions. By this, recently, the Beer group has reported the 
synthesis and anion binding properties of two redox-active imidazoliophane isomers 1.5 
(syn) and 1.6 (anti).45 As evidenced by spectrophotometric titration, 1.5 was found to 
form 1:1 complexes in acetonitrile with I¯ (Ka = 423(42) M-1), Br¯ (Ka = 125(7) M-1) and 
Cl¯ (Ka = 79(5) M-1). Investigation through Osteryoung square-wave voltammetry 
(OSWV) in acetonitrile for receptor 1.5 revealed “two wave behaviour” associated with 
the emergence of a new wave at more negative potential and disappearance of the wave 
corresponded to the free receptor. Upon addition of halides ion (I¯, Br¯ and Cl¯), a new 
oxidation peak also has been observed.  In contrast, the anti isomer 1.6 did not show 
any significant changes upon the addition of halides in both experiments. 
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1.2.3 Anion-π and lone pair electron-π interaction 
 
Tetraoxacalix[2]arene[2]triazine 1.7, an example of electron-deficient macrocyclic host 
was produced by the Wang group in 2013.7 The single crystal X-ray structure 
determination of this system revealed two opposing triazine rings moieties that serve as 
a pair of tweezers, interacting with the anions through cooperative anion-π and lone 
pair electron-π interactions (Figure 1.2). The interaction is established by the short 
distances of anions to the centroid or the plane of the triazine ring. It is also worth noting 
that from the X-ray structures of the anion complexes, there is no evidence of hydrogen 
bonding interactions between anions and arene C-H moieties, which confirms that the 
host interacts with the anion guest solely through anion-π and lone pair electron-π 
interactions. Fluorescent titration experiments in acetonitrile shows that the receptor 
forms the strongest complex (1:1) with NO3¯ (Ka = 16950 M-1), followed by Cl¯ (Ka = 4246 
M-1), BF4¯ (Ka = 673 M-1), PF6¯ (Ka = 291 M-1) and SCN¯ (Ka = 239 M-1). 
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(a) (b) (c) 
 
Figure 1.2 Single crystal X-ray structures of a) Et4N+(1.7.NO3¯)  b) Et4N+(1.7.BF4¯)  c) 
Et4N+(1.7.PF6¯)7. Reproduced with permission from reference 7. 
 
1.2.4 Halogen bonding 
 
The term halogen bonding is used to describe the non-covalent interaction or weak 
electrostatic attraction between an electron deficient, positively polarised atom 
(halogen) and Lewis base (O, S, N, etc.).46 Halogen bonding (XB) shows similar 
characteristic in comparison with hydrogen bonding particularly regarding stringent 
directionality and bond strength.35 So far this interaction has only been widely exploited 
in solid state crystal engineering46 compared to solution phase applications, particularly 
in solution phase anion recognition.  
Work by Raatikainen and co-workers has demonstrated the excellent halogen bond (XB) 
donor abilities in the solid states of bipodal and tripodal cationic ligands having 2-
iodoimidazolium units 1.8 and 1.9. Suitable crystals of 1.8 and 1.9 for X-ray 
crystallography have been obtained in the form of 1.8•(Br¯)2, 1.82•Br¯(CF3SO3¯)2•H2O 
and 1.9•(Br¯)3(CH3CN)2.  In this study, the halogen bond donor abilities were measured 
using “normalised contact”, Nc which is defined as follows:47,48 
Nc = Dij / (rvdWi + rPj) 
   Where, Dij = experimental distance between the atom i and anion 
j 
     rvdWi = van der Waals radius for atom i  
     rPj = Pauling radius for anion j 
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X-ray data of 1.8•(Br¯)2 and 1.9•(Br¯)3(CH3CN)2 both revealed that iodine is strongly 
bonded to Br¯ via a linear, short and charge-assisted XB with I-Br¯ distance of 3.041 and 
3.047 Å, respectively and Nc value of 0.78.  
 
Also, an elegant example of catenane host system, 1.10-1.11 exploiting halogen and 
hydrogen bond for anion recognition in solution phase has been described by Gilday and 
Beer.49 
 
 
In order to study the anion binding properties of this system, the halide hosts underwent 
anion exchange to afford 1.10.PF6 and 1.11.PF6 on addition of aqueous NH4PF6. The 
binding of these compounds were evaluated using 1H NMR spectroscopic titrations in a 
mixture of [D]chloroform/[D4]MeOH 1:1. Both of the compounds showed strongest 
affinity toward iodide, I¯ ion (Ka = 220 and 340 M-1) in comparison with Cl¯ and Br¯ ions 
particularly due to greater halogen-bond-donor ability of the iodine atom compared 
with two other anions. In contrast, both of these compounds did not show any 
complexation with AcO¯ ion. Contrary to expectations based on anion basicity, it was 
found that the trend in anion selectivity of these compounds is in the order, I¯ > Br¯ > Cl¯. 
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The author concluded that the contradictory results was due to a few possible reasons, 
first the interlocked binding domains are more appropriate for larger anions such as I¯. 
Secondly, in the competitive protic solvent mixture, the Cl¯ ion is more prone to 
desolvation effect that accounted for the lower affinity. With respect to halogen 
bonding interactions, the larger halide anions experience greater degree of charge-
transfer type reaction between the respective catenane’s bromo- and iodopyridinium 
halogen-bond-donor motif.  
Latest work reported by Ghosh and co-workers described the synthesis and anion 
binding behaviour of compound 1.12 (halogen bonding analogue) and compound 1.13 
(hydrogen bonding analogue).50 In acetonitrile solution, compound 1.12 has high 
selectivity toward dihydrogenphosphate (H2PO4¯) anion even in the presence of ten 
equivalents of other competitive anions and able to detect H2PO4¯ ion at a very low 
concentration of 0.018 µM. On the other hand, the hydrogen bond analogue, 1.13, albeit 
showing similar binding behaviour, binds H2PO4¯ significantly weaker than that of 1.12.50  
As shown by X-ray crystal structure, 1.12 interacts with H2PO4¯ ion through solitary C-
I…..anion halogen bonding interactions.  
 
1.2.5 Metal or Lewis acid coordination 
 
Lewis acids or metal centres are able to from bonds with anions by overlapping of 
orbitals due to their electron deficient nature. Taking advantage of this feature, many 
macrocyclic hosts containing metal centres have been developed. The presence of a 
metal centre in an anion host facilitates strong interactions51 as well as addressing the 
limitation of hydrogen bonding-based receptors in aqueous solvents due to the 
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competition of anions and solvents at the hydrogen bonding sites.52 A benzimidazole-
based fluorescent sensor described by Saluja and co-workers provides an example of 
anion sensing through Lewis acid coordination.53 Cation displacement approach was 
employed for the recognition of phosphate ion (Figure 1.3).54 The addition of Cu2+ ion to 
1.14 at pH 7 led to maximum quenching (association constant, Ka = 5.34 x 103 M-1). 
However, upon addition of PO43- anion to Cu(II) complex of 1.14, the fluorescence 
intensity of 1.14 was fully restored, which resulted in enhanced fluorescent emission at 
420 nm. From fluorescent intensity (time-dependence) experiments, it was revealed 
that sensor Cu.1.14 required 9.5 min to achieve equilibrium in the recognition of 
phosphate anion.      
 
Figure 1.3 Recognition of PO43- anion using Cu(II) complex of 1.14 based on cation 
displacement approach. 
 
 
1.3 Classes of anion receptors  
 
In the past decades, many classes of anion receptors having different kinds of 
functionalities have been prepared and reported. Here, we focus on just four classes of 
anion receptors which are within the scope of this study. The following sections describe 
detailed examples of anion receptors based-on calixarenes and imidazoles as well as 
metal-based and ion pair receptors.   
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1.3.1 Imidazole-based hosts 
 
Imidazoles are a class of heterocyclic compounds that are essential in biological 
processes, and are common functional groups in structures in the human body, such as 
histamine and histidine.55 Due to their amphoteric nature, imidazole compounds can 
serve as selective and effective anion, cation or neutral molecule sensors that are 
capable of interacting with a broad range of drugs and proteins. The acidity of the NH 
proton of imidazole can also be tuned by varying the electronic properties of the 
substituents attached to the ring.  In addition, the presence of a basic nitrogen atom 
within the ring, which can coordinate to cations, makes imidazole a suitable candidate 
for the construction of metal-based and ditopic anion receptors.55 The following 
sections discuss several examples of imidazole- and benzimidazole-based anion 
receptors.  
 
1.3.2.1 Imidazole  
 
Elegant examples of imidazolium based receptors namely imidazoliophane, 1.15 and 
bromoimidizoliophane, 1.16 have been reported by the Beer group.56 These receptors 
were then converted to hexafluorophosphate salts upon addition to aqueous NH4PF6. 
This study was conducted to compare the binding affinity between 1.15 and 1.16, which 
are hydrogen-bonding receptor and halogen-bonding receptors, respectively. The anion 
binding properties of both receptors were evaluated using 1H NMR spectroscopy toward 
fluoride, chloride, bromide and iodide ions (as TBA salts) in CD3OD/D2O 9:1.  
Receptor 1.15 binds halide weakly (Ka (Cl) = 133 M-1, Ka (Br) = 130 M-1, Ka (I) = 102 M-1), 
while receptor 1.16, with addition of bromine atom to its molecular structure, binds 
anions strongly particularly for bromide ion (Ka (Cl) = <10 M-1, Ka (Br) = 889 M-1, Ka (I) = 
184 M-1), which is sevenfold stronger than that of 1.15. This data also provides an insight 
into why 1.15 is unable to discriminate the respective anions while 1.16 showed a very 
high selectivity for bromide. Recognition of bromide ion is accomplished through pure 
halogen bonding in aqueous media due to the addition of a bromine atom to the 
macrocyclic framework which enhanced its ability to recognise anions.  
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A year later, a similar series of charged-assisted bidentate chloro-, bromo- and iodo-
imidazoliophane receptors were utilised in halogen anion recognition (Cl¯, Br¯ and I¯).57 
The anion binding properties of these series have been investigated by means of 1H NMR 
spectroscopy, fluorescence spectroscopy, X-ray structural determination as well as 
computational DFT calculation. Of all the compounds synthesised, only 1.17 and 1.18 
showed significant perturbation in the chemical shift of internal naphthalene protons 
and increase in the fluorescence intensity band upon addition of Br- and I- ions (as TBA 
salt). The author concluded that 1.17 and 1.18 selectively bind I- and Br-, respectively via 
pure halogen bonding in aqueous methanolic (CD3OD:D2O 9:1) solvent media.  
 
A pincer-shaped diimidazolium salt 1.19 has been reported by Marullo and co-workers 
for the selective recognition of dicarboxylate anion.58 In this molecule, the two cationic 
groups are arranged in a pincer-like fashion which converges on the anion to allow 
effective interaction with the guest anions.  The binding constants of the anion 
complexes formed were determined on the basis of 1H NMR studies showing a 1:1 
complex formation. Of all the anions (halide, monocarboxylate and dicarboxylate) 
tested, 1.19 preferentially binds dicarboxylate anions with the relative binding strength 
order of fumarate < oxalate < succinate < tartrate. The authors concluded that the 
flexibility of the alkyl spacer of the dicarboxylate anion greatly influenced the 
conformation of the dicationic host for maximum interaction with the anions. 
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Water-soluble imidazolium-based receptors 1.20-1.22 which selectively recognise 
monophosphate nucleotide in aqueous solution at physiological pH of 7.4 have been 
reported by Yousuf and co-workers.59 Evidence for binding came from fluorescence, 1H 
NMR spectroscopy and density functional theory (DFT) studies. Receptor 1.20 consists 
of imidazolium units with bridging benzyl moieties bind AMP strongly through strong H-
π interaction with a binding stoichiometry of 1:1.  On the other hand, receptor 1.21 
preferentially coordinates GTP in a 1:1 fashion. The presence of an electron-withdrawing 
N atom in acridine moiety of 1.21 strengthens the H-π interaction between 1.21 and 
GTP which results in fluorescence quenching at physiological pH. In contrast, receptor 
1.22 which has naphthalene-imidazolium based cyclic structure selectively recognised 
pyrophosphate (PPi) in a 2:1 fashion. The recognition process of PPi by 1.22 proceeds 
through the formation of an excimer due to π-π interactions between the fluorophores.  
 
Additionally, the F¯ ion signalling potential of the imidazole NH group also has been 
described.41 This sensor 1.23 in CH3CN:H2O (9:1, v/v) underwent a colour change from 
yellow to red, and the intensity of peaks at 550 nm gradually decreased and was 
replaced by a new peak at 477 nm. The colour change observed is ascribed to charge 
transfer interaction between fluoride bound NH of imidazole and the electron deficient 
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nitro group at the para position. Fluoride was found to bind in 1:1 fashion to NH group 
with a binding constant of 1.42 x 104 M-1. 
 
Cametti and co-workers have synthesised imidazole-based receptors for the assessment 
of the relative strength of halogen bond (XB) (receptor 1.24) over hydrogen bond (HB) 
(receptor 1.25) and the effect of halogen atom polarisability toward halogen bond 
strength (receptor 1.26).60 1H NMR titration experiment was carried out in DMSO to 
determine the binding affinity of 1.24.I¯, 1.25.I¯ and 1.26.I¯ toward Cl¯ ion. Compound 
1.24.I¯, the XB-based receptor showed better affinity for Cl¯ ion of more than one order 
of magnitude compared to HB-based receptor 1.25.I¯, while compound 1.26.I¯ did not 
show any interaction with the Cl¯ ion, consistent with the generally accepted 
electrostatic model of XB.61–63 Binding of 1.24 with AcO¯ ion also showed higher affinity 
than Cl¯ and increase in association constant of 10-fold over HB-based receptor 1.25. In 
addition, in the case of H2PO4¯ ion binding, receptor 1.24 also showed greater affinity of 
40 times more than receptor 1.25. 
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1.3.2.2 Benzimidazole 
 
A series of benzimidazole-based receptors 1.27-1.31 has been prepared and reported 
by the Gale group64 and their binding properties towards various anions were 
investigated using 1H NMR spectroscopy in DMSO-d6/0.5% water solution and single 
crystal X-ray crystallography.  
 
 
 
In the case of compound 1.27, evidence from 1H NMR titration and single crystal X-ray 
structure suggested that Cl¯ interacts with only one NH group via a single hydrogen bond 
due to the formation of an intramolecular hydrogen bond between the hydrogen bond 
of urea and benzimidazole nitrogen atom (Figure 1.4a). In contrast, the addition of more 
basic anions such as SO42¯, OAc¯ and benzoate induced the formation of the other 
tautomer that allows all three NH groups to interact with the anions as evidenced by the 
broad resonance observed in 1H NMR spectrum and by the X-ray single crystal structure 
of benzoate complex of 1.27 (Figure 1.4b).  
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a) b) 
 
 
Figure 1.4 a) The conformation of compound 1.27 in the presence of chloride b) The single 
crystal X-ray structure of the benzoate complex of compound 1.27.64 Reproduced with 
permission from reference 64. 
 
Likewise, receptor 1.28-1.31 showed similar results to 1.27 except that receptor 1.30 
shows a very high selectivity towards dihydrogen phosphate ion compared to others due 
to the presence of methyl group in the benzimidazole ring that allows the anions to 
donate two hydrogen bonds to the benzimidazole groups (Figure 1.5). The authors 
concluded that tautomeric switching concept offer methods in discriminating different 
types of anions.  
 
Figure 1.5 The proposed binding mode of compound 1.30 with dihydrogen phosphate. 
 
Cyclo[2]bezimidazole, 1.32 has been reported by Abraham and co-workers for the 
selective recognition of fluoride, bifluoride and oxoanions hydrophosphate and 
benzoate.65 The authors suggested that the luminescence ‘turn on’ upon binding with 
the anions was caused by the inhibition of an Excited State Intramolecular Proton 
Transfer Process (ESIPT). In the case of fluoride anion complex, the intensity of the 
emission peak at 412 nm increased almost 150 times compared to that of free receptor 
1.32. In addition, effective transformation of fluoride into bifluoride, HF2¯66 was 
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confirmed by NMR studies which revealed the formation of a 1:1 complex with HF2¯with 
association constant of 100 000 ± 10% M-1 and 60-fold turn-on of the luminescence. The 
smaller Stokes shift of complexed 1.32 than that of free 1.32 also an indicator of ESIPT 
process inhibition. It was also revealed that the anion binding event is associated with 
the stabilization of the 1-4Hin (1.33) tautomer due to the formation of four hydrogen 
bonds between the NH groups of the molecule and the anion.  
 
A strong colorimetric sensor for F¯ and CN¯ ions based on anthraimidazolediones 1.34 
has been prepared by Kumari and co-workers.67 While 1.34 can recognise both F¯ and 
CN¯ ions in organic media, in aqueous CH3CN (9:1) media, it can only recognise CN¯ ion 
due to the high hydration energy of F¯ ion (ΔHhyd = -505 kJ/mol) over CN¯ ion (ΔHhyd = -
67 kJ/mol). An intramolecular charge-transfer (ICT) process has been addressed to 
explain the significant red-shifts observed upon addition of F¯ and CN¯ ions. 
 
A chemodosimeter based on benzimidazole 1.35 for selective recognition of F¯ ion has 
been described by Li and co-workers in 2011.68 The chemodosimeter approach in anion 
sensing particularly for F¯ ion has drawn attention due to its high selectivity and a large 
spectroscopic shift. Anion binding behaviour was investigated in acetonitrile using 
fluorescence spectroscopic technique. This receptor can report the presence of F¯ ion 
selectively, based on the fluorescence “turn-on” with 62–fold increase in the emission 
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intensity to that of free receptor and detection limit of 2.72 x 10-6 mol L-1.   The addition 
of F¯ ion initiates the cyclisation from pyridinium 1.35 to pyrido[1,2-α]benzimidazole 
1.36 confirmed by single crystal X-ray structure. The observed enhancement of 
fluorescence at 481 nm corresponds to the extended conjugation in compound 1.36. 
 
 
1.3.2 Pre-organised anion hosts based on organic frameworks  
 
In recent years, there has been an increasing amount of literature on pre-organised 
anion hosts based on organic frameworks. To name the few, preorganised scaffolds such 
as calixarene69–74, trialkylbenzene28,75–77, tris(2-aminoethyl)amine and tricarboxylic ester 
trindane have been widely used in templating the anion receptors in such a way that the 
anions can be encapsulated inside the cavity of the receptor with a high degree of steric 
fit. The choice of scaffolds used is also very important to enhance the selectivity and 
affinity of the anion binding. The following subsections will discuss the anion binding 
properties of two most common scaffold that will be used in this work which are 
trialkylbenzene and calixarenes. 
 
1.3.2.1  Trialkylbenzene-based hosts 
 
One elegant example of trialkylbenzene-based host is compound 1.37, which is capable 
of sensing iodide ion. While there has been much research on the sensing of F¯ and Cl¯ 
ions, there has been little information in the recognition of iodide ion, particularly due 
to its large size and low charge density.72,78,79 On the basis of this, a benzimidazole-based 
tripodal receptor 1.37 has been designed to selectively bind iodide ion over a broad 
concentration range without interference from any other anions.80 1H and 13C NMR 
spectra revealed that 1.37 adopts conformation A (Figure 1.6) which is essential for 
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strong encapsulation of anions. This receptor is able to selectively coordinate to I¯ in 
CH3CN/H2O (99:1, v/v, pH = 7.91) that results in a strong static quenching of the emission 
at λmax 318 and 408 nm.55 The NH2 group of receptor 1.37 binds iodide in 1:1 fashion 
confirmed by 1H NMR spectra with binding constant and detection limit of (1.5±0.2) x 
103 M-1 and 7.45 x 10-6 M, respectively. 
 
Figure 1.6 Conformation A adopted by 1.37. 
 
 
Another example of a trialkylbenzene-based host is compound 1.38, which consists of 
triazole and pyrene moiety as the anion and cation binding site and fluorescence 
signalling unit, respectively. 81 The UV titration experiments have been carried out in the 
presence of a variety of anions of different topologies, such as the halides, nitrate, 
sulphates, phosphates, carboxylates and dicarboxylates. Of all the anions tested, citrate 
is the only ion that can show significant fluorescence changes from green to blue, 
visually observed by standard UV lamp. Receptor 1.38 selectively binds citrate at 1:1 
ratio with an association constant and detection limit of 8.2 × 103 M¯1 and 3.7 × 10−6 M. 
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Another example of trialkylbenzene-based receptor is compound 1.39, synthesised by 
Chawla and co-workers82 showing selectivity towards the sensing of fluoride and acetate 
ion. The addition of the above-mentioned anions induced the colour changes from 
colourless to yellow-green, visible by naked-eye. It is postulated that the intermolecular 
charge transfer (ICT) from the amide pyridinium unit (electron-rich anion binding site) 
to the nitrobenzene fragment (electron deficient unit) is the driving force of the 
bathochromic shift, hence the colour changes.  
 
 
A ‘pin-wheeled’ type anion receptors comprise of pyridinium and urea groups, 1.40-
1.41, have been extensively studied by Steed and co-workers.83 1H NMR titration 
experiments show that compound 1.40 effectively binds halides (Cl¯ and Br¯) and 
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oxyanions  such as NO3¯, AcO¯ and  H2PO4¯) through pyridinium C-H···A- interactions. 
DFT calculation performed shows that the chloride ion is encapsulated within the cavity 
through multiple C-H···Cl and N-H···Cl interactions and the capsule is sealed by C-H···π 
interaction when a p-tolyl group is introduced as the end group. On the other hand, 
compound 1.41, comprises of two anion binding sites;  3-aminopyridium pocket and 
urea group interacts with chloride through charge assisted N-H···Cl and is zipped-up by 
the urea group through α-urea tape motif. 
 
 
       
 
In another work, Ghosh and co-worker has synthesised two elegant tripodal anion 
receptors based on a hexasubstituted aryl core, 1.42 and 1.43, which differ from each 
other on the position of the nitro substituent at ortho and para position, 
respectively.84,85 
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Although both of the compounds contain the same cavity, they show different binding 
modes towards various anions. The addition of anions such as fluoride, chloride, nitrate 
and acetate (as TBA salt) to compound 1.43 results in the formation of dimeric capsular 
assembly (Figure 1.7) while in the case of compound 1.42, only the addition of fluoride 
ion results in the formation of the dimeric capsular assembly while the rest of the anions 
(chloride, nitrate and acetate) drive the compound to form a zipper-like assembly 
(Figure 1.8).  
a) 
 
 
b) 
 
Figure 1.7 a) Formation of a dimeric capsular assembly with fluoride ion and water through 
hydrogen bonding interactions with receptor 1.42 b) Partial structure of the fluoride complex of 
1.43 showing the hydrogen bonding pattern of the [F2(H2O)6]2− cluster and its interactions with 1.43. 
Reproduced with permission from reference 84 and 85. 
 
Figure 1.8 shows that, in the presence of nitrate ions, compound 1.42 shows a zipper-
like assembly, in contrast with compound 1.43 that prefer to form a dimeric capsular 
assembly. In compound 1.43, dimeric capsular assembly is enforced through the CH···O 
interaction between cleft bound nitrate with the aryl CH that bring the similarly charged 
anion into close proximity. Conversely, the formation of zipper-like assembly in 
compound 1.42 was driven by various interactions such as three strong NH···O between 
amide protons of 1.42 and two oxygen atoms of nitrate and also through one 
intermolecular CH…O interaction between aryl C-H and another oxygen atom of the 
nitrate.  
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a)  
 
b)  
 
 
Figure 1.8 a) Formation of a dimeric capsule with encapsulated nitrate ion through hydrogen 
bonding interactions of nitrate anions with receptor 1.42 b) Formation of a zipper-like assembly 
with encapsulated nitrate ion through hydrogen bonding interactions of nitrate anions with 
receptor 1.43. Reproduced with permission from reference 84 and 85. 
   
In recent work reported by the Davis group, a tris-thiourea compound based on a 
triethylbenzene core, 1.44 has shown its effectiveness as anion carriers with the value 
of 0.0019 mol% carrier: lipid, among the lowest value reported in the literature.86 In 
comparison with compound 1.45, 1.44 binds chloride ion 20 times stronger with a 
binding constant of 8 x 108 M-1. Based on the structure of the scaffold, the compactness 
of the cyclohexane-based system possibly allows some weak interactions between the 
thiourea group thus favouring non-binding conformation that eventually results in low 
binding constant. In contrast, the benzene-based scaffold allows the binding groups 
spread apart and minimise the weak interaction between the binding groups. 
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From the single crystal structure of 1.44 + Me4N+Cl−, it is revealed that the two molecules 
of receptor formed a cage that surrounds  a cyclic (Cl−⋯H2O)2 dianionic cluster (Figure 1.9) 
suggesting that the presence of this dimeric species might also be responsible for anion 
transport. 
 
 
 
Figure 1.9 Structure of (1.44·Cl−·H2O)2 as obtained by crystallisation of 1.44 + Me4N+Cl−. One 
molecule of 1.44 is coloured pale cyan, and the two Me4N+ cations outside the cavity are omitted for 
clarity. Reproduced with permission from reference 86. 
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1.3.2.2  Calixarene-based hosts 
 
There is a wealth of literature on the development of calix-based receptors. As a 
macrocyclic ligand, calixarenes have an advantage of recognising larger anions due to 
their medium to large cavity making them suitable host compounds for ionic species. In 
addition to that, the framework of calixarenes allows the positioning of functional 
groups which can facilitate the interaction with a guest molecule. Of key recent 
importance are the tetrameric and pentameric calix[4]imidazolium 1.46 and 
calix[5]imidazolium 1.47 described by Young Chun and co-workers.70 
 
These receptors were synthesised in a one pot reaction to afford the new type of 
positively charged imidazolium based homo-calix compounds that were observed as a 
single crystal structure of calix[4]imidazolium 1.46 in the form of a chloride salt, 
1.46.4Cl.X.H5O2 [X=Cl/Br=0.5Cl. 0.5Br] and calix[5]imidazolium 1.47 in the form of a 
bromide salt, 1.47.5Br.[F.H5O2]. The anion sensing ability of these two receptors has 
been investigated using fluorescence and NMR spectroscopy as well as theoretical 
calculations. Receptor 1.46 strongly binds F¯ ion over other anions with a binding 
constant of 8.3x104 M-1 in aqueous media in a 1:1 fashion. In contrast, 1.47 can recognise 
neutral molecule such as C60 fullerene via π+-π interaction in aqueous media due to its 
larger cavity compared to receptor 1.46. 
 
A ditopic tetrapodal imidazolium-based 1,3-alternate calix[4]arene 1.48 has been 
reported by  Willans and co-workers.29 This receptor binds Cl¯, MeCO2¯ and malonate2¯ 
as 1:1 anion complexes and binds NO3¯ and Br¯ in 1:2 fashion. In terms of overall stability 
constant, the bonds of two equivalent of Cl¯, Br¯ and MeCO2¯ with the receptor are 
equally strong except that in the case of Cl¯, the first equivalent of chlorides shows lower 
affinity (K12 > K11) suggesting the positive allosteric effect in which binding of the first 
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chloride anion facilitates the binding of the second. In contrast, malonate show low 
binding affinity as the small cavity between the two imidazolium groups could not 
accommodate the binding of the large size malonate anion.  
 
 
X-ray crystallography study confirmed the 1,3-alternate conformation of the calixarene 
core with large amounts of enclathrated solvent. The imidazolium groups were found to 
adopt either in or out arrangement that depends on whether they are oriented inwards 
or outwards towards the calixarene pseudo C4 axis (Figure 1.10a and 1.10b). For 
instance, the chloride complexes of 1.48 formed in-out and out-out conformers that are 
capable of chelating a single anion in a pincer-like fashion thus enhanced the solution-
state binding. In addition to that, the X-ray data also provides information on the binding 
mechanism between the receptor and anions which mainly occur via acidic NCHN 
groups and sp2 hybridised imidazolium CH groups . The highlighted feature of this work 
is the inclusion of an imidazolium group between in-out pair of the chloride complexes 
which caused distortion of the calixarene framework thus allows edge-to-face π 
interaction (Figure 1.10c).  
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Figure 1.10 a) In-out and b) Out-out binding regions in imidazolium groups in the X-ray crystal 
structure of the Cl¯ salt of 1.48 c) View of molecule 1.48 highlighting the in-out geometry and 
the inclusion of an imidazolium moiety from an adjacent molecule.29 Reproduced with 
permission from reference 29. 
 
In 2012, the same group synthesised tetrakis(methyl-imidazolium)calix[4]arene 1.49 
and examined its interactions with various anions (Cl¯, Br¯, NO3¯, AcO¯ and PO4¯).30 
Evidence of binding was obtained from 1H NMR spectroscopic studies and also from an 
X-ray single crystal structure. Different modes of interaction were observed upon 
addition of different types of anions. Downfield shift at C4 and C5 was observed upon 
addition of Cl¯, Br¯, NO3¯ with Cl¯ showed the most pronounced shift, followed by Br¯ 
and NO3¯. The X-ray crystal structure of 1.49 revealed the interaction of Br¯ with the 
hydroxyl groups on the lower rim of the calix[4]arene (Figure 1.11). While the addition 
of AcO¯ and PO43¯ at one equivalent exhibited a downfield shift of the C2 proton 
resonance; suggesting the binding of the anion to the imidazolium C2 protons at the 
upper rim of 1.49, the second equivalent of these anions interacts with the acidic lower 
rim causing partial deprotonation of the hydroxyl groups.  
 
 
Figure 1.11 Single crystal X-ray structure of 
1.49.Br¯.30 Reproduced with permission from 
reference 30. 
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Receptors 1.50 and 1.51, derived from bis(N-imidazolyl)calix[4]arene system have been 
utilised by Dinares and co-workers for anion recognition.87 Both receptors consist of two 
imidazole units that are directly bonded to the upper rim of the calixarene structure. 
The binding affinity of 1.50 and 1.51 was evaluated using 1H NMR spectroscopic titration 
in acetonitrile. In acetonitrile, anions are bound strongly to 1.50 and 1.51 with a 1:1 and 
1:2 host:guest stoichiometry observed, respectively. The binding stoichiometry of 1:2 
observed for receptor 1.50 is due to the interference of isopropyl group in the 
interaction between both imidazolium moieties and the anion, inside the receptor 
cavity. It is also revealed that receptor 1.50 only formed 1:1 complexes with small anions 
such as Cl¯ and CN¯. Interestingly, both of the receptors showed strong affinity to 
benzoate anion (Ka = 404 M-1 and K1 = 9374 M-1, K2 = 429 M-1 respectively) over other 
anions tested, most probably due to a strong (C-H)+···RCO2¯ hydrogen bond. Receptor 
1.50 also showed strong anion binding to malonate (1:1) with a binding constant of               
1142 M-1. The calixarene unit of both receptors was found to adopt a pinched cone 
conformation with the substituted rings parallel upon anion coordination.88 
  
Calix[4]arene derivatives consisting of two ferrocenyl imine, 1.52 and two ferrocenyl 
amine, 1.53 have been described as selective receptors for Cl¯ and Br¯ ions.89 A 1:1 
adduct was formed with both anions evidenced by cyclic voltammogram and UV/Vis 
spectra. In comparison with 1.53, compound 1.52 which is a Schiff base compound 
showed a greater anodic shift of 202-302 mV. On the other hand, Cl¯ complexes of 1.52 
and 1.53 produced the largest shift of the ferrocene/ferrocenium redox couple. The 
recognition process involves the oxidation of ferrocene unit (Fc) to Fc+ which 
subsequently binds anions through electrostatic interaction.        
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A series of calix[4]arene based receptors containing squaramide moieties 1.54-1.5673 
has also been utilised for anion recognition via the formation of hydrogen bonding in 
the case of 1.54 and deprotonation of N-H group by strong basic anions in the case of 
1.55 and 1.56. Receptor 1.54 preferentially binds H2PO4¯ ion (log Ka = 4.72) over F¯ ion 
(log Ka = 4.66) and CH3COO¯ (log Ka = 4.34) in DMSO forming 1:1 anion complex 
confirmed by UV/Vis spectroscopy and Job’s plot. Titration experiment of 1.55 and 1.56 
with CH3COO¯ in DMSO showed a bathochromic shift from a shorter wavelength (345 
nm) to a longer wavelength (370 nm) due to internal charge transfer (ICT) transition 
indicated a typical Bronsted acid-base reactions.90 Receptors 1.54 and 1.55 have 
potential as colorimetric sensors for F¯ and CH3COO¯ ions due to colour changes that 
are observable by the “naked-eye” caused by direct deprotonation of the N-H group.  
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Work by the group of Gotor91 has produced a BODIPY-based bis(calix[4]pyrrole) 1.57 for 
recognition and sensing of α,ω-dicarboxylates of different chain length (C2, C5 and C7-
C12) as well as naphthalene dicarboxylates  (Figure 1.12). In this case, changes in the 
UV/Vis and the quenching of the fluorescence emission led to the suggestion that 1.57 
showed high affinity toward α,ω-dicarboxylates of C9 and C10 chain length, most 
probably due to the simultaneous coordination of both terminal carboxylate moieties to 
both calixpyrrole units.  
 
 
 
 
 
Figure 1.12 The molecular structure of the 
aliphatic and aromatic dicarboxylates. 
 
 
Recognition of cyanide ion in CH3CN/DMSO (3%) is also possible using 1.58, nitrovinyl 
substituted calix[4]pyrrole, a dual-functional reaction-based chemosensor.42 In this 
system, while the pyrrole N-H groups serve as a hydrogen-bonding site for halide anions 
such as Cl¯ and Br¯, the vinylic nitro group provides a site for the attachment of CN¯ ion, 
proved by the gradual disappearances of vinylic protons signals in 1H NMR spectrum 
upon addition of CN¯ ion. Nucleophilic additions of CN¯ to 1.58 results in compound 1.59 
which is unstable and undergoes elimination to form cyanide adduct 1.60. UV/Vis 
titration experiments revealed the selectivity of receptor 1.58 toward CN¯ ion even in 
the presence of an excess of other inhibitory anions.   
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Recently, Chang and co-workers have demonstrated the effect of geometrical 
isomerism on anion affinity in hexapyrrolic calix[4]pyrrole system using UV/Vis and NMR 
spectroscopy, X-Ray crystallography and DFT methods.92  From X-ray single crystal 
structure analysis, it was confirmed that trans-1.61 adopts a 1,2-alternate conformation 
while cis-1.61 adopts 1,3-alternate conformation (Figure 1.13).93 Negative mode ESI MS 
revealed both isomers bind anions in 1:1 fashion. Cis-1.61 showed greater anion affinity 
compared to trans-1.61 particularly in the case of chloride (116 times difference), 
dihydrogen phosphate (6 times difference) and benzoate (126 times difference). While 
cis-1.61 shows high binding constant (Kas >104 M-1) and high cross-reactivity,94 trans-1.61 
shows lower binding constants with high selectivity due to the high directionality of the 
hydrogen bonding. The interaction cis-1.61 and trans-1.61 with fluoride ion were also 
investigated in solution by 1H NMR titration in acetonitrile. Addition of fluoride to the 
solution of trans-1.61 caused significant downfield shift of pyrrole NH protons on the 
side arm suggesting the anion complex was formed via hydrogen bonding in contrast 
with cis-1.61 which formed anion complex via anion-π interaction.95 
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a) cis-27 
 
Figure 1.13 Single crystal X-ray structure of  
     a) cis-1.61 adopting 1,3-alternate conformation  
            b) trans-1.61 adopting 1,2-alternate 
conformation.95 Reproduced with permission from 
reference 95. 
 
b) trans-1.61 
 
 
1.3.3 Preorganised metal-based receptors. 
 
Recent developments in the field of anion binding and sensing have led to a renewed 
interest in the construction of metal based receptors. A considerable amount of 
literature has been published on metal based receptors particularly due to the diversity 
of their geometries, redox activities, photophysical activities and their abilities to act as 
Lewis acids.96 Metal-based receptors exploit a combination of electrostatic attraction 
coordination and hydrogen bonds to interact with the guest molecules. Therefore, it is 
often observed that a metal-based receptor employs N-H group as part of their 
molecular structure which can serve as hydrogen bond donor.    
In addition, metal ions also play important roles in the pre-organisation of the host 
molecules. The presence of metal ions will provide extra binding sites that can improve 
the selectivity and sensitivity of the host molecules. Moreover, the electron withdrawing 
characteristic of metals can enhance hydrogen bond donor ability of the host molecules 
which subsequently increase the strength of host-guest interaction.97   
A wide range of anion hosts based on metal complexes such as copper(II)98,99, 
ruthenium(II)100, osmium(II)100,101, rhenium(I)102, europium(III)103 has been synthesised 
and reported. Detailed examples of transition metal-based receptors and lanthanide-
based receptors are discussed in the following section. 
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1.3.3.1 Transition metal-based receptors 
 
The important role of metal ions as structural and signalling elements in anion binding 
and sensing systems has been demonstrated by the Steed group.104 As in receptors 
1.62a-1.62c, the two anion-binding aminomethylpyridine ligands are organised by the 
semi-labile Ru(II) centre that acts as a structural core. The receptors bind strongly to Cl¯ 
followed by acetate and nitrate ion in CDCl3 solution forming both 1:1 and 2:1 anion 
complexes. The binding events of the anions to the hosts was observed through the 1H 
NMR resonance of methylene protons Ha and Hb, in which the strongly bound anion, 
for instance, Cl¯ collapsed the resonance to singlet while weakly bound anion such as 
CF3SO3¯ did not cause any significant changes even at excess concentration.  The authors 
suggested that in the presence of tightly bound anion, i.e. Cl¯, a more symmetric 16-e¯ 
exchange intermediate was formed from the dissociation of Cl¯ driven by the transient 
anion.   
                   
Receptor 1.62c comprises a carbazole derivative, 1.63 and has been described as a 
fluorescent anion chemosensor capable of sensing various anions such as Cl¯, Br¯, NO3¯ 
and MeCO2¯. The presence of these anions resulted in partial quenching of the 
fluorescence (factor of ≈2.5) and a shift to shorter wavelength (λ = 447 nm for Cl¯, Br¯ 
and MeCO2¯ and λ = 456 nm for NO3¯). A strong absorption state at λ = 370 nm region 
was attributed to charge transfer from p-orbital of Cl¯ to an orbital localised over the 
central metal and pyridyl ligands that account for the mechanism for the anion to 
quench the intraligand charge transfer (ILCT) process.105  
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Another  series of potential colourimetric and a fluorometric metal-based sensor for F¯, 
CN¯ and AcO¯ ion recognition have been reported by Maity and co-workers.100 These 
sensors are an elegant example of Ru(II) and Os(II) complexes 1.65-1.68 derived from 
terpyridyl-imidazole ligand 1.64. Anion binding properties were investigated using a 
combination of techniques such as spectrophotometric, steady-state and time-resolved 
fluorimetric, 1H NMR spectroscopic, cyclic voltammetric and single crystal X-ray 
crystallographic techniques. Time-resolved emission studies revealed that 
metalloreceptors 1.65-1.68 show longer lifetimes compared to that of 1.64, their purely 
organic counterparts106 due to the presence of ruthenium(II) and osmium(II) that are 
known to show outstanding photophysical and electrochemical properties.107 Significant 
visual colour change, remarkable absorption spectra and emission spectral changes 
provide evidence that all metalloreceptors 1.65-1.68 can selectively recognise CN¯, F¯ 
and AcO¯ in decreasing selectivity trend with lower limit of detection in the range of      
10-8 M to 10-9 M. The authors concluded that the recognition process of selective anions 
proceeds via deprotonation of the imidazole NH proton(s) of the complexes.  
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Further example of metalloreceptor based on Cu(II) ion has been described Goswami 
and co-workers for the selective sensing of dihydrogen phosphate (DHP) by 
incorporating Cu(II) ions into receptor 1.69.108 In this system, the incorporation of a 
Cu(II) centre into the organic framework results in an open cavity of the metal template 
pre-organized macrocyclic receptor 1.70 which allows better encapsulation of DHP ion 
thus enhancing the selectivity of the Cu(II) complex toward DHP anion over other anions 
studied (iodide, bromide, chloride, fluoride, acetate, phosphate, nitrate, benzoate, and 
(-)-mandelate). 
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Figure 1.14 Equilibrium process showing the co-operative binding of Cu2+ and DHP to receptor 
1.69.108 
 
Additionally, Ling and co-workers have described the synthesis of ruthenium(II) 
polypyridyl complex [Ru(tpy)(H4bbdip)]2+ (tpy = terpyridine, H4bbdip = 2,6-
bis(benzo[1,2-d:4,5-d’]diimidazole-2’-yl)pyridine) 1.71 as colorimetric sensor for F¯ and 
OAc¯.109   
 
Significant changes in the absorption spectra of complex 1.72 has been observed upon 
addition of F¯ and OAc¯ anions, where the first band at 480 nm was shifted to 507 nm (0-
2 equivalent) and shifted progressively to 528 nm upon addition of more than 2 
equivalent of the respective anions as well as significant colour changes from yellow to 
red. The binding interaction between complex 1.72 and anions was investigated by 
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means of 1H NMR spectroscopy. Upon titration with F¯ and OAc¯ anions, the chemical 
shifts of C-H proton around N-H were gradually shifted to upfield, which is correlated 
with the results of UV/Vis absorption titrations indicated that the binding occurs through 
hydrogen bonding and proton transfer from N-H to F¯ and OAc¯, respectively. 
Similarly, Yang and co-workers110 reported the high selectivity of a ruthenium(II) 
complex  carrying both imidazole and indole groups 1.73 toward AcO¯ ion (Ka = 30700 
M-1). The addition of 40 µM of AcO¯ to the complex solution results in a very significant 
colour change from yellow to light orange which was not visible upon addition of other 
anions at the same concentration. It was deduced that AcO¯ binds to indole proton of 
1.73 in 1:1 stoichiometry via hydrogen bonding (Figure 1.15), which was confirmed by 
significant perturbation of C-H protons around N-H group.  
 
 
Figure 1.15 Binding of 1.73 to AcO¯ via hydrogen bonding. 
 
Other work, published by He and co-workers has described the anion binding studies of 
dinuclear phosphine gold(I) complexes (1.74-1.76) with bridging 
bis(dicyclohexylphosphino)methane auxiliary ligands and various receptor pendant 
groups toward various anions (F¯, AcO¯, H2PO4¯, Cl¯, Br¯ and I¯).96 
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The anion binding abilities of these complexes were investigated by means of UV/Vis 
spectrophotometry and NMR spectroscopy. Upon addition of the basic anions (F¯, AcO¯ 
and H2PO4¯), a significant change in UV/Vis spectra were observed, in contrast with the 
addition of Cl¯, Br¯ or I¯. This is particularly due to the acidity of the hydrogen bond donor 
that enables it to form a strong hydrogen bond with basic anions. For complex 1.74 and 
1.75, the titration experiments were conducted in DMSO while for complex 1.76, a less 
competitive solvent, CH2Cl2 was used. Based on the binding constants, all of the 
complexes showed similar anion selectivity trends of F¯ > AcO¯ > H2PO4¯ > Cl¯ ≈ Br¯ ≈ I¯, 
which is consistent with the trend in anion basicity.111 
Ramdass and co-workers have synthesised a range of colorimetric sensors of rhenium(I) 
complexes containing amide 1.77, urea 1.78 and thiourea derivatives 1.79 of 2,2-
bipyridine ligands.102  
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Compounds 1.77-1.79 showed colour changes from light yellow to red upon addition of 
anions (CN¯, F¯, CH3COO¯ and H2PO4¯), in which the intensity of the colour was strongly 
influenced by the binding constant of the anion complex. All receptors 1.77-1.79 bind 
strongly to CN¯ in acetonitrile with binding constants of 3.0 x 104 M-1, 6.5 x 104 M-1 and 
8.7 x 104 M-1, respectively. Evidence from 1H NMR spectroscopy revealed the mechanism 
of recognition involves deprotonation of the NH protons of the amide/urea /thiourea 
moiety of the receptors.  
A metalla-bowl 1.80 capable of sensing multicarboxylate anions (oxalate, tartrate and 
citrate) has been reported by Mishra and co-workers.112 This metalla-bowl consists of 
two bis-amides as four potential hydrogen-bond donors and two Ru-acceptors as a 
signalling unit. Overall, all anions formed 1:1 complex with 1.80 in methanol and show 
increasing complex stability along the series, oxalate (4.0 x 104 M-1) < tartrate (5.0 x 104 
M-1) < citrate (5.5 x 104 M-1). Proton NMR titration experiments revealed the strong 
bidentate H-bonding interaction between amidic N-H and multicarboxylate anions.  
 
Furthermore, the Steed group has reported the anion binding ability of acyclic 
bis(thioureas) 1.81-1.82 and their complexes with ruthenium(II) 1.83-1.84 for selective 
halide anion sensing (Cl¯, Br¯ and I¯).24 In comparison with the free ligand 1.81-1.82, 
both 1.83 and 1.84 bound Cl¯ very strongly in acetone with binding constant of more 
than the value that can be accurately measured by NMR spectroscopic titration.  
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In both cases, the vital role of the coordinating metal was clearly demonstrated 
particularly in the enhancement of the preorganisation and acidity of the hydrogen-
bond donor of bis(thiourea) receptors.24,113 Additionally, the positive charge imparted 
by the metal centre contributes to the effectiveness of this receptor over the neutral 
free ligands.  In the case of 1.84, the presence of the metal inhibits the formation of 
intramolecular hydrogen bonding from the thiourea NH groups to the pyridyl nitrogen 
atom in free ligand 1.82 thus allow the Cl¯ ion to interact with both thiourea groups.   
Complexes 1.85 and 1.86 are water-soluble metallomacrocycles based on flexible 
imidazole ligand with spacers (as in 1.85, where M = Pd and spacer = anthracenyl) or 
linkers (as in 1.86, where M=Pd and linkers = ferrocene).114 In these compounds the 
palladium(II) square planar ion act as a structural element and imparts a positive charge 
to the receptor. Fluorescence titration of 1.85 carried out in aqueous solution revealed 
strong fluorescence enhancement induced by HSO4¯ due to the dissociation of H+ from 
the HSO4¯ ion. Upon addition of HSO4¯, the fluorescent is ‘turned on’ instead of ‘turned 
off’ which is in contrast with other reports.115 Utilisation of ‘turned on’ system in anion 
sensing can prevent false response and as well as producing better signal to noise ratio 
as the detection occurs relative to the dark background.116 On the other hand, the 
binding event of receptor 1.86 was investigated using cyclic voltammetric and square 
wave voltammetric method in acetonitrile. Upon addition of HSO4¯, obvious changes of 
the Ep values was observed indicating strongest interaction at the redox centre and 
subsequent appearance of the second wave at more negative potential confirmed the 
formation of receptor-anion complex. 
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A benzimidazole-based Co3+ receptor 1.87 has been described by Sharma and co-
workers capable of distinguishing I¯ and HSO4¯ over other anions, using electrochemical 
and spectroscopic techniques, respectively in MeOH/H2O (8:2, v/v) solution.117 Addition 
of I¯ to 1.87 caused a change in the electrochemical signal, ΔE1/2 = 145 mV even in the 
presence of other anions. On the other hand, the addition of HSO4¯ to 1.87 showed the 
formation of 1:1 anion complex from hydrogen bond interaction between HSO4¯ and N-
H of benzimidazole which is observed using UV/Vis spectroscopy. 
 
The recognition of any anions in water has been a challenge in designing anion receptors 
due to the high hydration energy possessed by anions. A cation displacement approach 
has been employed by many researchers to overcome this problem. Using this concept, 
Saluja and co-workers prepared a Cr3+ complex of benzimidazole-based compound 1.88 
for the detection of F¯ and HSO4¯ ion.118 Fluorescence titration experiments show 
complex 1.88.Cr3+ binds F¯ and HSO4¯ ion in HEPES-buffered CH3CN/H2O (8:2, v/v) 
solution with binding constants of (2.89±0.25)x105 and (2.30±0.20)x106 M-1, respectively.  
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In 2014, the Yam group reported the syntheses and characterisation of 
alkenylplatinum(II) complexes with amide-based terpyridine ligands, 1.89 and 1.90.119 
They chose to study square planar d8 platinum(II) polypyridine complexes due to the 
spectroscopic and luminescence properties that these complexes possess as well as the 
ability of the complexes to self-assemble via Pt---Pt and aromatic π---π stacking 
interactions. The addition of Cl¯ or Br¯ ions to the acetonitrile solution of 1.89 reduced 
the intensity and resulted in a slight red shifts at 467 nm that corresponds to the low-
energy MLCT/LMCT absorption band. Upon anion inclusion, the electron density of the 
amide group is enhanced, which allows photoinduced electron transfer that is 
responsible for the phosphorescence quenching. On the other hand, the phenyl group 
in 1.89 was replaced with hexyl groups to afford complex 1.90 which has better solubility 
in a less polar solvent such as acetone. The addition of 0 to 2 equivalent of F¯ ion to 
acetone solution of 1.90 showed similar observation to that of 1.89 except with more 
pronounced changes, and subsequent addition of F¯ ion has resulted in dramatic colour 
changes from yellow to orange-red.  
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Another series of platinum(II) terpyridine complexes with amide-, urea- and 
sulphonamide- containing ligands attached to calixarene scaffold (1.91-1.93) have also 
been reported recently.120  
             
By having a bigger pocket of binding site, complex 1.91 binds H2PO4¯ ion stronger than 
complexes 1.92 and 1.93 that show a better encapsulation of a smaller anion such as 
fluoride due to the smaller cavity. Among all of the complexes, complex 1.92 show 
significant colourimetric changes upon addition of anions, which can be detected 
directly by naked eye (Figure 1.16). 
 
Figure 1.16 Colourimetric changes upon the addition of anions into the yellow solution of 
complex 1.92. Reproduced with permission from reference 120. 
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The anion binding event of complex 1.93 towards F¯, OH¯ and H2PO4¯ has been studied 
in detail with 1H NMR titration in dicholoromethane-d2. The addition of F¯and OH¯ into 
the solution of complex 1.93 results in the disappearance of the sulphonamide NH 
proton, which possibly due to the deprotonation process with the calixarene phenolic 
proton remain unaffected. In contrast, when titrated with H2PO4¯ ion, both of the 
sulphonamide NH and calixarene phenolic proton signals shifted further downfield 
suggesting the binding of the anion to the binding site instead of deprotonation process. 
The broadening of the above-mentioned proton signals also suggests the presence of 
self-aggregation of the molecules. 
 
Platinum-based pincer-type complexes, 1.94 has been reported as an irreversible 
chemodosimeter for the high selectivity detection of CN¯ ion in aqueous solution.121 This 
complex can detect CN¯ ion despite the presence of up to 20 equivalents of other anions 
such as F¯, OAc¯ and H2PO4¯. The mechanism of CN¯ ion detection is through the 
displacement of the terpyridine by two CN¯ ions (Figure 1.17). The displacement of the 
terpyridine ligand is confirmed from the fluorescence quenching of complex 1.94 that is 
observable under the UV-lamp (365 nm).  
 
 
Figure 1.17 a) Dipyridylbenzene ligand displacement by two CN¯ ions b) Quenching of the 
fluorescence of complex 1.94 under the UV-lamp (365 nm). 
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1.3.3.2 Lanthanide-based receptors 
 
Apart from transition metals-based metalloreceptors, the past decades have seen the 
rapid development of lanthanide-organic chromophore complexes in the field of anion 
recognition, as lanthanide complexes can display sharp and intense emission bands and 
versatile colour changes upon interaction with anion guests.103 Additionally, lanthanide 
complexes can provide strong electrostatic interactions with anions due to their positive 
charge and oxophilic character.122 Apart from that, lanthanide complexes can respond 
to a wide range of analytes through different sensing mechanism. In contrast with 
transition metal ions, direct excitation of lanthanide ions is inefficient due to their low 
absorption coefficient, and it is susceptible to interference caused by solvent molecules 
such as water which subsequently leads to nonradiative deactivation processes.123 Often 
attached to lanthanide ions are antenna chromophores or sensitizers which can shift the 
excitation wavelength of lanthanide to the visible region. Recent reports on lanthanide 
complexes, particularly Eu3+ and Tb3+ have discussed the roles of lanthanide complexes 
in bioanalytical applications.124–126 
An antenna ligand, 2-(3,4,5-trimethoxyphenyl)imidazo[4,5-f]-1,10-phenanthroline 
scaffold was utilised by Zheng and co-workers103 to construct europium-based 1.95 
anion sensor. 
 
The photophysical properties of 1.95 were determined via UV/Vis and fluorescence 
spectroscopy in dimethylsulfoxide. The addition of eight equivalents of fluoride ion to 
complex 1.95 resulted in the disappearance of a peak at 283 nm which corresponded to 
the aromatic moiety and phenanthroline heterocyclic ring and emergence of a new peak 
at 294 nm indicated the formation of hydrogen bond between complex 1.95 and F¯ ion. 
The similar effect was also observed upon addition of 3-10 equivalents of acetate ion (as 
the tetrabutylammonium, TBA salt). Titration of complex 1.95 with five equivalents of 
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F¯, H2PO4¯ and AcO¯ ions displayed prominent colour changes from pink to purple, blue 
and green, respectively (Figure 1.18). 
 
Figure 1.18 Colour changes upon addition of F¯, H2PO4¯ and AcO¯ ions (a: no anion; b: 5 eq. F¯; c: 
5 eq. of H2PO4¯; d: 5 eq. of AcO¯ ) into the solution of complex 1.95. Reproduced with 
permission from reference 103. 
  
Similarly, Butler and co-workers have synthesised series of europium(III) complexes 
1.95-1.100 based on triazacyclononane, which were utilised in the recognition of oxy-
anions in aqueous media.125 The ligands consist of two strongly absorbing arylalkynyl-
pyridyl chromophores, generating “bright” complexes which are useful in the 
construction of responsive emissive probes. In this system, the binding of several oxy 
anions such as carboxylates, lactate and citrate were assessed by means of emission 
spectral titrimetric analysis. Water molecules were replaced by oxy-anions or amino acid 
residues (hard donor) to form complexes 1.95-1.100. The displacement of water 
molecules causes a change in the spectral fingerprint as well as an increase in the 
emission intensity. Complexes 1.96-1.99 bind strongly to lactate, benzoate and 
bicarbonate with binding affinity ranging from log Ka = 3 to 4. Other than oxy-anions, 
receptor 1.98 binds strongly to fluoride ions in 50% aqueous methanol due to the large 
steric demand at the metal centre. The hydrophilic characteristic of this complexes 
enables it to be internalised readily into mammalian cells for staining purposes. The 
brighter the complexes, the more advantages it can offer in bioanalytical application. 
Brighter complexes often require less excitation light and lower concentration which will 
cause less photodamage to the living specimen in the former case and the latter case 
will minimise disturbances of metal ion homeostasis.127   
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More sophisticated d-f mixed-metal complexes have been described by Shinoda and co-
workers,124 combining Pt(II) and lanthanide(III) centres to specifically recognize the 
chirality of succinate anions. In this system, a platinum(II) complex has been attached to 
the pyridine moieties of cyclen-lanthanide complexes to yield series of mixed-metal 
complexes 1.101-1.104. Single crystal X-ray structure determination of complex 1.104 
revealed two different metal centres were successfully incorporated into the single 
complex (Figure 1.19).  
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Figure 1.19 Single crystal X-ray structure of complex 1.104.124 Reproduced with permission 
from reference 124. 
 
In this work, circular dichroism (CD) spectroscopy was employed to determine the 
absolute configuration and enantiomeric excess of monocarboxylate and dicarboxylate 
anions. In this system, the Pt2+ and Ln3+ centres formed strong binding with the 
dicarboxylate anions, proved by selective CD responses governed by the chain length 
and chirality of the dicarboxylate substrates.  
 
1.3.4 Ion pair receptors 
 
Another class of receptors are ion-pair or ditopic receptors which are designed to 
simultaneously recognise both anions and cations. The common designs of ion-pair 
receptors are illustrated in Figure 1.20.128 The first design emphasises the formation of 
cascade complex comprises of anions forming a bridge to encapsulate two cations. For 
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separated ion pair (design b), the cation and anion sites are located further apart in 
contrast with contact ion pair (design c) where both of sites are nearby.     
 
Figure 1.20 Common designs of ditopic receptors: a) Cascade complex b) Heteroditopic 
receptor for separated ion pairs c) and contact ion pairs. 
 
Oligoether-strapped ion-pair receptor 1.105 synthesised by Park and co-workers is one 
of an elegant example of its type, consists of both a strong anion-binding site and two 
possible cation recognition sites.129 The crystal structure of CsCl complex of receptor 
1.105 revealed two complexation modes for cation by the oligoether (A) and within the 
tetrapyrrolic “cup” of calix[4]pyrrole (B) as shown in Figure 1.21. 
 
 
Figure 1.21 Single-crystal X-ray structure of the cesium chloride 
complex of receptor 1.105129 Reproduced with permission from 
reference 129.  
 
The 1H NMR spectroscopy and isothermal titration calorimetry (ITC) method were 
employed to determine the binding constant with both methods concurring to give a 
selectivity series of F¯ > AcO¯ > Cl¯. The binding constant for F¯ in CD3CN is remarkably 
high which is 4.88 x 108 M-1, contributed by hydrogen bond interaction as well as 
stabilizing anion-π interactions of two phenyl groups presence in the moieties. The 
effect of counterion has also been studied by treating [1.105.F]¯ and [1.105.Cl]¯ with 
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alkaline metal ion salts namely Li+, K+, Na+ and Cs+ in a mixture of acetonitrile/methanol 
(9:1 v/v). Different complexation modes have been observed depending on the metal 
salts used. Cs+ ion was proved to bind to the cup of the calix[4]pyrrole moiety forming 
receptor mediated ion-pair complex for both [1.105.F]¯ and [1.105.Cl]¯, confirmed by a 
significant downfield shift in β-pyrrolic proton signals along with little changes in 
oligoether moiety.  In contrast, the addition of K+ cation to [1.105.F]¯ caused a significant 
downfield shift of ether bridges as well as upfield shift of pyrrole N-H protons indicated 
that ion pair [K+.F¯] is bound within the receptor cavity. A similar result was found upon 
addition of Li+ cation to [1.105.Cl]¯.  
Similarly, benzocrown-ether-capped ion-pair receptor 1.106, designed by Park and co-
workers formed stable 1:1 complexes with fluoride and chloride ions (as 
tetraalkylammonium salts) in CDCl3.130 Formation of two different ion-pair complexes 
depending on the nature of the cation has been clearly demonstrated as well. Single-
crystal structural studies revealed that calix[4]pyrrole moiety of 1.106 adopts a partial 
cone conformation suitable for cation and anion sensing (Figure 1.22a). On the other 
hand, CsF complex of 1.106 formed a receptor-shared ion-pair complex in which the 
fluoride ion is bound tightly inside the cavity, while cesium ion is bound within the 
calix[4]pyrrole (Figure 1.22b). In contrast, single crystal X-ray structure of LiCl complex 
of 1.106 revealed the formation of water-separated dimeric ion-pair complex 
[{1.106.LiCl-(H2O)}2] (Figure 1.22c). 
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Figure 1.22 a) Partial cone conformation of calix[4]pyrrole moiety of 1.106 b) CsF complex of 
1.106 c) LiCl of 1.106.130 Reproduced with permission from reference 130. 
 
In 2012, the Beer group reported the synthesis of a heteroditopic receptors 
comprised of calix[4]-diquinone triazole 1.107 and their interaction with cations (K+, Na+ 
and NH4+) and anions (Cl¯, Br¯ and I¯).131 Binding experiments, carried out using 1H NMR 
spectroscopy and UV/Vis spectroscopy in 2% D2O/CD3CN revealed that 1.107 underwent 
a conformational change to enable the lower rim oxygen and triazole nitrogen donors 
to complex with the cation with selectivity trend of Na+ (460 M-1) > K+ (155 M-1) > NH4+. 
The anion binding experiments conducted revealed the selectivity trend of Cl¯ (178 M-1) 
> Br¯ (67 M-1) > I¯ (31 M-1) suggested that bistriazole-isophthalamide cavity of 1.107 is 
more suitable for the inclusion of Cl¯ ion. Compared to the cation-free form of receptor 
1.107, the association constants are significantly enhanced by 3 to 11 times greater for 
the halides ion in the presence of all cations.  
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Recently, a ferrocene-strapped system 1.108-1.110 having an electrochemically-active 
sensing unit was reported by Alfonso and co-workers.132 Voltammetric studies of 1.108-
1.110 revealed a reversible two-electron oxidation wave at E1/2 = 623 mV for 1.108 and 
one-electron oxidation wave at E1/2 = 630 mV and E1/2 = 675 mV, for 1.109 and 1.110, 
respectively, corresponding to the ferrocene couple. The addition of anions, such as 
AcO¯ and H2PO4¯ to 1.108-1.110 in acetonitrile, resulted in a cathodic shift of the cyclic 
voltammetric wave. Conversely, the addition of HSO4¯ results in a slight anodic shift, 
contributed by the acidic nature of HSO4- that promotes a guest-to-host proton transfer 
reaction accompanied by hydrogen bonding and electrostatic reaction.   
 
McConnell and co-workers have studied the ion-pair binding properties of a series of 
ditopic calix[4]diquinone receptors 1.111-1.115 in acetonitrile.133 It contains 
calix[4]arene subunit for cation recognition and diquinone units for anion recognition. 
Enhanced binding of ion-pairs over ‘free ions’ was observed for receptor 1.111, 1.112 
and 1.114 (1:1 stoichiometry) showing selectivity trend of the following order; NH4Cl > 
KCl > NaCl in 0.5% v/v H2O/CH3CN. In the case of receptor 1.111 and 1.112, 1H NMR 
spectroscopic titration study carried out in CD3CN/D2O (98/2, v/v) shows that the 
presence of coordinating cation enables chloride ion recognition which could not be 
achieved in its absence.  
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An elegant example of ion-pair receptors 1.116-1.117 based on anion-π interaction has 
been produced by Chen and co-workers.134 The ability of these receptors to interact with 
ion pairs was examined by fluorescence and 1H NMR titration experiments. The titration 
of fluoride ion with [1.116.Zn]2+ and [1.116.Pb]2+ resulted in an enhancement of 
fluorescence intensity band at 425 nm, with the association constants of  1.53 x 105 M-1 
and 3.71 x 103 M-1, respectively. The presence of Zn2+ ion has tremendously increased 
the binding constant more than 23-fold from its parent compound 1.116 (Ka = 6.59 x 103 
M-1). Additionally, anions such as chloride, bromide and nitrate that were not recognised 
by 1.116 have successfully bound to [1.116.Zn]2+ with a binding constant of 7.39 x 103 
M-1, 1.59 x 103 M-1and 4.25 x 103 M-1, respectively. Likewise, in the presence of metal 
ions such as K+, Cs+, Ca2+ and Sr2+, cyanide ion was found to bind to 1.117 with binding 
constant ranging from 3.46 x 103 M-1 to 8.36 x 103 M-1. The author concluded that the 
mechanism of ditopic interaction of 1.116 with Zn2+ and anion species proceeds via 
interaction of anion with the electron-deficient triazine ring, [anion-1.116-Zn]2+. 
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Another ditopic receptor derived from 1.118 has been reported by the Carreira-Barral 
group.98 Spectrophotometric titrations carried out for the Cu(II) complex of 1.118 
revealed the formation of anion binding complex with decreasing affinity as follows: 
MeCO2¯ ~ Cl¯ (log K11 > 7) > NO2¯ > H2PO4¯ > Br¯ > HSO4¯ > NO3¯ (log K11 < 2). The single 
crystal X-ray structure of the [Zn(1.118)Cl2] complex revealed that the ligand adopted 
‘bent propeller’ conformation due to the presence of intramolecular slipped π-π 
stacking interaction between N atom of the pyridine ring and the benzylurea fragment135 
while chloride anion is coordinated via hydrogen-bonding with the NH group of the urea 
fragment (Figure 1.23a). On the other hand, the single crystal structure of 
[Cu(1.118)NO3] revealed the interaction between the [Cu(1.118)(ONO2)(OHMe)]+ cation 
with nitrate ion via bifurcated hydrogen bond, forcing the ligand to adopt an ‘open wing 
butterfly’ conformation (Figure 1.23b). The addition of different anions leads to different 
binding stoichiometry, for instance, the addition of HSO4¯ provokes the formation of a 
1:1 species, while the addition of other anions such as Cl¯, NO2¯, H2PO4¯ and Br¯ results 
in the formation of 1:2 (metal/anion) species.  
 
 
  
Figure 1.23 a) ‘Bent propeller’ conformation of [Zn(1.118)Cl2] b) ‘Open wing   
                      butterfly’ conformation of [Cu(1.118)NO3].98 Reproduced with permission from 
reference 98. 
 
Recently, Romanski and Karbarz have reported an ion-pair receptor, 1.119 that is consist 
of anthraquinone-thiourea unit responsible for anion binding and a crown ether-based 
cation binding site.136 In the presence of sodium ion, receptor 1.119  has shown a very 
high affinity toward Cl¯ and Br¯ ions which is 3.09 times and 4.28 times, respectively, 
more strongly associated in comparison with the absence of sodium ion. Upon titration 
with one equivalent of different salts, namely NaCl, KCl and NH4Cl, the crown ether unit 
has shown a high selectivity toward Na+ ion with binding constant, K = 30900 M¯1 over 
K+ and NH4+ ions with binding constant of 6900 M¯1 and 4450 M¯1, respectively. The 
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authors also suggest that the association of sodium ion to the crown ether unit 
diminishes the electron density in the phenyl ring linked with the anion binding site, thus 
reinforces stronger anion binding.  
 
1.4 Summary 
 
Over recent years, the important progress achieved in anion sensing and binding has 
been exemplified by numerous systems that have been described in this field. 
Furthermore, the concept of pure anion binding has been extensively exploited in real-
world applications, such as sensing, catalysis and the medicinal use of transmembrane 
anion transport. It is also anticipated that this research field will continue to grow in the 
coming years.    
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1.5 Project Aims and Overview 
 
The aim of this project is to get closer towards fully understanding how imidazole urea 
derivatives and their transition metal complexes interact with variety of anions in organic 
solvents. While studies on the interactions of pyridyl urea derivatives and their complexes 
with various anions have been well-documented, there is very little published research on 
how imidazole urea interacts with the anions and how the imidazole group contributes in 
the hydrogen bonding interactions in the molecule.  The choice of ligands for the synthesis 
of these hosts was inspired through the work of Barboiu group in which the imidazole urea 
synthesised was capable of forming mixed ion–water channel-like superstructures, useful 
for ion recognition as well as supramolecular transport devices.137,138 
 
In the previous sections, we have described different types of anion receptors and how 
they have been constructed, particularly involving the necessary interactions needed to 
encapsulate or bind with the respected anions. Of particular interest is the use of 
electrostatic interaction and hydrogen bonding in the design of anion receptors. Hydrogen 
bond-based anion receptor such as ureas, amide and thioureas have been well studied due 
to the high degrees of directionality and are often easy to prepare, although some of them 
may display poor solubility in less competitive organic solvents. The preparation of 
imidazole urea compounds and their transition metal complexes as well as their 
interaction with various anions wil be discussed in detail in Chapter 2 and 3.  
 
On the other hand, when selecting a core to base an anion receptor on, there are merits 
and weaknesses that need to be accounted for. For instance, ligand frameworks based on 
organic molecules are highly versatile as well as being more stable as the introduction of 
the anions will not alter the structure of the receptors. Therefore for this purpose, we 
decided to use two common organic scaffolds derived from 1,3,5-tribromo-2,4,6-
triethylbenzene and tetrakis-p-bromomethylated mesityl calix[4]arene (Figure 1.24).  
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Figure 1.24 Organic scaffolds; 1,3,5-tribromo-2,4,6-triethylbenzene and tetrakis-p-
bromomethylated mesityl calix[4]arene.  
 
The former is chosen due to the degree of preorganisation that it can offer in which all the 
three binding arms can be projected in one direction to form a conical conformation. 
Similarly, the latter can provide similar degree of preorganisation and would be able to 
encapsulate at least two anions simultaneously. The anion receptor based on the organic 
scaffolds can be prepared by reacting the desired scaffold with imidazole urea compounds 
synthesised prior the reaction (Scheme 1.1). The synthesis of these organic-based anion 
hosts and their binding behaviour towards anions will be discussed in detail in Chapter 4. 
 
 
 
Scheme 1.1 Stepwise synthesis pathway of imidazole urea compounds based on organic scaffold. 
The ligand is connected to the organic core through N atom and there is a possibility of 
isomerism.  
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However, despite the versatility of the organic molecules, one of the drawbacks of using 
organic scaffold is the reaction is often unpredictable and highly dependent on the nature 
of their structure in this case, which may lead to the formation of isomers. Thus, another 
option of using transition metal as the core is also considered in the preparation of the 
suitable anion receptors. Although metal-based anion receptors are often more 
predictable in in terms of their geometry, it is highly dependent on the lability of the 
transition metals. For example, labile transition metals such as copper and cobalt could be 
easily replaced by anions such as chloride and cyanide. Therefore, we decided to use three 
different less labile metals namely platinum(II), palladium(II) and ruthenium(II) as a base 
for the host complexes. For this purpose, we have prepared a series of tripodal [9]ane-S3-
capped Ru(II) complexes (Scheme 1.2) as well as bipodal Pt(II) and Pd(II) complexes using 
chelating ligands such as ethylenediamine, cyclohexanediamine and 1,2-
Bis(diphenylphosphino)ethane (Scheme 1.3).  
 
 
 
Scheme 1.2 Preparation of ruthenium(II) complexes using mixed ligands system of 
trithiacyclononane and imidazole urea ligands.  
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a)  
 
b)  
 
 
Scheme 1.3 a) Preparation of Pt(II) complexes using mixed ligands system of ethylenediamine or 
cyclohexanediamine and imidazole urea ligands b) Preparation of Pd(II) complexes using mixed 
ligands system of ethylenediamine or 1,2-Bis(dipehnylphosphino)ethane (dppe) and imidazole 
urea ligands. 
 
The synthesis of the transition metal-based anion receptors and their binding behaviour 
towards selected anions will be investigated using 1H NMR titration spectroscopy where 
appropriate. Data from the titration experiments will be able to provide information on the 
degree of pre-organisation and flexibility of the hosts synthesised and is discussed in detail in 
Chapter 5 and 6. 
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Chapter 2 
Coordination chemistry and anion binding profiles of imidazole 
compounds containing urea derivatives. 
 
2.1 Introduction and Project Aims 
 
The main aim of this research is to investigate the anion binding properties and 
coordination chemistry of a set of imidazole compounds containing urea derivatives to 
characterise the ligands’ metal coordination and anion binding modes and hence design 
new imidazole urea-based anion hosts. Imidazoles are a class of heterocyclic compounds 
that are essential in biological processes and are common functional groups in biological 
molecules, such as histamine and histidine.1 Due to their amphoteric nature, imidazole 
compounds can serve as selective and effective anion, cation or neutral molecule 
sensors that are capable of interacting with a broad range of drugs and proteins. The 
acidity of the NH proton of imidazole can also be tuned by varying the electronic 
properties of the substituents attached to the ring.  Also, the presence of a basic 
nitrogen atom within the ring, which can coordinate to cations, makes imidazole a 
suitable candidate for the construction of metal-based and ditopic anion receptors.1 
Initial studies on simple urea derivatised imidazole compounds by the Barboiu group2 
has shown the ability of these compounds to form a homomeric association of the urea 
and imidazole functional groups giving rise to a dipolar proton channel. With this in 
mind, we have prepared series of imidazole ligands containing urea derivatives which 
are interesting in the context of cation and anion binding.3 
2.2 Results and Discussions 
2.2.1 Synthesis and crystal structure of imidazole urea ligands 
 
A series of imidazole ligands containing urea derivatives (2.1-2.8) were readily 
synthesised in good yield via one-pot reaction of histamine with appropriate isocyanates 
in a continuous nitrogen stream for 18 hours or overnight. The (unoptimised) isolated 
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yields are also high (80-95%) similar to related pyridine urea analogues.4 The 
formation of the imidazole urea ligands with aliphatic chains and tert-butyl groups, 2.1-
2.3 and 2.8 was confirmed by  characteristic NH urea signals in the 1H NMR spectrum of 
the products at 5.88 (N1-H) and 5.79 (N2-H) ppm for all four compounds. The ESI-MS 
results also show a molecular ion peak (M+H+) of 211, 267, 323 and 211 for compounds 
2.1-2.3 and 2.8, respectively. On the other hand, for the imidazole urea ligands with 
aromatic substituents, the urea NH signals were observed in the range of 7.47-6.09 (N1-
H) and 7.49-6.82 (N2-H) ppm. The formation of the compounds, 2.4-2.7 has also been 
supported by the ESI-MS results showing molecular ion peaks (M+H+) of 245, 276, 288 
and 265, respectively. Of all the imidazole urea compounds synthesised, four of them 
yielded single crystals that are suitable for Single Crystal X-Ray Diffraction (SC-XRD) 
analysis. Table 2.1 below summarises the crystallographic data for all the crystals 
obtained and the details of the molecular structure and crystal packing will be discussed 
further.  The synthesis route of imidazole urea derivatives is depicted in Scheme 2.1.  
 
 
Scheme 2.1 Synthetic pathway of imidazole ligands containing urea derivatives (2.1-2.8).  
 
Imidazole-derived compounds as-synthesised can show tautomerism at nitrogen atoms 
if the two nitrogen atoms present in the five membered is not symmetrically 
substituted.5 This means that the hydrogen atom can either be bonded to the N1 or N2 
atom and can be interconverted between N(1) and N(2)-type isomer as illustrated in 
Figure 2.1. 
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Figure 2.1 Interconversion between N(1) and N(2) type tautomers. 
 
Table 2.1 Crystallographic data for compound 2.1, 2.4, 2.6 and 2.7 
 2.1 2.4 2.6 2.7 
Formula C10H18N4O 
C13H16N4O. 
CH3NO2 
C16H22N4O C12H13ClN4O 
Formula 
weight 
210.28 305.34 286.38 264.71 
Space group P21/c Pca21 P212121 P21 
a / Å 11.1384(4) 12.3460(3) 8.2251(2) 9.6232(4) 
b / Å 5.6178(3) 13.9709(3) 9.7345(2) 4.8410(2) 
c / Å 17.6812(5) 9.1894(2) 18.8588(4) 13.9243(5) 
Α / ° 90 90 90 90 
β / ° 94.171(3) 90 90 109.642(3) 
γ / ° 90 90 90 90 
V / Å3 1103.44(7) 1585.03(6) 1509.97(6) 610.93(4) 
Z 4 4 4 2 
Dcalc / g cm-3 1.266 1.280 1.260 1.439 
Rint 0.0488 0.0578 0.0871 0.0708 
R1 [I ≥ 2σ (I)] 0.0427 0.0476 0.0384 0.0519 
wR2 [all data] 0.0896 0.0976 0.0864 0.1128 
 
All of the crystal structures of the synthesised imidazole urea ligands are prone to form 
N1 type isomers, as this form is less sterically hindered in comparison to the N2 type 
isomer, particularly in solid state. A single crystal of 2.1 was obtained from slow 
evaporation of an acetonitrile solution of the compound and characterised by X-ray 
crystallography. Compound 2.1 crystallises in monoclinic system with space group P21/c. 
 
Figure 2.2 Molecular structure of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐butyl)urea 
(2.1) 
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The molecules are not linked together by a typical urea -tape as observed in most of 
urea and bis(urea) systems.6–9 Instead, there are intermolecular hydrogen bonds 
between imidazole nitrogen, N1 with the hydrogen atoms of the urea group, H3 and H4 
with N···H distances of 3.066(16) and 3.274(16) Å, respectively. The crystal is also 
stabilised by another hydrogen bond between the urea oxygen, O1 with the hydrogen 
atom of the imidazole group, N2-H with O1···H2 distance of 2.7758(4) Å (Figure 2.3). 
 
Figure 2.3 Hydrogen bonding patterns in the molecular packing of compound 2.1. 
 
Single crystals of 2.4 were obtained from the slow evaporation of nitromethane. This 
compound crystallises as a nitromethane solvate, which is analogous to the previously 
reported structures of 2.410 and its phenyl analogue2 which crystallise as acetonitrile 
solvates. It crystallises in orthorhombic system with a space group Pca21 different from 
the previously reported acetonitrile solvate, which crystallised in the monoclinic system 
(P21/n). However, this structure is isostructural to the acetonitrile solvate reported by 
the Steed group.  
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Figure 2.4 Molecular structure of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐
methylphenyl)urea (2.4). 
 
This compound exhibits a typical hydrogen bonded urea α-tape motif10,11 with short and 
symmetrical interactions between the oxygen atom, O1 and H3 and H4 based on urea 
nitrogen atoms with distances of 2.898(2) and 2.838(2) Å, respectively and is consistent 
with the previously reported structure of acetonitrile solvate.12 The formation of the 
urea α-tape network allows the adjacent molecules to aggregate along the tape axis in 
an alternating fashion. In addition to that, there is also a formation of a second ‘zigzag’ 
hydrogen bonded tape between the imidazole nitrogen atoms (Figure 2.5).  
 
Figure 2.5 Crystal packing of compound 2.4. 
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On the other hand, compound 2.6 crystallises from the slow cooling of methanol in the 
orthorhombic system with space group P212121. Similarly to compound 2.4, the 
structure is characterised by a urea α-tape motif arising from hydrogen bonds between 
O1 and H1 and H2, with the bond lengths of 2.844(2) and 3.029(2) Å, respectively.  
 
 
Figure 2.6 Molecular structure of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐butylphenyl)urea (2.6). 
 
In the packing, a similar ‘zigzag’ hydrogen bonding pattern forms from the interactions 
between the imidazole nitrogen atoms with a distance of 2.851(2) Å (Figure 2.7). 
 
 
 
Figure 2.7 Hydrogen bonding patterns in the molecular packing of compound 2.6. 
 
Colourless single crystals of 2.7 were isolated via slow evaporation of methanol and 
characterised by X-ray crystallography. Compound 2.7 crystallises in the monoclinic 
system in the chiral space group P21.  
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Figure 2.8 Molecular structure of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐
chlorophenyl)urea (2.7). 
 
In contrast to compounds 2.4 and 2.6, this compound does not exhibit a typical urea -
tape, instead the molecule forms a three-dimensional network that is linked by 
intermolecular hydrogen bond between imidazole nitrogen, N1 with hydrogen atom of 
the urea group, H3 and H4 with bond lengths of 3.244(5) and 2.979(4) Å, respectively. 
There is also an intramolecular hydrogen bond between the oxygen atom, O1 with the 
hydrogen atom of the aromatic chain, H8 with a distance of 2.873(5) Å, forming a six-
membered ring. The presence of electron withdrawing substituent promotes CH…O 
intramolecular interactions as previously described.13 In the packing, the molecule is 
also stabilised by a hydrogen bond between urea oxygen, O1 with hydrogen of an 
imidazole group, N2 with a distance of 2.765(4) Å (Figure 2.9). 
 
Figure 2.9 Hydrogen bonding patterns in the crystal packing of compound 2.7. 
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In conclusion, there are some factors that influence the formation of urea -tape 
between the urea moiety. For compound 2.1, the less steric aliphatic butyl chain inhibit 
the formation of urea -tape as the molecules assemble themselves through the 
formation of a NH⋯N imidazolyl– urea hydrogen-bonded synthon.14 However, In the 
case of imidazole urea with an aromatic chain such as compound 2.4, the presence of 
nitromethane solvate promotes the formation of urea -tape as the oxygen of the 
nitromethane interacts with the CH imidazole (O2-H2A with a distance of 2.466 Å)  thus 
leaving the urea group free to interact with each other. In addition, the hydrogen 
bonding patterns in imidazole derivatives containing urea derivatives are also highly 
influenced by the chain length and substituents of the urea group. From the crystal 
structure of all the imidazole urea compounds, it can be observed that in some 
compounds namely 2.4 and 2.6, the self-complementary hydrogen bond donor and 
acceptor capacity of the imidazole groups allow the hydrogen bond interaction between 
the basic imidazole nitrogen with the imidazole N-H proton thus leaving the urea moiety 
free to form the usual hydrogen bonded α-tape motif. In addition, the presence of 
electron donating substituents in compound 2.4 and 2.6 decrease the acidity of the urea 
N-H protons, thus promotes the self-complementary interaction between NH···N of the 
imidazole groups.  On the contrary, the presence of an electron withdrawing substituent 
in compound 2.7 contributes to the greater acidity of the urea N-H compared to that of 
imidazole N-H, thus promotes the NH···N interaction between urea N-H and basic 
imidazole nitrogen and disrupts the α-urea tape formation. This is an interesting finding 
in which the simultaneous interactions of urea and imidazole H-bonding moieties can 
be structurally tuned for specific potential application for example in the generation of 
multiple supramolecular architectures.    
 
2.2.2 Transition metal complexes of imidazole urea ligands  
 
One of the aims of this project is to synthesise a series of metal-based anion receptors 
from various transition metals. The basic nitrogen atom in imidazole groups makes them 
suitable as ligands for transition metals. Unlike pyridyl systems, the smaller size of 
imidazole groups could potentially result in the less steric crowding at the metal centre 
and hence higher metal:ligand stoichiometry. For example, the complexation reactions 
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of imidazole urea ligands with transition metal salts namely cobalt(II) and nickel(II) were 
performed with higher metal to ligand ratio of 1:6. For copper(II) metals, the reaction 
was performed with metal:ligand ratio of 1:4 based on the common coordination 
number of copper(II) metals. Different metals salts such as copper(II) chloride dihydrate, 
copper(II) nitrate hydrate, cobalt(II) chloride hexahydrate, cobalt(II) nitrate 
hexahydrate, nickel(II) chloride hexahydrate and nickel(II) nitrate hexahydrate have 
been used for this purpose. For these complexation reactions, 0.003 mmol of ligands 
2.1-2.4 and 2.6-2.8 in 0.2 mL of methanol was reacted with selected transition metals 
dissolved in water in 2 mL vials.  
Most of the reactions showed colour changes after the addition of the ligands to the 
respective transition metals solution indicating that the complexation reaction has taken 
place. The solution mixture was then heated in a water bath at about 50 °C for 5 minutes 
and briefly sonicated to allow dispersion and thorough mixing. The mixture was then left 
to evaporate at room temperature to obtain transition metal complexes of the imidazole 
urea ligands. With the exception of ligand 2.3, all of the complexation reactions gave a 
coloured solution upon addition of the metal ions. In contrast, the addition of metal ions 
to ligand 2.3 results in the immediate precipitation of the complexes. The coloured 
solution of the complexes was left to evaporate to afford pure compounds or single 
crystals. Precipitates obtained were filtered, isolated and dried in the dessicator. For the 
synthesis of Co(II) and Ni(II) complexes, the ratio of metal:ligand was decided on the 
maximum coordination number of six, giving octahedral complexes, while for Copper(II), 
the metal:ligand ratio is fixed at 1:4 based on the common coordination number of 
Copper(II) metal although in some cases, Cu(II) might form a five-coordinated complexes 
due to Jahn-Teller distortion effect as reported previously by our group.10 These 
metal:ligand ratio are used in the calculated data of the elemental analysis. Table 2.2 
summarises the colour of the complexes formed along with the metal:ligand ratio and 
the elemental analysis results.  
From the elemental analysis data, it is suggested that there are also some complexes 
that were not fully dried and still contain some amount of water. However, there are 
two complexes, namely [Ni(2.6)6](NO3)2 and [Co(2.8)6]SO4 which are impure and might 
contain unreacted starting materials that affect their elemental analysis percentages. 
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Table 2.2 Physical data of transition metal complexes of imidazole ureas (the calculated values are enclosed in the bracket) 
Entry Complex Metal: 
Ligand ratio 
Colour Microelemental analysis 
C (%) H (%) N (%) 
1 [Co(2.1)6]Cl2.2H2O 1:6 Pink 50.91 (50.48) 8.01 (7.91)  23.13 (23.55)  
2 [Co(2.1)6](NO3)2 1:6 Pink 49.32 (49.89)  7.78 (7.54)  24.26 (25.21)  
3 [Co(2.1)6]SO4.5H2O 1:6 Purple 47.69 (47.83)  7.32 (7.89)  21.86 (22.31)  
4 [Cu(2.1)4]Cl2.2H2O 1:4 Blue 47.84 (47.49) 7.40 (7.57)  21.86 (22.15)  
5 [Cu(2.1)4](NO3)2 1:4 Blue  46.30 (46.70)  7.07 (7.06)  23.80 (24.51)  
6 [Ni(2.1)6]Cl2.2H2O 1:6 Light blue 50.26 (50.49)  7.70 (7.91)  22.87 (23.55)  
7 [Ni(2.1)6](NO3)2 1:6 Light blue 49.20 (49.89)  7.56 (7.54)  24.36 (25.21)  
8 [Co(2.2)6]Cl2 1:6 Purple 58.17 (58.38)  9.08 (9.10)  19.15 (19.45)  
9 [Co(2.2)6](NO3)2 1:6 Purple 56.26 (56.64)  8.78 (8.83)  20.12 (20.45)  
10 [Co(2.2)6]SO4.5H2O 1:6 Purple 55.00 (54.73)  8.63 (9.08)  18.10 (18.24)  
11 [Cu(2.2)4]Cl2 1:4 Blue  55.51 (56.05)  8.64 (8.74)  18.34 (18.68)  
12 [Cu(2.2)4](NO3)2 1:4 Blue  53.94 (53.68)  8.41 (8.37)  19.83 (20.12)  
13 [Ni(2.2)6]Cl2 1:6 Light blue 57.82 (58.39)  9.04 (9.10)  18.95 (19.45)  
14 [Ni(2.2)6](NO3)2 1:6 Light blue 56.94 (56.65) 8.91 (8.83)  20.32 (20.45)  
15 [Co(2.3)6]Cl2.2H2O 1:6 Purple blue 61.86 (61.61)  9.78 (9.91)  15.74 (16.12)  
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16 [Co(2.3)6](NO3)2 1:6 Purple 61.11 (61.25)  9.56 (9.71)  16.33 (17.20)  
17 [Co(2.3)6]SO4.5H2O 1:6 Dark purple 59.32 (59.50)  9.50 (9.89)  15.03 (15.42)  
18 [Cu(2.3)4]Cl2 1:4 Blue 60.39 (60.71)  9.66 (9.62)  15.35 (15.73)  
19 [Cu(2.3)4](NO3)2 1:4 Purple  58.63 (58.83)  9.29 (9.28)  16.59 (17.06)  
20 [Ni(2.3)6]Cl2.4H2O 1:6 Light green-blue 60.64 (60.71)  9.68 (10.00)  15.38 (15.73)  
21 [Ni(2.3)6](NO3)2 1:6 Light green-blue 60.50 (61.26)  9.64 (9.71)  16.47 (17.20)  
22 [Co(2.4)6]Cl2 1:6 Green  58.81 (58.71)  6.32 (6.06)  20.07 (21.07)  
23 [Co(2.4)6](NO3)2 1:6 Pale pink 56.45 (56.82)  5.94 (5.87)  21.48 (22.09)  
24 [Co(2.4)6]SO4 1:6 Pale pink 57.32 (57.80)  5.96 (5.97)  19.81 (20.74)  
25 [Cu(2.4)4]Cl2 1:4 Dark blue 54.37 (56.18)  6.15 (5.80)  18.34 (20.16)  
26 [Cu(2.4)4](NO3)2 1:4 Dark blue 53.92 (53.62)  5.92 (5.54)  18.28 (21.65)  
27 [Ni(2.4)6]Cl2.2H2O 1:6 Light blue 57.82 (57.18)  6.41 (6.11)  18.33 (20.78)  
28 [Ni(2.4)6](NO3)2 1:6 Light blue 56.84 (56.83)  6.19 (6.87)  18.73 (22.09)  
29 [Co(2.6)6]Cl2 1:6 Purple-blue 62.61 (62.39)  7.31 (7.20)  18.48 (18.19)  
30 [Co(2.6)6](NO3)2 1:6 Purple 60.61 (60.65)  7.10 (7.00)  19.10 (19.16)  
31 [Co(2.6)6]SO4.H2O 1:6 Purple 60.15 (60.21)  7.06 (6.92)  17.56 (18.32)  
32 [Cu(2.6)4]Cl2 1:4 Blue 59.00 (60.06)  6.96 (6.93)  17.28 (17.51)  
33 [Cu(2.6)4](NO3)2 1:4 Blue-green 57.58 (57.66)  6.78 (6.65)  18.66 (18.91)  
78 
 
34 [Ni(2.6)6]Cl2.2H2O 1:6 Light blue 60.81 (60.46)  7.16 (7.06)  17.78 (18.39)  
35 [Ni(2.6)6](NO3)2 1:6 Light blue 61.61 (60.66)  7.17 (7.00)  19.04 (19.16)  
36 [Co(2.7)6]Cl2 1:6 Light blue 50.03 (50.33)  4.60 (4.58)  19.21 (19.57)  
37 [Co(2.7)6](NO3)2 1:6 Light purple 48.59 (48.82)  4.45 (4.44)  20.29 (20.56)  
38 [Co(2.7)6]SO4.4H2O 1:6 Purple  47.74 (47.64)  4.44 (4.78)  20.29 (18.52)  
39 [Cu(2.7)4]Cl2 1:4 Blue 48.35 (48.31)  4.77 (4.39)  18.45 (18.78)  
40 [Ni(2.7)4]Cl2 1:6 Light blue 49.38 (49.31)  4.81 (4.71)  18.95 (19.17)  
41 [Ni(2.6)6](NO3)2 1:6 Light blue 48.62 (48.83) 4.56 (4.44) 20.12 (20.56) 
42 
[Co(2.8)6]Cl2.2H2O 1:6 Purple  50.80 (50.48)  7.88 (7.91)  23.47 (23.55)  
43 
[Co(2.8)6](NO3)2 1:6 Pink  49.36 (49.89)  7.69 (7.54)  24.33 (25.21)  
44 
[Co(2.8)6]SO4 1:6 Purple  42.39 (50.87)  6.75 (7.68)  19.58 (23.73)  
45 
[Cu(2.8)4]Cl2.2H2O 1:4 Blue 47.29 (47.49)  7.46 (7.57)  21.72 (22.15)  
46 
[Cu(2.8)4](NO3)2 1:4 Blue 46.38 (46.70)  7.25 (7.06)  23.43 (24.51)  
47 
[Ni(2.8)6]Cl2.4H2O 1:6 Light blue 48.92 (49.25)  7.61 (7.99)  22.60 (22.97)  
48 
[Ni(2.8)6](NO3)2 1:6 Light blue 50.00 (49.89)  7.79 (7.54)  24.56 (25.21)  
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The paramagnetic nature of the transition metals complexes of imidazole urea ligands 
limits the use of NMR spectroscopy to characterise the complexes. However, FTIR data 
can provide some valuable information regarding the essential stretching vibration that 
occurs or changes before and after the complexation reaction. For most of the 
complexes, the v(NH) stretch is shifted towards higher energy upon complexation with 
metals in comparison to the respective ligand. This indicates that the hydrogen bonding 
between the urea moieties and imidazole groups is weakened upon coordination to the 
metal ion as the coordination inhibits inter-ligand interactions. In most of the cases, the 
v(C=O) stretch of the complexes are shifted to higher energy possibly due to the 
formation of NH···anion hydrogen bonding in the complexes instead of NH···O hydrogen 
bonding in the free ligand. The important FTIR stretching vibrations of the remaining 
imidazole urea compounds and their complexes are listed in Table 2.3. 
 
Table 2.3 FTIR stretching vibration of free imidazole urea ligands and their transition metal 
complexes. 
 
Entry Compounds Selected FTIR stretching vibrations 
ν (N-H) ν (C=O) ν (C-H 
imidazole ring) 
ν (C=N-
C=C) 
imidazole 
1 Free ligand 2.1 
3290 
1650 1564      1454 
2 [Co(2.1)6]Cl2 3376 1652 1548 1436 
3 [Co(2.1)6](NO3)2 3366 1656 1546 1435 
4 [Co(2.1)6]SO4 3363 1656 1550 1435 
5 [Cu(2.1)4]Cl2 3363 1650 1550 1435 
6 [Cu(2.1)4](NO3)2 3368 1646 1550 1435 
7 [Ni(2.1)6]Cl2 3364 1646 1550     1435 
8 [Ni(2.1)6](NO3)2 3363 1656 1550     1436 
9 Free ligand 2.2 3306 1617 1570     1434 
10 [Co(2.2)6]Cl2 3363 1653 1551     1463 
11 [Co(2.2)6](NO3)2 3371 1647 1551     1435 
12 [Co(2.2)6]SO4 3363 1648 1551     1435 
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13 [Cu(2.2)4]Cl2 3367 1648 1552     1436 
14 [Cu(2.2)4](NO3)2 3363 1649 1551     1435 
15 [Ni(2.2)6]Cl2 3363 1653 1552     1435 
16 [Ni(2.2)6](NO3)2 3363 1649 1551     1436 
17 Free ligand 2.3 3309 1611 1570     1450 
18 [Co(2.3)6]Cl2 3308 1616 1575     1459 
19 [Co(2.3)6](NO3)2 3308 1620 1575     1459 
20 [Co(2.3)6]SO4 3303 1622 1573      1462 
21 [Cu(2.3)4]Cl2 3299 1622 1572      1463 
22 [Cu(2.3)4](NO3)2 3308 1630 1573     1463 
23 [Ni(2.3)6]Cl2 3308 1635  1564      1467 
24 [Ni(2.3)6](NO3)2 3328 1636 1567      1466 
25 Free ligand 2.4 3304  1633 1558 1448 
26 [Co(2.4)6]Cl2 3329  1654 1540 1450 
27 [Co(2.4)6](NO3)2 3377  1660 1544 1451 
28 [Co(2.4)6]SO4 3366 1664 1558 1447 
29 [Cu(2.4)4]Cl2 3371 1654 1547 1436 
30 [Cu(2.4)4](NO3)2 3363  1651 1545 1435 
31 [Ni(2.4)6]Cl2 3363  1656 1546 1436 
32 [Ni(2.4)6](NO3)2 3363  1656 1544 1436 
33 Free ligand 2.6 3359 1632 1554     1408 
34 [Co(2.6)6]Cl2 3363 1649 1551     1435 
35 [Co(2.6)6](NO3)2 3328 1634 1553     1410 
36 [Co(2.6)6]SO4 3328 1634 1553     1410 
37 [Cu(2.6)4]Cl2 3338 1635 1550     1410 
38 [Cu(2.6)4](NO3)2 3321 1652 1549     1410 
39 [Ni(2.6)6]Cl2 3308 1653 1549     1410 
40 [Ni(2.6)6](NO3)2 3324 1653 1549     1410 
41 Free ligand 2.7 3309 1611 1564 1462 
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42 [Co(2.7)6]Cl2 3348 1671  1539 1490 
43 [Co(2.7)6](NO3)2 3317 1679 1539 1491 
44 [Co(2.7)6]SO4 3297 1679 1544 1491 
45 [Cu(2.7)4]Cl2 3269 1661 1544 1490 
46 [Ni(2.7)4]Cl2 3553 1671 1539 1490 
47 Free ligand 2.8 3348 1648 1559      1447 
48 [Co(2.8)6]Cl2 3297 1640 1555 1450 
49 [Co(2.8)6](NO3)2 3349 1639 1555 1450 
50 [Co(2.8)6]SO4 3287 1637 1555 1450 
51 [Cu(2.8)4]Cl2 3297 1640 1558      1450 
52 [Cu(2.8)4](NO3)2 3353 1641 1557       1450 
53 [Ni(2.8)6]Cl2 3328 1641 1556 1450 
54 [Ni(2.8)6](NO3)2 3327 1640 1558 1450 
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2.2.2.1 Single crystal X-ray Diffraction (SC-XRD) analysis 
 
Despite the large number of complexes prepared, only three formed crystals suitable 
for SC-XRD analysis. All of the crystals were obtained from slow evaporation of the 
methanol:water (10:1) mixture. The elemental analysis and FTIR data of the complexes 
are consistent with the formula of the isolated crystals. Table 2.4 summarises the 
crystallographic data for these coordination complexes. 
  
Table 2.4 The crystallographic data of coordination complexes 2.9-2.11. 
 
 2.9 2.10 2.11 
Formula 
[Co(C12H13ClN4O)6] 
(NO3)2.CH3OH 
[Ni(C12H13ClN4O)6] 
(NO3)2.(CH3OH)2 
[Co(C12H13ClN4O)6]
(Cl)2 
Formula 
weight 
1803.28 1835.10 1718.11 
Space 
group 
P1 P1 R3 
a / Å 13.2050(12) 13.2143(9) 15.7778(6) 
b / Å 13.2170(12) 13.2247(9) 15.7778(6) 
c / Å 13.3182(12) 13.2483(9) 28.7892(11) 
α / ° 73.249(2) 73.531(3) 90 
β / ° 74.350(2) 73.859(3) 90 
γ / ° 73.579(3) 73.568(2) 120 
V / Å3 2089(3) 2079.7(2) 6206.6(4) 
Z 1 1 3 
Dcalc / g 
cm-3 
1.433 1.465 1.379 
Rint 0.0638 0.0769 0.0545 
R1 [I ≥ 2σ 
(I)] 
0.1011 0.0964 0.0691 
wR2 [all 
data] 
0.2544 0.2191 0.1914 
 
A pink-coloured crystal of formula [Co(C12H13ClN4O)6](NO3)2.CH3OH (2.9) was obtained 
from the reaction of ligand 2.7 with cobalt(II) nitrate hexahydrate and was characterised 
using X-ray crystallography. The crystal formed from the slow evaporation of a 
methanol:water solution containing complex 2.9. This structure exhibits unidentate 
coordination of six imidazole moieties to the cobalt centre, arranged in an octahedral 
geometry, in which two of the ligands are severely disordered. The bond lengths of the 
cobalt centre to all nitrogen atoms are fairly symmetrical in the range of 2.143(5) to 
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2.151(5) Å, in contrast with the previously reported copper(II) complex of ligand 2.4 that 
exhibit a Jahn-Teller distorted octahedral geometry.10  
 
Figure 2.10 Molecular structure of the cobalt(II) complex of ligand 2.7 (2.9).  (H atoms omitted 
for clarity). 
 
In the packing, the oxygen atom of the NO3¯anion, (O5) form hydrogen bond with the 
urea hydrogen (H8) with a distance of 3.007(9) Å (Figure 2.11). A hydrogen bond 
between the urea oxygen atom and the hydrogen atom of the imidazole group that is 
observed in the structure of ligand 2.7 is also retained. Selected bond lengths and angles 
of complex 2.9 are listed in Table 2.5. 
 
 
Figure 2.11 Hydrogen bonding interaction (O5···H8) in one asymmetric unit of the cobalt(II) 
complex of ligand 2.7 (2.9) 
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Table 2.5 Selected bond lengths and bond angles for complex 2.9. 
Bond Bond lengths (Å) 
Co1-N1 2.151(5) 
Co1-N5 2.149(5) 
Co-N9 2.143(5) 
 
Hydrogen Bonds  Bond lengths (Å) Hydrogen Bonds  Bond 
lengths (Å) 
N2A-H2A-O3A1 2.847(12) N7 H7 O53 3.032(9) 
N2B-H2B-O3A1 2.601(19) N8 H8 O53 3.007(9) 
N2B-H2B-O3B1 2.91(2) N8 H8 O63 3.065(9) 
N3A-H3A-O61 2.978(10) N10 H10 O23 2.852(9) 
N4-H4B-O41 2.968(9) N11A H11A O44 3.059(10) 
N4-H4B-O61 3.124(9) N11B H11B O44 3.181(17) 
N6-H6-O1A2 2.829(10) N12 H12A O44 2.983(8) 
N6-H6-O1B2 3.135(17) N12 H12A O54 3.110(8) 
 
1-1+X,+Y,+Z; 2+X,+Y,1+Z; 32-X,1-Y,1-Z; 43-X,1-Y,-Z 
    
Bond Bond angles (ο) Bond  Bond angles 
(ο) 
N1-Co1-N11 180.0 N9-Co1-N11 88.84(18) 
N5-Co1-N1 90.79(19) N91-Co1-N1 88.84(18) 
N5-Co1-N11 89.29(19) N91-Co1-N51 89.32(19) 
N51-Co1-N11 90.71(19) N9-Co1-N51 90.69(19) 
N51-Co1-N1 89.29(19) N9-Co1-N5 89.31(19) 
N5-Co1-N51 180.00(1) N91-Co1-N5 90.68(19) 
N9-Co1-N1 91.16(18) N9-Co1-N91 180.0 
N91-Co1-N11 91.16(18)   
 
The reaction of ligand 2.7 with nickel(II) nitrate hexahydrate gave a crystal of 
[Ni(C12H13ClN4O)6] (NO3)2.(CH3OH)2 (2.10) isostructural with 2.9. Complex 2.10 show the 
same coordination mode as 2.9. The Ni-N bond lengths are symmetrical in the range of 
2.097(5) to 2.104(5) Å, but somewhat shorter than the Co-N distances in 2.9 consistent 
with the smaller ionic radius of Ni(II). 
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Figure 2.12 Molecular structure of the nickel(II) complex of ligand 2.7 (2.10). 
 
A hydrogen bond between the counter ion, NO3- with the urea moiety of the ligand is 
observed in a similar manner to compound 2.9. The hydrogen bond between the urea 
oxygen and a hydrogen atom of the imidazole group that is observed in the structure of 
ligand 2.7 is also retained in this complex. Selected bond lengths and angles of complex 
2.10 are listed in Table 2.6. 
  
Figure 2.13 Hydrogen bonding interaction (O5···H24) in one asymmetric unit of the nickel(II) 
complex of ligand 2.7 (2.10) 
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Table 2.6 Selected bond lengths and bond angles for complex 2.10. 
Bond Bond lengths (Å) 
Ni1-N1 2.104(5) 
Ni1-N11 2.100(5) 
Ni1-N21 2.097(5) 
Hydrogen Bonds  Bond lengths (Å) Hydrogen Bonds  Bond lengths 
(Å) 
N2-H2A-O31 2.879(8) N13A-H13A-O64 3.155(19) 
N3-H3-O42 3.020(9) N14-H14-O64 3.023(8) 
N3A-H3A-O42 3.235(19) N14-H14A-O44 3.067(8) 
N4-H4B-O42 3.064(8) N22-H22-O25 2.811(9) 
N4-H4B-O52 3.029(8) N22-H22-O2A5 3.175(17) 
N12-H12-O13 2.805(9) N23-H23-O55 3.064(8) 
N12-H12-O1A3 3.183(16) N24-H24-O55 3.023(8) 
N13-H13-O64 3.020(9) N24-H24-O25 3.086(8) 
11-X,1-Y,1-Z; 2+X,+Y,-1+Z; 3+X,+Y,1+Z; 41-X,2-Y,2-Z; 5+X,-1+Y,+Z 
    
Bond Bond angles (ο) Bond  Bond angles 
(ο) 
N1-Ni1-N11 179.999(1) N211-Ni1-N1 91.04(19) 
N1-Ni1-N11 90.73(19) N211-Ni1-N11 88.95(19) 
N11-Ni1-N11 89.27(19) N211-Ni1-N111 90.62(18) 
N111-Ni1-N1 89.27(19) N21-Ni1-N11 90.61(18) 
N111-Ni1-N11 90.73(19) N21-Ni1-N111 89.39(18) 
N111-Ni1-N111 180.0 N211-Ni1-N111 89.38(18) 
N21-Ni1-N1 88.95(19) N211-Ni1-N21 179.999(1) 
N21-Ni1-N11 91.05(19)   
 
 
Compound 2.11, [Co(C12H13ClN4O)6](Cl)2 is formed from the reaction between ligand 2.7 
with cobalt(II) chloride hexahydrate. It crystallises from slow evaporation of methanol 
and adopts the trigonal system with space group R3 Similar to compound 2.9 and 2.10, 
the cobalt centre is bonded to six monodentate imidazole urea ligand, 2.7 and arranged 
in an octahedral geometry. There is still hydrogen bonding between the urea oxygen 
atom and the hydrogen atom of an imidazole group, consistent with the hydrogen 
bonding motif that is seen in compound 2.7, 2.9 and 2.10. 
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Figure 2.14 Molecular structure of cobalt(II) complex of ligand 2.7 (2.11) showing the ligand 
disorder. 
 
In the packing, the molecules are arranged in three-dimensional network forming a 
helical structure with chloride anion encapsulated in the binding pocket. The chloride 
ion forms hydrogen bonds with the hydrogen of the urea moiety, N4-H4-Cl2 and N4A-
H4AC-Cl2, with N…Cl distances of 3.062(5) and 3.297(9), respectively. Selected bond 
lengths and angles of complex 2.11 are listed in Table 2.7. 
 
Figure 2.15 Crystal packing diagram of cobalt(II) complex of ligand 2.7 (2.11)  
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Table 2.7 Selected bond lengths and bond angles for complex 2.11. 
Bond Bond lengths (Å) 
Co1-N1 2.164(2) 
Hydrogen Bonds  Bond lengths (Å) Hydrogen Bonds  Bond lengths 
(Å) 
N2-H2-O11 2.802(5) N4-H4-Cl2 3.062(5) 
N2-H2-O1A1 3.050(9) N4A-H4AC-Cl2 3.297(9) 
12/3-Y+X,1/3+X,1/3-Z 
    
Bond Bond angles (ο) Bond  Bond angles 
(ο) 
N11-Co1-N12 89.20(9) N12-Co1-N13 180.0 
N13-Co1-N14 90.79(9) N12-Co1-N1 90.80(9) 
N11-Co1-N14 89.20(9) N15-Co1-N13 89.20(9) 
N15-Co1-N14 180.0 N12-Co1-N15 90.80(9) 
N15-Co1-N1 89.20(9) N11-Co1-N1 180.0 
N13-Co1-N1 89.20(9) N12-Co1-N14 89.20(9) 
N11-Co1-N13 90.80(9) N14-Co1-N1 90.80(9) 
N11-Co1-N15 90.80(9)   
 
2.2.3 Solution state anion binding studies of imidazole ureas with halides. 
 
The solution state binding properties of compounds 2.1 and 2.2 were investigated using 
1H NMR spectroscopic titrations in CD3CN solvent with some anionic guests. This study 
was performed as a control experiment for comparison with the preorganised anion 
receptors discussed in the following chapters. The binding isotherms are shown in Figure 
2.17. During the titration, important signals namely CH1 and CH2 protons of imidazole 
as well as NH3 and NH4 protons of urea (Figure 2.16) were followed to investigate the 
anion binding behaviour of the respective compounds. 
 
Figure 2.16 Important protons followed during the anion binding titration experiments. 
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 Significant chemical shift changes in the resonances assigned to the urea protons (NH3 
and NH4) were observed, with very small shifts for the other CH protons of the imidazole 
unit. In all cases, the addition of chloride, bromide and iodide anions causes the 
resonances of the urea protons to be shifted further downfield indicating binding to the 
anions. After the addition of 6 equivalent of anions, chloride was found to give rise to 
the largest chemical shift change for compound 2.1 (Δ 1.43 ppm) and 2.2 (Δ 1.32 ppm), 
followed by bromide, (Δ 0.88 ppm) and (Δ 0.93 ppm), respectively.  Iodide ion showed 
the least chemical shift change than chloride and bromide ions, consistent with its larger 
size and its smaller charge to radius ratio.  On the other hand, the addition of 0.2 
equivalent of fluoride ion (as TBA salt) to the acetonitrile-d3 solution of compound 2.1 
results in the broadening of the NH3 urea resonance and a downfield change in the 
chemical shift of the NH resonances. After two equivalents, the signal had disappeared 
completely indicating the deprotonation of the urea NH protons. This result is in 
agreement with previous work data 15–17 as fluoride is highly basic. 
a) 
 
b)  
 
Figure 2.17 Binding isotherms for the urea proton (H3) of a) compound 2.1 and b) 
compound 2.2 with various anions in CD3CN.   
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Job plot analysis of the 1H NMR titrations carried out in acetonitrile-d3 revealed a 
maximum at a 50% mole fraction, consistent with the proposed 1:1 binding 
stoichiometry; this proved to be true for all three anions (TBACl, TBABr and TBAI) for 
which an appreciable binding interaction was noted (Figure 2.18). 
 
Figure 2.18  Job plot of binding by 2.1 with tetrabutylammonium chloride in 
acetonitrile-d3 showing 1:1 host to guest ratio. The maximum amount 
of shift is shown by the NH protons of the urea groups. 
  
In two cases, the binding constants, K1 (Table 2.8) were determined by 1H NMR 
spectroscopic titration using an online tool, Bindfit.18,19 However, in the case of the 
titration of compound 2.1 and 2.2 with TBA iodide, the binding constant could not be 
refined due to the poor fit to the experimental data. 
Table 2.8 Binding constants determined by 1H NMR spectroscopic titrations for compounds 2.1 
and 2.2 in CD3CN.  All anions used are TBA salts.  a = Binding constant of compound 2.3 in CDCl3 
could not be refined due to poor fit to the experimental data.   
 
Stoichiometry Compounds 
Anion 
H:G 2.1 2.2 
Chloride 
1:1 177±2% 116±2% 
Bromide 
1:1 63.44±1% 25±1% 
Iodide 
1:1 a a 
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In contrast, the solution state binding properties of compound 2.3 were performed 
using 1H NMR spectroscopic titrations in a less polar solvent, CDCl3 with fluoride, 
chloride, bromide and iodide ions. The binding isotherms are shown in Figure 2.19. 
Significant chemical shift changes in the resonances assigned to the urea protons (NH3 
and NH4) were observed, with very small shifts for the CH protons of the imidazole 
group. Addition of chloride, bromide and iodide, moved the chemical shifts of the urea 
protons further downfield indicating a hydrogen-bonding interaction involving the 
halide anions with the urea N-H groups. For compound 2.3, the binding constant could 
not be calculated accurately and refined due to the poor fit of the experimental data 
which results in high percentage of error. Thus, the anion-binding behaviour of this 
compound are discussed based on the changes in the chemical shift of the urea protons. 
Titration of compound 2.3 with chloride ion results in the largest shift of urea protons 
(Δ 1.13 ppm), followed by bromide, (Δ 0.75 ppm). A similar result was found as iodide 
ion is bound more weakly to the urea NH than both of the anions afore-mentioned (Δ 
0.73 ppm), consistent with its larger size and its smaller charge to radius ratio.  On the 
other hand, the addition of 0.2 equivalent of fluoride ion (as TBA salt) to the chloroform-
d3 solution of compound 2.3 results in the downfield shift of NH3 urea resonance from 
5.32 to 5.54 pm with significant broadening of the peak. After 0.8 equivalents, the NH3 
and NH4 urea signals have totally disappeared indicating the deprotonation of the urea 
protons. This result is consistent with data published elsewhere15–17 as fluoride ion is 
highly basic and would be able the deprotonate urea protons. From the binding 
isotherms of compound 2.1, 2.2 and 2.3, it is shown that the chemical shifts changes do 
not differ significantly in the less polar solvent chloroform. 
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Figure 2.19 Binding isotherms for the urea proton (NH3) of compound 2.3 with various 
anions in CDCl3.   
 
The chemical shift change for all imidazole urea derivatives with aliphatic chain after the 
addition of 3 equivalent of NBu4X is summarised in Table 2.9. 
Table 2.9 The chemical shift change (Δδ) in ppm of the CH1 and CH2 protons of the imidazole 
ring and NH3 and NH4 protons of the urea group after the addition of 3 equivalent of NBu4X at 
room temperature. 
Compounds Solvent Protons Cl¯ Br¯ I¯ 
2.1 CD3CN CH1 0.05 0.03 0.01 
CH2 0.06 0.02 0 
NH3 
1.25 0.67 0.17 
NH4 
1.07 0.64 0.16 
2.2 CD3CN CH1 0.06 0.03 0.01 
CH2 0.07 0.02 0.01 
NH3 
1.3 0.63 0.16 
NH4 
1.17 0.62 0.18 
2.3 CDCl3 CH1 0.09 0.06 0.03 
CH2 0.09 0.06 0.05 
NH3 
1.27 0.92 0.73 
NH4 
1.24 1.05 0.85 
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Solution state anion binding studies were also performed on the imidazole urea 
compounds with aromatic substituents, namely compounds 2.6 and 2.7. The titration 
experiments for both of the compounds were carried out in a more competitive solvent, 
DMSO-d6 as both of the compounds were not very soluble in acetonitrile-d3. In contrast 
to compound 2.1-2.3, compound 2.6 and 2.7 are showing more complex speciation 
accompanied by slow guest complexation kinetics or conformational change on the 1H 
NMR spectroscopic timescale, as evidenced by significant broadening and splitting of 
several peaks at room temperature. As a result, binding constants could not be reliably 
determined. 
In detail, for compound 2.6 and 2.7, changes in the chemical shifts were observed for 
four different protons, namely the CH proton neighbouring the nitrogen atom in the 
imidazole ring (CH1 and CH2) and the protons of the urea group (NH3 and NH4). Both of 
the compounds appear to have more complex speciation in comparison with 
compounds 2.1–2.3, as evidenced by significant broadening and splitting of several 
peaks at room temperature. 
The addition of 0.2 equivalent of fluoride anion (as TBA salt) has resulted in the splitting 
of all the above-mentioned proton signals. For example, the CH1 signal of compound 2.6 
at 8.42 ppm has split into two peaks at 8.42 and 8.54 ppm. The same trend was also 
observed for a CH2 signal from 7.55 ppm to 7.55 and 7.52 ppm, as well as the splitting 
of the urea signals, NH3 from 6.89 ppm to 6.89 and 6.79 ppm and for NH4 from 6.08 to 
6.08 and 6.25 ppm. Adding more equivalent of fluoride moved the split signal of CH1 
further downfield until it disappears after 0.6 equivalent of fluoride added. For the CH2 
proton of the imidazole, the split signal at 7.52 moved further upfield and later merged 
with the signals of the aromatic CH protons.  
The signal of NH3 urea proton also moved further upfield when fluoride ion was added. 
For NH4 proton, the addition of 0.2 equivalent of fluoride ion also causes the signal to 
split and eventually disappear after subsequent addition of the fluoride ion (Figure 2.20). 
The anion binding stoichiometry has not been determined due to the splitting patterns 
of the proton resonances.  
Titration of compound 2.7 with fluoride ion (as TBA salt) (Figure 2.21) also resulted in 
the same binding pattern as compound 2.6, splitting and disappearance of all the signals 
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due to the deprotonation of all the designated protons. A possible explanation for the 
splitting of the signals is the presence of two different isomers of compound 2.6 and 2.7, 
in which one of the isomers does not bond to the anions, while the other responds well 
to the anions added. As imidazole compounds can show tautomerism, this would explain 
the presence of two different isomers.  
 
Figure 2.20 Stack plot showing the 1H NMR spectrum of compound 2.6 in DMSO-d6 in the 
presence of fluoride ion as tetrabutylammonium salt. 
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Figure 2.21 Stack plot showing the 1H NMR spectrum of compound 2.7 in DMSO-d6 in the 
presence of fluoride ion as tetrabutylammonium salt. 
 
Titration of compound 2.6 and 2.7 with the chloride ion also show the splitting trend of 
the peak, however, in contrast with fluoride ion, only two protons interact with the 
chloride anion, the CH1 proton of the imidazole ring and the NH4 urea proton (Figure 
2.22 and 2.23). The addition of up to 2 equivalent of chloride caused the splitting of the 
CH1 signal into two peaks;  until it remains unchanged after more than 2 equivalent 
chloride ion added.  
96 
 
 
Figure 2.22 Stack plot showing the 1H NMR spectrum of compound 2.6 in DMSO-d6 in the 
presence of chloride ion as tetrabutylammonium salt. 
 
Figure 2.23 Stack plot showing the 1H NMR spectrum of compound 2.7 in DMSO-d6 in 
the presence of chloride ion as tetrabutylammonium salt. 
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On the contrary, although titration of compound 2.6 and 2.7 with bromide ion does 
show similar observation with chloride ion titration, the changes in the chemical shifts 
were less pronounced in comparison with the chloride ion (Figure 2.24 and 2.25). This 
observation has been anticipated as bromide ion has a larger size and smaller charge to 
radius ratio compare to chloride ion.  
On the other hand, the addition of iodide ion to the solution of compound 2.6 and 2.7 
does not result in any significant changes to the chemical shifts of the designated 
protons except a less pronounced broadening of the CH1 of the imidazole ring (Figure 
2.26 and 2.27). 
 
Figure 2.24 Stack plot showing the 1H NMR spectrum of compound 2.6 in DMSO-d6 in the 
presence of bromide ion as tetrabutylammonium salt. 
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Figure 2.25 Stack plot showing the 1H NMR spectrum of compound 2.7 in DMSO-d6 in the 
presence of bromide ion as tetrabutylammonium salt. 
 
 
Figure 2.26 Stack plot showing the 1H NMR spectrum of compound 2.6 in DMSO-d6 in the 
presence of iodide ion as tetrabutylammonium salt. 
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Figure 2.27 Stack plot showing the 1H NMR spectrum of compound 2.7 in DMSO-d6 in the 
presence of iodide ion as tetrabutylammonium salt. 
 
 
Table 2.9 The chemical shift change (Δδ) in ppm of the CH1 and CH2 protons of the imidazole 
ring and NH3 and NH4 protons of the urea group after the addition of 3 equivalent of NBu4X at 
room temperature. 
Compounds Solvent Protons Cl¯ Br¯ I¯ 
2.6 DMSO-d6 CH1 0.39 and 0 0.04 and 0 0 
CH2 0 0 0 
NH3 0 0 0 
NH4 0.18 and 0 0.05 and 0 0 
2.7 DMSO-d6 CH1 0.48 and 0 0.09 and 0 0 
CH2 0 0 0 
NH3 0 0 0 
NH4 0.32 and 0 0.06 and 0 0 
 
The designated protons in all of the compounds, 2.1, 2.2, 2.3, 2.6 and 2.7, are shifted 
downfield or upfield and becomes broad after the addition of fluoride anion and 
disappears completely much before the complete addition of TBAF, possibly due to the 
hydrogen bonding interaction with the fluoride ions followed by deprotonation.20–23 For 
other halide ions namely chloride, bromide and iodide ions, the 1H NMR titration 
experiment shows that the anions formed a hydrogen bonding only with N-H group of 
urea ions in the case of compound 2.1-2.3. Conversely, in compound 2.6 and 2.7, the 
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anions are connected to the imidazole urea compounds through hydrogen bonding 
interactions with CH1 (imidazole ring) and NH3 protons. 
2.3 Summary 
 
We have synthesised a series of imidazole compounds containing urea derivatives that 
comprise of an imidazole group, which serves as the cation binding sites and urea groups 
that show hydrogen bonding interaction with anions. The imidazole urea compounds 
bind to transition metals namely Cu(II), Co(II) and Ni(II) in unidentate fashion. It is also 
possible that the anion binding behaviour of the molecules revealed through 1H NMR 
titration experiments with halide anions was caused by the urea conformation along 
with the imidazole tautomerism. Moreover, the broadening and splitting of the 
designated chemical shifts upon the addition of the halide anions into the solution of 
compound 2.6 and 2.7 indicates the presence of isomers for imidazole urea with 
aromatic substituents, while there are no isomers found for imidazole ureas with 
aliphatic chains. These findings have led this project to the design of anion receptors 
based on organic frameworks and transition metals, which is discussed in detail in the 
following chapters. 
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2.4 Experimental 
 
All solvents used in the synthesis and purification were of analytical reagent grade. 
Anhydrous solvents were prepared on an SPS solvent purification system. Commercial 
reagents were used as supplied, without further purification. 
 
2.4.1 Instrumentation and Analytical Measurements 
 
All NMR spectra were obtained from a Bruker Avance 400 at a frequency of 400 MHz for 
1H and 100 MHz for 13C, while 1H, 13C, 1H-1H COSY, 1H-13C HSQC and  1H-13C HMBC spectra 
were obtained from a Varian INOVA 500 spectrometer at a frequency of 500 MHz for 1H 
and 125 MHz for 13C. All chemical shifts are reported in parts per million (δ) relative to 
tetramethylsilane as an internal reference. Electrospray ionisation (ESI) mass 
spectrometry was recorded on a TQD mass spectrometer instrument. Fourier 
transforms infrared spectra were recorded with a Perkin-Elmer Spectrum 100 FT-IR 
spectrometer in which for each spectrum, 64 scans were conducted over a spectral 
range of 4000 to 600 cm-1 with a resolution of 4 cm-1. Elemental analysis was performed 
using an Exeter Analytical CE-400 Elemental Analyser. The single crystal diffraction data 
for all compounds were collected at 120 K on an Agilent XCalibur diffractometer 
(Sapphire-3 CCD detector, graphite monochromator, λMoKα radiation λ = 0.71073 Å) 
equipped with Cryostream (Oxford Cryosystems) open flow nitrogen cryostat. 
Structures were solved and refined using the SHELX programs24 operating within the 
Olex2 interface25, or solved using Superflip.26  
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2.4.2 Synthesis of imidazole ligands 
Synthesis of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐butyl)urea (2.1) 
 
 
The synthesis of this compound was performed according to the published procedures 
described by Barboiu group.2 At 40 °C, histamine (1.10 g, 9.9 mmol) was dissolved in 
anhydrous chloroform (120 ml). Subsequently, a solution of n-butyl isocyanate (0.98 g, 9.9 
mmol) in anhydrous chloroform (10 ml) was slowly added via the dropping funnel over the 
course of 2 hours, before refluxing for a further 18 hours. The resulting white precipitate 
was filtered under reduced pressure, washed with chloroform (3 x 50 ml) and dried under 
vacuum for three hours to yield the pure product as a white powder (1.56 g, 7.42 mmol, 
75%). 1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 11.84 (1 H, br s, H2), 7.52 (1 H, d, J 1.1, H1), 
6.76 (1 H, s, H3), 5.88 (1 H, t, J 5.6, H6), 5.79 (1 H, t, J 5.6, H7), 3.21 (2 H, m, H5), 2.97 ( 2 H, 
m, H8), 2.57 (2 H, t, J 7.1 H4), 1.30 (2 H, m, H9), 1.25 (2 H, m, H10) , 0.85 (3 H, t, J 8.0, H11). 
13C {1H} NMR: δC {1H} (101 MHz; DMSO) 158.46 (Cf), 135.01 (Ca), 39.96 (Cc), 39.35 (Cb), 
32.62 (Ce and Cg), 28.27 (Cd), 20.00 (Ch and Ci), 14.18 (Cj). FTIR: νmax/cm-1 3084 (NH), 1647 
(CO), 1562 and 1502 (imid. ring), m/z (ESI-MS) 211 [M+H]+ 210 [M]+, 443 [2M+Na]+. Elem. 
Anal. Calc. (%) (C10H18N4O) C, 57.12; H, 8.63; N, 26.64 %; Found: C, 56.76; H, 8.54; N, 26.52 
% 
Synthesis of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐octyl)urea (2.2) 
 
 
At 40 °C, histamine (1.10 g, 9.9 mmol) was dissolved in anhydrous chloroform (120 ml). 
Subsequently, a solution of n-butyl isocyanate (0.98 g, 9.9 mmol) in anhydrous chloroform 
(10 ml) was slowly added via the dropping funnel over the course of 2 hours, before 
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refluxing for a further 18 hours. The resulting white precipitate was filtered under reduced 
pressure, washed with chloroform (3 x 50 ml) and dried under vacuum for three hours to 
yield the pure product as a white powder (2.25 g, 8.42 mmol, 85%). 1H NMR: δH (400 MHz; 
DMSO-d6; Me4Si) 11.83 (1 H, br s, H2), 8.33 (1 H, s, H1), 7.53 (1 H, s, H3), 5.88 (1 H, t, J 5.6, 
H6), 5.79 (1 H, t, J 5.6, H7), 3.21 (2 H, dt, H5), 2.95 ( 2 H, q, H8), 2.58 (2 H, t, J 7.1 H4), 1.24 
(12 H, m, H9-H14), 0.86 (3 H, t, J 8.0, H15). 13C {1H} NMR: δC {1H} (101 MHz; DMSO) 158.45 
(Cf), 134.99 (Ca), 39.80 (Cc), 39.69 (Cd), 31.72 (Cg), 30.49 (Ch), 29.25 (Ci), 29.18 (Cj), 28.17 
(Ck), 26.89 (Cl), 22.56 (Cm), 14.42 (Cn). FTIR: νmax/cm-1 3306 (NH), 1617 (CO), 1570 (imid. 
ring). m/z (ESI-MS) 267 [M+H]+.  Elem. Anal. Calc. (%) (C14H26N4O): C, 63.12; H, 9.84; N, 21.03 
%; Found: C, 61.89; H, 9.64; N, 20.70 % 
 
Synthesis of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐dodecyl)urea (2.3) 
 
 
At 40 °C, histamine (1.10 g, 9.9 mmol) was dissolved in anhydrous chloroform (120 ml). 
Subsequently, a solution of n-butyl isocyanate (0.98 g, 9.9 mmol) in anhydrous chloroform 
(10 ml) was slowly added via the dropping funnel over the course of 2 hours, before 
refluxing for a further 18 hours. The resulting white precipitate was filtered under reduced 
pressure, washed with chloroform (3 x 50 ml) and dried under vacuum for three hours to 
yield the pure product as a white powder (2.55 g, 7.92 mmol, 80%). 1H NMR: δH (400 MHz; 
DMSO-d6; Me4Si) 7.58 (1 H, s, H1), 6.79 (1 H, s, H3), 5.88 (1 H, t, J 5.6, H6), 5.79 (1 H, t, J 5.6, 
H7), 3.21 (2 H, dt, H5), 2.95 ( 2 H, q, H8), 2.58 (2 H, t, J 7.1 H4), 1.24 (20 H, m, H9-H18), 0.86 
(3 H, t, J 8.0, H19). 13C {1H} NMR: δC {1H} (101 MHz; DMSO) 158.45 (Cf), 134.99 (Ca), 117.60 
(Cb), 39.78 (Cd), 31.76 (Ce), 30.47 (Cg), 29.52 (Ch-l), 29.32 (Cm), 29.18 (Cn), 28.19 (Co), 
26.86 (Cp), 22.56 (Cq), 14.40 (Cr). FTIR: νmax/cm-1 3309 (NH), 1611 (CO), 1570 (imid. ring). 
m/z (ESI-MS) 323.9 [M+H]+.  Elem. Anal. Calc. (%) (C18H34N4O): C, 67.04; H, 10.63; N, 17.37 
%; Found: C, 66.62; H, 10.45; N, 17.24 % 
 
104 
 
Synthesis of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐methylphenyl)urea (2.4) 
 
At 40 °C, histamine (1.10 g, 9.9 mmol) was dissolved in anhydrous chloroform (120 ml). 
Subsequently, a solution of p-tolyl isocyanate (1.32 g, 9.9 mmol) in anhydrous chloroform 
(10 ml) was slowly added via the dropping funnel over the course of 2 hours. The solution 
mixture was then heated to reflux for further 18 hours. The resulting white precipitate was 
filtered under reduced pressure, washed with chloroform (3 x 50 ml) and dried under 
vacuum for three hours to yield the pure product as a white powder (2.22 g, 9.1 mmol, 
92%). 
1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 10.15 (1 H, br s, H2), 8.41 (1 H, s, H1), 7.55 (1 H, d, 
J 1.1, H3), 7.26 (2 H, m, H8), 7.01 (2 H, m, H9), 6.82 (1 H, br s, H7), 6.09 (1 H, t, J 5.7, H6), 
3.34 (2 H, dt, H5), 2.66 (2 H, t, J 6.9, H4), 2.21 (3 H, s, H10). 13C {1H} NMR: δC {1H} (101 MHz; 
DMSO) 155.67 (Cf), 147.29 (Cc), 141.06 (Ca), 138.49 (Cb), 135.14 (Ce), 130.04 (Cg), 129.46 
(Ch), 121.48 (Cj), 118.11 (Ci), 28.05 (Cd), 20.75 (Ck). FTIR: νmax/cm-1 3307 and 3107 (NH), 
1553 (CO), 1597 (Ph C-C), 1511 (imid. ring). m/z (ESI-MS) 245 [M+H]+ 244 [M]+, 489 [2M+H]+. 
Elem. Anal. Calc. (%) (C13H16N4O): C, 63.91; H, 6.60; N, 22.93 %; Found: C, 63.5; H, 6.54; N, 
22.93 %. 
 
Synthesis of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(3‐nitrophenyl)urea (2.5) 
 
 
At 40 °C, histamine (1.10 g, 9.9 mmol) was dissolved in anhydrous chloroform (120 ml). 
Subsequently, a solution of p-tolyl isocyanate (1.32 g, 9.9 mmol) in anhydrous chloroform 
(10 ml) was slowly added via the dropping funnel over the course of 2 hours. The solution 
mixture was then heated to reflux for further 18 hours. The resulting white precipitate was 
105 
 
filtered under reduced pressure, washed with chloroform (3 x 50 ml) and dried under 
vacuum for three hours to yield the pure product as a yellow powder (2.63 g, 9.6 mmol, 
97%). 1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 11.85 (1 H, br s, H2), 9.17 (1 H, s, H11), 8.53 
(1 H, s, H2), 7.73 (1 H, m, H8), 7.64 (1 H, m, H10), 7.57 (1 H, d, J 1.1, H9), 7.51 (1 H, s, H3), 
7.49 (1 H, s, H7), 7.47 (1 H, s, H6), 3.37 (2 H, q, H4), 2.69 (2 H, t, J 6.9, H5). 13C {1H} NMR: δC 
{1H} (101 MHz; DMSO) 155.31 (Cf), 148.57 (Cc), 142.39 (Ca), 135.19(Cg & Ck), 130.31 (Ce), 
123.98 (Ch), 115.80 (Ci), 111.86 (1 C, Cj),.68 (1 C, Cd), 27.83 (1 C, Ce). m/z (ESI-MS) 276 
[M+H]+. FTIR: νmax/cm-1 3307 (NH), 1597 (CO), 1533 (imid. ring). Elem. Anal. Calc. (%) 
(C12H13N5O3): C, 52.36; H, 4.76; N, 25.44 %; Found: C, 51.51; H, 4.67; N, 25.00 % 
 
Synthesis of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐butylphenyl)urea (2.6) 
 
 
At 40 °C, histamine (1.10 g, 9.9 mmol) was dissolved in anhydrous chloroform (120 ml). 
Subsequently, a solution of p-tolyl isocyanate (1.32 g, 9.9 mmol) in anhydrous chloroform 
(10 ml) was slowly added via the dropping funnel over the course of 2 hours. The solution 
mixture was then heated to reflux for further 18 hours. The resulting white precipitate was 
filtered under reduced pressure, washed with chloroform (3 x 50 ml) and dried under 
vacuum for three hours to yield the pure product as a white powder (2.65 g, 9.2 mmol, 
93%). 1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 11.84 (1 H, br s, H2), 8.43 (1 H, s, H1), 7.55 
(1 H, d, J 1.1, H3), 7.27 (2 H, m, H8 & H11), 7.02 (2 H, m, H9 & H10), 6.82 (1 H, br s, H7), 6.11 
(1 H, t, J 5.7, H6), 3.34 (2 H, dt, H5), 2.66 (2 H, t, J 6.9, H4), 2.48 (2 H, d, J 1.1, H12), 1.50 (2 
H, m, H13), 1.28 (2 H, m, H14), 0.88 (3 H, t, H15). 13C {1H} NMR: δC {1H} (101 MHz; DMSO) 
155.68 (Cf), 138.68 (Cc, Cg & Cj), 135.15 (Ca), 128.79 (Ch), 118.12 (Cb & Ci), 39.57 (Cd), 34.59 
(Ce), 33.79 (Ck), 22.15 (Cl & Cm), 14.26 (Cn). FTIR: νmax/cm-1 3359 (NH), 1632 (CO), 1554 
(imid. ring). m/z (ESI-MS) 288 [M+H]+. Elem. Anal. Calc. (%) (C16H22N4O): C, 67.11; H, 7.74; 
N, 19.56 %; Found: C, 66.16; H, 7.64; N, 19.53 % 
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Synthesis of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐chlorophenyl)urea (2.7) 
 
At 40 °C, histamine (1.10 g, 9.9 mmol) was dissolved in anhydrous chloroform (120 ml). 
Subsequently, a solution of p-tolyl isocyanate (1.32 g, 9.9 mmol) in anhydrous chloroform 
(10 ml) was slowly added via the dropping funnel over the course of 2 hours. The solution 
mixture was then heated to reflux for further 18 hours. The resulting white precipitate was 
filtered under reduced pressure, washed with chloroform (3 x 50 ml) and dried under 
vacuum for three hours to yield the pure product as a white powder (2.61 g, 9.1 mmol, 
92%). 1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 11.84 (1 H, br s, H2), 8.73 (1 H, s, H1), 7.56 
(1 H, d, J 1.1, H3), 7.42 (2 H, dd, H8), 7.25 (2 H, dd, H9), 6.83 (1 H, br s, H7), 6.23 (1 H, t, J 
5.7, H6), 3.34 (2 H, dt, H5), 2.66 (2 H, t, J 6.9, H4). 13C {1H} NMR: δC {1H} (101 MHz; DMSO) 
155.43 (Cf), 140.08 (Cc & Cj), 135.16 (Ca & Cb), 128.89 (Ci), 124.78 (Cg), 119.45 (Ch), 39.59 
(Cd & Ce). FTIR: νmax/cm-1 3309 (NH), 1611 (CO), 1564 (imid. ring). m/z (LC ESI-MS) 265 
[M+H]+. Elem. Anal. Calc. (%) (C12H13ClN4O): C, 54.45; H, 4.95; N, 21.17 %; Found: C, 53.95; 
H, 4.89; N, 20.77 % 
 
Synthesis of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(tert-butyl)urea (2.8) 
 
 
At 40 °C, histamine (1.10 g, 9.9 mmol) was dissolved in anhydrous chloroform (120 ml). 
Subsequently, a solution of tert-butyl isocyanate (1.96 g, 9.9 mmol) in anhydrous 
chloroform (10 ml) was slowly added via the dropping funnel over the course of 2 hours. 
The solution mixture was then heated to reflux for further 18 hours. The resulting white 
precipitate was filtered under reduced pressure, washed with chloroform (3 x 50 ml) and 
107 
 
dried under vacuum for three hours to yield the pure product as a white powder (1.79 g, 
8.5 mmol, 86%). 1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 11.82 (1 H, br s, H2), 7.49 (1 H, s, 
H1), 6.73 (1 H, s, H3), 5.66 (1 H, br s, H6), 5.61 (1 H, t, J 5.6, H7), 3.16 (2 H, q, H5), 2.54 ( 2 
H, t, J 7.1, H4), 1.18 (9 H, s, H8). 13C {1H} NMR: δC {1H} (101 MHz; DMSO) 157.78 (Cf), 134.97 
(Ca & Cb), 49.36 (Cg), 40.08 (Cd & Ce), 29.76 (Ch). FTIR: νmax/cm-1 3348 (NH), 1648 (CO), 
1559 (imid. ring). m/z (ESI-MS) 212.3 [M+2H]2+. Elem. Anal. Calc. (%) C10H18N4O: C, 57.12; 
H, 8.63; N, 26.64%; Found: C, 57.08; H, 8.59; N, 26.59% 
 
2.4.3 Crystallographic Data: 
 
Single crystal crystallographic analysis were performed on a Bruker Photon D8 Venture 
diffractometer (ImuS microsource, λMoKα, λ = 0.71073 Å) equipped with a Cryostream 
(Oxford Cryosystems) open-flow nitrogen cryostat, at 120 K. The data collection and 
refinement was kindly carried out by Dr Dmitry S. Yufit.  
Crystals of compound 2.1 were grown in nitromethane by slow evaporation of the 
solvent.  
Crystal data for 2.1, C10H18N4O, M = 210.28, colourless plate, 0.02 x 0.02 x 0.2 mm3, 
monoclinic, space group P21/c, a = 11.1384(4), b = 5.6178(3), c = 17.6812(5) Å, α = 90.00, 
β = 94.171(3), γ = 90.00°, V = 1103.44(7) Å3, Z = 4, Dc = 1.266 g/cm3, F000 = 456, MoKα 
radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 56.0º, 12467 reflections collected, 2672 
unique (Rint = 0.0488).  Final GooF = 1.027, R1 = 0.0427, wR2 = 0.0896, R indices based 
on 2672 reflections with I >2σ (I) (refinement on F2), 208 parameters, 0 restraints.  Lp 
and absorption corrections applied, µ = 0.086 mm-1. 
 
Crystals of compound 2.4 were grown from nitromethane by slow evaporation of the 
solvent.  
Crystal data for 2.4, C13H16N4O.CH3NO2, M = 305.34, colourless plate, 0.02 x 0.02 x 0.2 
mm3, orthorhombic, space group Pca21, a = 12.3460(3), b = 13.9709(3), c = 9.1894(2)Å, 
α = 90.00, β = 90.00, γ = 90.00°, V = 1585.03(6) Å3, Z = 4, Dc = 1.280 g/cm3, F000 = 648, 
MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 55.98º, 21748 reflections collected, 
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3835 unique (Rint = 0.0578).  Final GooF = 1.028, R1 = 0.0476, wR2 = 0.0976, R indices 
based on 3835 reflections with I >2σ (I) (refinement on F2), 201 parameters, 1 restraints.  
Lp and absorption corrections applied, µ = 0.093mm-1. 
 
Crystals of compound 2.6 were grown from methanol by slow evaporation of the 
solvent.  
Crystal data for 2.6, C16H22N4O, M = 286.38, colourless block, 0.02 x 0.02 x 0.2 mm3, 
orthorhombic, space group P212121, a = 8.2251(2), b = 9.7345(2), c = 18.8588(4) Å α = 
90.00, β = 90.00, γ = 90.00°, V = 1509.97(6) Å3, Z = 4, Dc = 1.260 g/cm3, F000 = 616, MoKα 
radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 56.0º, 29162 reflections collected, 2085 
unique (Rint = 0.0871).  Final GooF = 1.036, R1 = 0.0384, wR2 = 0.0864, R indices based 
on 2085 reflections with I >2σ (I) (refinement on F2), 203 parameters, 0 restraints.  Lp 
and absorption corrections applied, µ = 0.082 mm-1. 
 
Crystals of compound 2.7 were grown from methanol by slow evaporation of the 
solvent.  
Crystal data for 2.7, C12H13ClN4O, M = 264.71, colourless block, 0.02 x 0.02 x 0.2 mm3, 
monoclinic, space group P21, a = 9.6232(4), b = 4.8410(2), c = 13.9243(5) Å, α = 90.00, β 
= 109.642(3), γ = 90.00°, V = 610.93(4) Å3, Z = 2, Dc = 1.439 g/cm3, F000 = 276, MoKα 
radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 144.9º, 6974 reflections collected, 2231 
unique (Rint = 0.0708).  Final GooF = 1.058, R1 = 0.0519, wR2 = 0.1128, R indices based 
on 2231 reflections with I >2σ (I) (refinement on F2), 215 parameters, 1 restraints.  Lp 
and absorption corrections applied, µ = 2.725 mm-1. 
 
Crystals of compound 2.9 were grown in methanol by slow evaporation of the solvent.  
Crystal data for 2.9, C72H78Cl6CoN24O6 .2NO3.CH3OH, M = 1803.28, pale pink plate, 0.22 
x 0.18 x 0.14 mm3, triclinic, space group P1, a = 13.2050(12), b = 13.2170(12), c = 
13.3182(12) Å, α = 73.249(2), β = 74.350(2), γ = 73.579(3)°, V = 2089.7(3) Å3, Z = 1, Dc = 
1.433 g/cm3, F000 = 935, MoKα radiation, λ = 0.71073 Å,  T = 120(2)K, 2θmax = 53.0º, 35618 
reflections collected, 8658 unique (Rint = 0.0638).  Final GooF = 1.029, R1 = 0.1001, wR2 
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= 0.2544, R indices based on 8658 reflections with I >2σ (I) (refinement on F2), 525 
parameters, 5 restraints.  Lp and absorption corrections applied, µ  = 0.474 mm-1. 
 
Crystals of compound 2.10 were grown in methanol by slow evaporation of the solvent.  
Crystal data for 2.10, C72H78Cl6NiN24O6.2NO3.2CH3OH, M = 1835.10, pale green plate, 
0.26 x 0.11 x 0.11 mm3, triclinic, space group P1, a = 13.2143(9), b = 13.2247(9), c = 
13.2483(9) Å, α = 73.531(3), β = 73.859(3), γ = 73.568(2)°, V = 2079.7(2) Å3, Z = 1, Dc = 
1.465 g/cm3, F000 = 954, MoKα radiation, λ = 0.71073 Å,  T = 120 K, 2θmax = 54.0º, 28147 
reflections collected, 9012 unique (Rint = 0.0769).  Final GooF = 1.037, R1 = 0.0964, wR2 
= 0.2191, R indices based on 9012 reflections with I >2σ (I) (refinement on F2), 542 
parameters, 67 restraints.  Lp and absorption corrections applied, µ  = 0.505 mm-1. 
 
Crystals of compound 2.11 were grown in methanol by slow evaporation of the solvent.  
Crystal data for 2.11, C72H78Cl6CoN24O6.2Cl, M = 1718.11, pale pink plate, 0.42 x 0.33 x 
0.21 mm3, trigonal, space group R3, a = 15.7778(6), b = 15.7778(6), c = 28.7892(11) Å, α 
= 90, β = 90, γ = 120, V = 6206.6(4) Å3, Z = 3, Dc = 1.379 g/cm3, F000 = 2667, MoKα 
radiation, λ = 0.71073 Å, T = 270K, 2θmax = 55.0º, 48744 reflections collected, 3179 
unique (Rint = 0.0545).  Final GooF = 1.095, R1 = 0.0691, wR2 = 0.1914, R indices based 
on 3179 reflections with I >2σ (I) (refinement on F2), 160 parameters, 10 restraints.  Lp 
and absorption corrections applied, µ = 0.531 mm-1. 
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Chapter 3 
Gelation studies of silver(I) complexes of imidazole derived urea 
compounds 
 
3.1 Background and Project Aims 
3.1.1 Introduction to supramolecular gels: Definition, formation and characterisation. 
Gels have been used widely in a number of products, such as hair gel, lubricants, 
adhesives, soaps, cosmetics and medical implants.1 These gels are constructed through 
the immobilisation of a liquid component by an entangled network that arises from 
cross-linking of the polymers. The widespread applications of gels are mainly due to their 
unique properties in that they are ‘solid-like’ and hence can support their own weight 
while exhibiting ‘liquid-like’ behaviour that allows them to be moulded, printed and 
injected as required.2 
By IUPAC3 definition, a gel can be defined as “a colloidal network that is expanded 
throughout its whole volume by a fluid”. Gels can be formed from different types of 
solvent, such as water, organic solvents and ionic liquid and are termed as hydrogel,4 
organogel5 and ionogel6 accordingly.  
Cross-linking bonds in covalent polymeric gels are generally very stable and not 
reversible which can limit the reusability and versatility of the gel. As a result there is 
growing interest in gels formed from ‘low molecular weight gelators’ (LMWGs).7 This 
type of gelator is made up of small molecules that self-assemble through non-covalent 
interactions such as hydrogen bonds, π-π stacking, van der Waals, charge-transfer and 
coordination interactions and solvophobic effects. The ease of disrupting the weak non-
covalent interactions gives LMWGs many advantages over traditional polymeric gels 
such as thermoreversibility, stimuli response8–10 and self-healing.11,12 On account of the 
dynamic nature of the noncovalent interaction, a broader range of potential application 
in areas such as catalysis,13 soft electronics, drug delivery and as crystal growth media14 
can be explored. 
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To form LMWGs, the gelator molecules are often briefly heated in particular solvents or 
a mixture of solvents until all the solids are completely dissolved and form a clear 
solution. During the cooling process, the gelator molecules undergo supramolecular 
assembly to form three-dimensional nano- or microstructures that immobilise the 
solvents thus giving rise to a stable gel.15 The first step to identify the formation of a gel 
is usually done by the popular inversion test, in which a gel is said to form if it can 
withstand its own weight and does not fall under gravity. However, the limitation of this 
test is it is highly dependent on container size and composition.16 Furthermore, in the 
identification of weak and partial gels, this method might give false results particularly 
if applied to viscous liquids, suspensions and strongly adhered solids.   
The formation of supramolecular gels is driven by the noncovalent interactions that 
connect the gelator molecules. However, the dynamic nature of these interactions has 
imparted difficulties in the characterisation of the supramolecular gels. There are 
various methods and techniques that can be employed to characterise supramolecular 
gels such as spectroscopic, X-ray, microscopic, thermal analysis, rheology as well as 
computational methods.17 Combination of all these techniques provide an insight on the 
self-assembled fibrillar networks (SAFINs) at molecular and bulk levels.  
For supramolecular gels, rheology provides useful information on the structures of the 
assemblies (their size or cross-linking density), about their dynamics, and even about 
their self-assembly mechanisms. Rheology18 is a study of deformation and flow of matter 
under the influence of an applied stress. In a typical rheology experiment, the gel sample 
is placed in between two plates where a given oscillatory stress is applied onto one of 
the plates. This applied stress then induced movement of the other plate, which is 
translated to an in and out-of-phase component. The two important parameters 
measured in a typical rheology experiment is G’, elastic storage modulus and G”, elastic 
loss modulus. G’ represents the elastic or solid-like properties of a gel, while G” 
represents the viscous or liquid-like properties of a gel. These parameters can be 
measured as a function of the applied oscillation strain, stress or frequency.19  
In typical rheology experiment, the value of G’ is kept invariant with frequency up to a 
yield stress and a sample is identified as a gel when the value of G’ exceed G” value at 
least an order of magnitude.20 A yield stress point is a point where gel state is changed 
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to sol state; a state where the solid will start to flow. Above the yield stress point, the 
decreasing value of G’ indicates the breakage of the network of the gel. The structure of 
a gel can be modelled mathematically from the behaviour, concentration dependence 
and magnitude of the moduli (G’ and G”).21 
X-ray diffraction is also a very useful approach, at least indirectly, to characterise the 
supramolecular gel. For instance, single crystal X-ray diffraction can be performed to get 
information on the packing of the supramolecular networks particularly the 
nonconvalent interactions such as hydrogen bond, π-π stacking, CH···π interaction and 
halogen bond that drive the formation of supramolecular gel, although the technique is 
limited by questions over the relevance of single crystal studies to the gel state. Another 
scattering technique, small-angle neutron scattering (SANS) can also be performed to 
investigate the structure of various substances at a mesoscopic scale ranging from 1 to 
1000 nm. In other words, this experiment provides the information about the structure 
on the nanoscale involved in the networks of a supramolecular gel. Small angle X-ray 
scattering (SAXS) and wide angle X-ray scattering (WAXS) are also useful to characterise 
the shape, size and distribution of the supramolecular gel fibres. These two techniques 
are similar to each other, except the diffraction maxima are observed at different angles. 
In SAXS, scattering intensity is measured at scattering angles (2θ) close to 0°, while in 
WAXS, the scattering angles is larger. From the key parameters obtained, the packing 
mode in the structure can be derived.22–24  
However, in cases where a single crystal structure cannot be obtained, computational 
approaches can be used to simulate molecular and atomic behaviour based on the 
fundamental description of atomic and molecular orbitals. The simulation can be done 
using different methods such as ab initio quantum mechanics, molecular mechanics or 
combination of both (semiempirical methods). The modelling is crucial to investigate the 
interaction between the gelators, which can aid in the understanding of the gelation 
mechanism.25–28 Using high-level energy minimisation and molecular dynamic 
calculations, possible modes of aggregation in gel network can be identified.   
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3.1.2 Urea-based gelators 
Hydrogen bonding is a versatile and directional interaction that is commonly utilized in 
the synthesis of self-assembled supramolecular structures.29–31 There are quite a 
number of reports on organo- and hydrogelators that contain the urea functionality and 
it is the hydrogen bonding interactions between urea groups that give rise to gelation 
behaviour.32–34 Each urea moiety can potentially form two strong and directional 
hydrogen bonds. Although supramolecular gel formation is normally associated with 
bisurea compounds, there are a few examples in which mono(urea) compounds are also 
able to form supramolecular gels. Recently, an L-histidine-derived mono(urea), 3.1 has 
been reported to form a stable gel in nitromethane with a concentration between 0.5 
and 2.0% (w/v) and partial gels in ethyl acetate as low as 0.3% (w/v).35 The morphology 
of the xerogel obtained from the nitromethane gel comprises of long entangled ribbon-
like fibres that exhibit a helical twist and are homochiral consistent with the use of non-
racemic L-histidine derivatives. Addition of cobalt(II) chloride to the gelator molecules 
at a very low metal:gelator molar ratio (1:0.05) in acetonitrile does not disrupt the gel 
formation, however when the ratio of metal gelator was increased (1:0.2), only a partial 
gel was formed. It is, therefore, suggested that the complexation of the metal to the N 
atom of the imidazole unit has interrupted the imidazole NH…N interactions that are also 
implicated in gel formation. In addition, the counter anions present also are likely to 
form hydrogen bonds to the urea group, further disrupting gelation.  
a) 
 
b) 
 
Figure 3.1 a) Molecular structure of gelator 3.1 b) SEM images of xerogels of compound 3.1 
obtained from gels of nitromethane (0.5% w/v) (reproduced with permission from reference 34) 
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In another example, a series of mono(urea)-based gelators (3.2-3.4), linked into dimers 
by a supramolecular hydrogen bond motif instead of by a covalent bond has been 
reported to form gels in 1,2,4-trichlorobenzene, 1,2-dibromoethane, 1,2-
dichlorobenzene and 1,3-dichlorobenzene.36 These monoureas were synthesised from 
the facile reaction between 5-aminosalicylic acid with appropriate isocyanate. The 
crystal structure of gelator 3.2 exhibits a head to head carboxylic dimer arrangement 
through strong intramolecular OH⋯H hydrogen bond that allows them to behave as a 
pseudobis(urea) (Figure 3.2). The formation of the dimer is also supported by ES+ mass 
spectrum of 3.2. The authors suggested that the gelation behaviour of these gelators 
are driven by the urea α-tape motif, similar to gelation behaviour of bis(urea) 
compounds. 
a) 
 
b) 
 
Figure 3.2 a) Molecular structure of gelators 3.2-3.4 b) short NH⋯O interactions in the gelator 3.2. 
Selected hydrogen bonding distances (Å) for compound 3.2, O⋯O 2.629(6); N⋯O 2.797(7), 2.816(7) 
(reproduced with permission from reference 35). 
 
Bis(urea) compounds are known to form supramolecular gels in various organic solvents 
due to the formation of the urea α-tape network. Recently, supramolecular gels have 
been applied as pharmaceutical growth media in which the crystallisation of important 
drugs in the gel phase could control the polymorphism and crystal habit. Kumari and co-
workers have designed a series of bis(urea) gelators, type A and type B gelators 
containing long chain alkyl (3.5-3.8) and perfluoroalkyl substituents (3.9-3.10), 
respectively.37 The fluorinated analogues could be potentially used as crystal growth 
media for some fluorinated drugs such as lansoprazole and fluoxetine. Type A gelators 
gelled cyclohexanone, 1-butanol, toluene and xylene while type B gelators gelled more 
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polar solvents namely DMSO, DMF and cyclopentanone at lower concentration, in the 
range of 0.2 to 10% wt giving a transparent gel that is suitable to be used as crystal 
growth media.  
 
 
Gelator 3.10 also formed a gel in perfluorodecalin at 10% wt to give opaque and 
thermoreversible gel. SEM micrographs of type B gelators shows that these gels are 
composed of more amorphous, less linear and cylindrical fibres ranging from 50 to 130 
nm in diameter in contrast to type A gels, which are more crystalline with ribbon-like 
fibres of diameter ranging from 0.9 to 5μm (Figure 3.3). The xerogel fibres also exhibit 
high aspect ratio that contributes to the highly entangled fibrous networks. To probe 
the supramolecular structure of the gel, small angle neutron scattering (SANS) analysis 
has been performed. The SANS results demonstrated that for type B gelators, the gel 
structure is retained up to its Tgel of the material (80 °C) but fully collapse to spherical 
aggregates after exceeding the Tgel. SANS data also revealed that the elastic properties 
of the fluorinated gels are not affected by the metastable nature when the gel was 
initially formed. 
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a) 
 
 
b) 
 
Figure 3.3 a) Gels in DMSO at the minimum gel concentration (mcg): from left to right 3.8 (3 
wt%), 3.10 (0.5 wt%), 3.6 (7 wt%), 3.7 (2.5 wt%), 3.5 (3 wt%) and 3.9 (0.2 wt%). The fluorinated 
gels have a markedly more transparent appearance. b) SEM micrographs of ethanol xerogels (i) 
large, flat ribbons of compound 3.8 typical of compound of type A, (ii) narrow cylindrical fibres 
of 3.10 typical of compounds of type B (reproduced with permission from reference 36). 
 
Wezenberg and co-workers has described a new set of photoresponsive bis(urea) 
LMWGs based on an overcrowded alkene switch.38 Under UV irradiation, trans bisureas 
3.11-3.13 can be transformed into cis isomers as illustrated in Figure 3.4a. Supergelator 
3.12 with a hexyl chain can form a gel in aromatic hydrocarbons at very low 
concentration of 0.4 mg/mL and upon UV irradiation (312 nm) the gel collapses to sol 
form. The process is reversible by irradiating the solution under UV light of 365 nm for 
15 minutes. From the X-ray structures of gelator 3.12 (Figure 3.4b), it was observed that 
the trans form allows intermolecular hydrogen bonding interaction that is necessary for 
gel formation, whereas in the cis form, this interaction is interrupted and thus results in 
gel dissolution. These photoresponsive gels are potentially useful in applications such as 
self-healing and drug delivery.  
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a) 
 
 
b) 
 
 
Figure 3.4 a) Photoisomerization behaviour and predicted urea hydrogen bonding pattern of 
trans and cis bis-urea LMWGs 3.11-3.13 b) crystal packing showing the intermolecular hydrogen 
bond arrays. The (R,R)-enantiomer is shown in blue, the (S,S)-enantiomer in pink. Hydrogen 
atoms have been omitted in the packing for clarity. Selected hydrogen bond distances (˚A): 
N⋯O: 3.053(2), 2.996(2), 2.940(2), 2.936(2) (reproduced with permission from reference 37). 
 
Sensing of organophosphorus (OP) based nerve agents, DMPP and GD using tris(urea) 
gels, 3.14 has been reported recently by Hiscock and co-workers.33 The sensing process 
is functioned via the suppression of the sol-gel phase change in toluene. Upon the 
addition of 0.1 mL (100 equivalents of the gelator) of DMPP, the gel was not formed at 
all, clearly showing a clear ON-OFF response in the absence versus presence of DMMP.  
Interestingly, the addition of another stimulant, GD, trigger the gel-sol phase change at 
a much lower concentration of 0.01 mL than DMMP, possibly due to the higher degree 
of polarity that strengthen the hydrogen bonding interactions. Both of the nerve agents 
contain phosphonate ion that binds to the urea groups resulting in inhibition of gel 
formation.  
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3.1.3 Metal-containing gels 
 
In recent years, there has been increasing interest in metal-containing low molecular 
weight gelators (LMWGs). Incorporation of the metal centres into gelators allows the 
design of materials that possess unique properties such as magnetism, colour, catalytic 
activity and redox behavior.39 In addition, the network structure in metallogels is cross-
linked by metal-ligand interactions, which can be tuned easily by changing the transition 
metal ions. There are two ways of preparing metallogels; first, the metal complexes of 
organic gelators are pre-formed before being tested for gelation with a variety of 
solvents. Alternatively, a coordination-induced in situ gelation approach can be 
adopted.15,40–42 To form metallogels, gelators having metal binding sites such as 
pyridine, bipyridine, terpyridines and carboxylates are used as the core of the 
metallogelators.43–45 One example is the use of pyridine-pyrazole based gelator 3.15 that 
gels in the presence of silver salts in water.46 The three- dimensional network 
interconnected by the ligand and the silver ions provides an excellent platform for the 
growth of silver nanoparticles. As the nanoparticles exclusively attach onto the gel 
fibres, they play a significant role in strengthening and stabilising the gel network. These 
silver nanoparticles have shown excellent catalytic activity in the reduction of 4-
nitrophenol and methylene blue with the presence of sodium borohydride. 
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Another series of bipyridine ligands, 3.16 to 3.18 that gel silver salts in DMSO:H2O has 
been reported by Tatikonda and co-workers.47 Of all the three ligands, only 3.17 and 
3.18 gel silver nitrate.  
 
From SEM micrographs, it has been shown that silver nitrate complex of 3.17 gels form 
fine and film-like fibres in contrast to silver nitrate complex of 3.18 that forms thicker 
nanofibrillar networks (Figure 3.5). When silver salts with different counter ions namely 
PF6–, BF4–, ClO4–, OAc– and CF3SO3– were used, only ligand 3.17 formed stable metallogel, 
while ligand 3.18 formed less stable gels that collapsed after few hours at room 
temperature. 
a) 
 
b) 
 
Figure 3.5 SEM micrograph of a) [3.17·AgNO3] gel in DMSO: H2O (8:2) b) [3.18·AgNO3] gel in 
DMSO: H2O (8:2) (reproduced with permission from reference 46). 
 
Apart from normal heating and ultrasonication, metallogels can also be formed under 
solvothermal conditions exemplified by the work of Knichal and co-workers in 2015.48 
They reported a metallogel that formed from the reaction of 5-allenyl-1,3-
benzenedicarboxylic acid, 3.19 and lead(II) acetate trihydrate. This metallogel only 
formed when the reaction mixture was heated to 100 °C for 72 hours with critical 
gelation concentration of 1%. The SEM micrographs of the gel show two most prominent 
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morphological features of the gel, the rod-like fibres of 40 nm in diameter and a large 
agglomeration of worm-like morphology of varying diameter ranging from 40-160 nm.  
a) 
 
b) 
 
c) 
 
Figure 3.6 a) Molecular structure of ligand 3.19 b) SEM micrograph of [3.19(PbOAc)] gel c) 
Coordination environment about the Pb(II) atom in 3.19. Thermal ellipsoids are shown with 
50% probability (reproduced with permission from reference 48).  
 
Recently, Wang and co-workers have prepared a ligand that comprises two metal 
coordination sites, the carboxyl part of tryptophan and the pyridyl segment, 3.20.49 This 
compound does not gel on its own but formed a pink and opaque metallohydrogel 
immediately after the addition of Co2+ ions (as chloride, nitrate and acetate salts) at pH 
7.0 to 8.0 without any heating or ultrasonication step. The metallohydrogel formed was 
robust, thermoreversible and able to show a rapid thixotropic response. SEM 
micrographs of the metallohydrogels show uniform nanofibrils with widths between 25 
and 40 mm and several micrometers in length. The metal ligand ion coordination 
interaction also contributes to the entangled fibrous morphology of the gels.  As 
suggested by the authors, this metallohydrogel could be potentially applied in the chiral 
recognition field, as it does not gel when a racemic mixture is used. 
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 a) 
   
b) 
 
d) 
 
c) 
 
Figure 3.7 a) Molecular structure of 3.20 having tryptophan and pyridyl unit b) Gelation test 
screening of 3.20 with various transition metals c) SEM micrograph of 3.20–Co metallohydrogel 
d) Gel–sol transitions of the 3.20–Co metallohydrogel triggered by various stimuli (thermal, 
mechanical, pH, and chemical reaction) (reproduced with permission from reference 49). 
 
Although most of reported works on metallogels employ one type of metal ion in their 
system, there are also some studies that incorporate two different metals as the 
structural part of their metallogelators.50,51 Using compound 3.21, that contains an o-
hydroxynaphthaldehyde unit, Sun et al. investigated the role of various cations and 
anions in the formation of metallogels.52 In DMSO solution of compound 3.21, the 
addition of metal ions such as Fe3+, Ag+, Hg2+, Cu2+, Zn2+, Ni2+, Fe2+ and Al3+ as perchlorate 
salts did not induce the formation of a gel. However, upon the addition of sodium 
acetate to the DMSO solution of compound 3.21 results in instant gelation as shown in 
Figure 3b. The authors suggested that the anions plays a critical role in the gelation.  
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Figure 3.8 (a) Molecular structure of 3.21 and (b) photographs of G (3.21) (1%, in DMSO), 
metallogels Zn(3.21), Cu(3.21) and Zn-Cu(3.21) (1%, in DMSO, for Zn(3.21), 3.21:Zn2+ = 1:1; for 
Cu(3.21), 3.21:Cu2+ = 1:1; for Zn-Cu(3.21), 3.21:Cu2+ :Zn2+ = 1 : 1 : 1) treated with different ions 
(G in the photograph is referred to 3.21) (reproduced with permission from reference 52). 
 
Different anions were compared and they reported that gels were only formed in the 
presence of these anions, SO42¯, HPO42-, AcO-, F-, Cl¯, NO3-, HSO4¯ and NO2¯, and remains 
as a solution with Br¯, I¯, SO32¯, HSO3¯, S2¯ and CN¯ in agreement with the Hofmeister 
series (Figure 3.9). The Zn-Cu(3.21) complex can also act as a Cu2+ and CN¯ controlled 
“OFF-ON-OFF” fluorescence switch due to the quenching of the fluorescence of Zn(3.21) 
complex upon the addition of Cu2+ ion. 
 
 
Figure 3.9 Photographs of solutions and gels from 3.21 (10 mg mL-1) and Cu(ClO4)2 in DMSO 
in the presence of various anions. (3.21: anion:copper perchlorate = 1:1:1) (reproduced with 
permission from reference 52). 
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3.1.3 Project Aims 
Previous reports have shown that the addition of a pyridyl group to the urea derivatives 
as a metal binding site can result in ‘switch on’ gelation because metal complexation 
removes competing urea-pyridyl hydrogen bonding interactions.53 Silver(I) ions are 
known to bind nitrogen-containing ligands  forming complexes with a linear geometry. 
The linear geometry of the silver(I) complexes would allow the self-assembly of the 
complexes to form extended one-dimensional linear polymeric structures for gel 
formation in appropriate solvents. With these in mind, we are interested in using 
imidazole urea compounds as discussed in Chapter 2 to produce metal-switched 
supramolecular gels based on the self-assembly of the urea functional group.54 To date, 
there has been little published work on the use of a silver(I) to link two urea-based 
ligands to give a gel-forming bis(urea) motif by metal complexation, with the exception 
of one earlier report of a silver(I) coordinated mono urea based gel system.55 
3.2 Results and discussion 
3.2.1 Gel studies and morphology of the gel 
 
The gelation test of ligands 2.1, 2.2, 2.3, 2.4, 2.5, 2.6 and 2.7 were carried out in 14 
organic solvents. About 10 mg of the ligands (2% w/v) were added into 2 mL vials 
containing organic solvents and were heated gently to dissolve the ligands. Then, the 
solution was sonicated. The solutions were allowed to cooled down to room 
temperature and the state was observed. At room temperature, all of the ligands are 
soluble in polar solvents such as methanol, ethanol, propanol and dimethyl sulphoxide. 
In solvents such as acetonitrile, THF, mixture of THF and water and nitomethane, all the 
ligands dissolved when the solution was heated briefly. However, none of the ligand 
formed gels in any of the solvents tested. The screening of the ligands in various solvents 
is summarised in Table 3.1. 
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Table 3.1 Gelation studies performed on ligands 2.1, 2.2, 2.3, 2.4, 2.5, 2.6 and 2.7 (2% w/v) in 
common organic solvents. 
 
Solvents Ligands 
2.1 2.2 2.3 2.4 2.5 2.6 2.7 
Acetone I I I I I I I 
Acetonitrile P P P P P P P 
THF:H2O (8:2) P P P P P P P 
THF:H2O (7:3) P P P P P P P 
THF P P P P P P P 
Diethyl ether I I I I I I I 
Nitromethane P P P P P P P 
Hexane I I I I I I I 
Chloroform I I I I I I I 
Dichloromethane I I I I I I I 
Methanol S S S S S S S 
Ethanol S S S S S S S 
Propanol S S S S S S S 
DMSO S S S S S S S 
*P = precipitate, I = insoluble, S = solution,  
 
In addition, the gelation screening of all the ligands was also performed in the presence 
of four different silver salts, namely i) silver tetrafluoroborate, silver perchlorate, silver 
hexafluorophosphate and silver nitrate in selected organic solvents, in which the ligands 
can be dissolved such as acetonitrile, THF:water (8:2), THF:water (7:3), THF, 
nitromethane, methanol, ethanol, propanol and DMSO. Samples were heated and 
sonicated briefly to ensure thorough mixing. Immediately after the heating and 
sonication process, the samples were cooled down to room temperature and the state 
of the samples are observed. The samples were kept in dark to protect them from light.  
127 
 
Interestingly, ligand 2.3, which does not form any gels by itself is found to gel THF/water 
mixtures (7:3) with the addition of 0.5 to 1.0 equivalents of silver tetrafluoroborate, 
silver perchlorate and silver hexafluorophosphate. Other than this solution mixture, 
ligand 2.3 also formed gels in THF, THF:water (8:2), DMSO and acetonitrile (2% w/v). In 
every case, aggregates formed upon the addition of the silver salts (tetrafluoroborate, 
perchlorate and hexafluorophosphate) to the solution of ligand 2.3 and within a few 
hours after brief sonication, slightly opaque gels at the concentration of 2% (w/v) were 
formed that did not flow under tube inversion. In contrast, the addition of silver nitrate 
to ligand 2.3 results in the formation of a white precipitate instead of a gel (Figure 4.1). 
The gel formed was kept in the dark to avoid the formation of metallic silver particles. 
The gelation experiments on every ligand with different types of aqueous silver salts are 
tabulated in Table 3.2. 
 
a) 
 
b) 
 
c) 
 
d) 
 
 
Figure 3.10 a) Precipitate from addition of i) AgBF4 and ii) AgNO3 to ligand 2.1 b) Precipitate from 
addition of i) AgBF4 and ii) AgNO3 to ligand 2.2 c) Precipitate from addition of AgBF4 to ligand i) 
2.4 ii) 2.5 iii) 2.6 iv) 2.7 d) Gel from addition of i) AgBF4, ii) AgPF6, iii) AgClO4 to ligand 2.3 and 
precipitate from addition of d) AgNO3 to ligand 2.3. 
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Table 3.2 Gelation screening of all ligands (2.1-2.7) in the presence of i) silver tetrafluoroborate, ii) silver hexafluorophosphate, iii) silver perchlorate and iv) silver nitrate 
in selected organic solvents.  
Solvents Ligands 
 2.1 2.2 2.3 2.4 2.5 2.6 2.7 
 i ii iii iv i ii iii iv i ii iii iv i ii iii iv i ii iii iv i ii iii iv i ii iii iv 
Acetonitrile P P P P P P P P P P P P P P P P P P P P P P P P P P P P 
THF:H2O (8:2) P P P P P P P P G G G P P P P P P P P P P P P P P P P P 
THF:H2O (7:3) P P P P P P P P G G G P P P P P P P P P P P P P P P P P 
THF P P P P P P P P G G G P P P P P P P P P P P P P P P P P 
Nitromethane P P P P P P P P P P P P P P P P P P P P P P P P P P P P 
Methanol P P P P P P P P P P P P P P P P P P P P P P P P P P P P 
Ethanol P P P P P P P P P P P P P P P P P P P P P P P P P P P P 
Propanol P P P P P P P P P P P P P P P P P P P P P P P P P P P P 
DMSO P P P P P P P P G G G P P P P P P P P P P P P P P P P P 
** P = precipitate, S = solution, G = gel, i = silver tetrafluoroborate, ii = silver hexafluorophosphate, iii = silver perchlorate, iv = silver nitrate 
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These results indicate that the formation of the metallogels strongly depends on the 
types of counter anions of the silver salts. In comparison with tetrafluoroborate, 
perchlorate and hexafluorophosphate anions, which are weakly coordinating anions, 
nitrate anions are able to act as hydrogen bond acceptors with the NH group of the urea 
moiety which directly disrupt the formation of α-urea tape that is responsible for the gel 
formation as often observed in bis(urea)s systems.54  
It is suggested that the dodecyl chains of ligand 2.3 also facilitate the formation of the 
fibrous networks due to the strong Van der Waals interactions56 between them and 
solvophobic effects that allow them to form one directional alignment of gelator 
molecules.55 In addition, it was also observed that ligand 2.3 forms a stable gel at 2:1 
(ligand: metal) and 1:1 ratio with silver tetrafluoroborate, while at 1:2 ratio, a 
metastable gel is formed (Figure 3.2). Subsequent addition of silver tetrafluoroborate 
results in the formation of precipitate instead of a gel. Nevertheless, due to the poor 
solubility of the ligand-silver aggregates in the solvent mixture, the silver metallogels 
were not thermoreversible upon heating although they appear to be robust and 
homogeneous.13,57  
 
Figure 3.11 Gels of ligand 2.3 with a) 0.5 equivalent b) 1.0 equivalent c) 2.0 equivalent of 
AgBF4 in THF:H2O 7:3 (v/v). 
 
To seek insight on the arrangement of the gelator molecules which contributes to the 
gelation, gelation tests have also been performed on ligand 2.3 with copper(II) 
tetrafluoroborate, which will form complexes of square planar, square pyramidal or 
Jahn-Teller distorted octahedral geometry, in contrast with the linear geometry of the 
silver complexes. After the addition of copper(II) tetrafluoroborate to the ligand 2.3 
solution in THF: H2O (7:3), the colour of the solution changed from colourless to blue, 
indicating a reaction between the ligands and the metal ion. The mixture was then 
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heated and briefly sonicated to ensure thorough mixing and maximum interaction 
between the ligand and the metal salt. After a while, a blue precipitate formed in the 
solution and no gel was observed (Figure 3.3). This could be likely due to the 4-6 
coordinate nature of the copper(II) ion that does not result in a geometry that allows 
the formation of α-urea tape hydrogen bonding motif that is responsible for the 
formation of the fibrous network in a gel. This result is also in agreement with the theory 
that in order to obtain fibrous aggregates for gels, linear or planar coordination of metal 
ions in the complex is necessary.58 This result is comparable to the previous report on 
the imidazole urea hydrogel in which the presence of copper(II) nitrate significantly 
reduces its yield point.59  
 
Figure 3.12 Precipitates formed upon addition of 0.25 equivalent copper(II) tetrafluoroborate 
to the solution of ligand 2.3 in THF: H2O (7:3) (v/v). 
 
To provide insights into the morphology of silver(I) metallogel of ligand 2.3, a xerogel 
was prepared from slow evaporation of the gel samples and then coated with Platinum 
prior to the examination by scanning electron microscope (SEM). At 2 wt. %, the dried 
xerogel features elongated fibres forming an entangled fibrillar network along with a 
slightly twisted fibril (Figure 3.4a). By increasing the concentration of the sample up to 
3 wt. %, helical left and right-handed fibres are observed (Figure 3.4b). Helical fibres are 
commonly observed in xerogels derived from ribbon-like fibres of chiral, racemic and 
achiral gelators as exemplified in previous work.35,59   
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Figure 3.13 SEM micrographs of a dried a) 2 wt. % xerogel b) 3 wt. %. Both gels were prepared 
thermally with sonication. 
 
3.2.2 Rheological properties of the metallogel 
 
The rheological properties of silver(I) metallogel of ligand 2.3 confirm that the material 
shows the characteristics of a true gel. A stress sweep at 2 wt. % (w/v) shows that at low 
stresses, storage modulus G′ is, at least, one order of magnitude greater than loss 
modulus G″, typically observed for gel-like materials (Figure 4.5).42 To elucidate the 
mechanical properties in terms of gel morphology, the values of initial modulus G° of 
the initial plateau and the values of the stress at which the gel breaks (yield point) are 
used. From the stress sweep rheometry data, the yield stress reaches a pronounced 
maximum at 0.5 equivalent of silver tetrafluoroborate. On addition of excess silver salts 
in the case of 1.0 and 2.0 equivalent of silver tetrafluoroborate, the yield point drops 
dramatically from 211 to 119 Pa and 112 Pa, respectively (Figure 4.6). The significant 
decrease in the yield point is possibly due to the increase in the number of anions that 
competes in the hydrogen bonding of the ureas.57   
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Figure 3.14 Stress sweep rheometry data for a 2 wt. % silver metallogel of compound 2.3 with 
0.5 equivalent of silver tetrafluoroborate. 
 
Figure 3.15 Stress sweep rheometry data for a 2 wt. % silver metallogel of compound 2.3 with 
0.5, 1 and 2 equivalents of silver tetrafluoroborate. 
 
As proved by rheometry data, 2:1 ratio is the optimum ratio for gelation, consistent with 
the 2-coordinate nature of Ag(I) and monodentate nature of ligand 2.3. We, therefore, 
propose a linear binding between two imidazole urea ligands of type 2.3 with one silver 
ion to form one-dimensional sheet that was linked by conventional urea α-tape 
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hydrogen bonding motif, which is typically seen in bis(urea)s systems (Scheme 3.1).60,61 
The rheometry data is also comparable to the previous report on the silver(I) metallogel 
of pyridyl urea.57 The binding stoichiometry of the ligand and silver ion can also be 
examined through a Job plot, however due to the formation of a gel in DMSO solvent, 
the experiment could not be carried out.  
 
Scheme 3.1 Proposed binding mode of ligand 2.3 to silver ion linked by conventional urea tape 
hydrogen bonding motif. 
 
On the other hand, the strength of gel is also influenced by the counter anions of the 
silver salts. The metallogel of silver tetrafluoroborate forms stronger gels compared to 
that of silver hexafluorophosphate and silver perchlorate; almost four times the yield 
stress (Figure 3.16). 
 
Figure 3.16 Stress sweep rheometry data for a 2 wt. % silver metallogel of compound 2.3 
hexafluorophosphate (AgPF6) and silver tetrafluoroborate (AgBF4). 
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3.2.3 Stability of the gel and formation of silver nanoparticle 
 
The most stable metallogel of ligand 2.3 formed from silver tetrafluoroborate, which 
proved to be stable at least over a period of weeks when stored in the dark. However, 
on an open bench, a brown colouration due to the formation of silver nanoparticles by 
photoreduction is observed when the gels are exposed to sunlight. It was anticipated 
that irradiating the metallogel under UV light at 365 nm would enhance the formation 
of silver nanoparticles.13,57 It is found that gels with 0.5 equivalent of silver 
tetrafluoroborate show colour changes from colourless to brown after being irradiated 
under UV light and a more intense brown colouration is observed as the irradiation time 
was increased from 1 hour to 24 hours (Figure 3.17). At regular intervals, a sample of 
the gel (0.15 mg, 100 mM) was dissolved in 2 ml DMSO and the UV/Vis spectrum of the 
solution was recorded. A typical surface plasmon of spherical silver nanoparticle 
characterised by a band that develops at around 430 nm was observed after about 3 
hours (Figure 3.18).13,57 
 
Figure 3.17 Gels of ligand 2.3 with 0.5 equivalent of AgBF4 in THF : H2O 7 : 3 (v/v) after i) 1 h, 
ii) 2 h, iii) 3 h, iv) 4 h, v) 5 h, vi) 6 h and vii) 24 h under UV 365 nm.  
 i)       ii)      iii)       iv)        v)         vi)        vii)     
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Figure 3.18 UV/vis spectrum of gels of ligand 2.3 with 0.5 equivalent of AgBF4 in THF:H2O 
(7:3) (v/v) after 1 h, 2 h, 3 h, 4 h, 5 h, 6 h and 24 h. 
 
In contrast, metallogels of ligand 2.3 with 1 and 2 equivalents of silver tetrafluoroborate 
form a grey-coloured gel and grey precipitate, respectively after UV light irradiation 
(Figure 3.19a). These colour changes indicated the formation of bulk silver57 due to the 
excess silver ions that are present in the solution. Apart from that, in the case of gel with 
1 equivalent of silver tetrafluoroborate, the formation of bulk silver has significantly 
weakened the gel (Figure 3.19b).  
a) 
 
b) 
 
Figure 3.19 a) Metallogels of ligand 2.3 with i) 0.5 equivalent ii) 1.0 equivalent iii) 2.0 equivalent 
of AgBF4 in THF:H2O (7:3) (v/v) after 24 h under UV light 365 nm b)Weakening of 
the gel with 1 equivalent of silver tetrafluoroborate after 24 h under UV light 365 
nm (left: fresh gel, right: gel after 24 hours). 
 
136 
 
The presence of the silver nanoparticles was further confirmed by Transmission Electron 
Microscopy (TEM) after being irradiated under UV light for 24 hours in the solvent 
mixtures of THF:water (7:3). A drop of the gel solution was applied to a copper grid, 
dried under vacuum and mounted on JEOL 2100F FEG TEM instrument at 200 kV 
operating voltage. 
For the silver metallogel of 2.3 with 0.5 equivalent of AgBF4, there was a small amount 
of nanoparticles formed, exclusively distributed in the gel fibre (Figure 3.20), which 
possibly contributes to the strength of the gel. In this sample, only small amount of 
nanoparticles formed as most of the silver ions coordinate to ligand 2.3. Irradiation 
under UV light also collapsed the fibrous nature of the gel and results in the leaching of 
some of the nanoparticles into the solution. However, when 2 equivalents of AgBF4 were 
used, more spherical-shaped silver nanoparticle were observed (Figure 3.21) 
 
Figure 3.20 TEM images of the metallogel of 2.3 with 0.5 equivalent of AgBF4. 
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Figure 3.21 TEM images of the metallogel of 2.3 with 2 equivalents of AgBF4. 
On the other hand, the use of 3 equivalents of AgBF4 not only promotes the growth of 
larger particles with a diameter in the range of  278 to 411 nm, but also promotes the 
growth of silver nanorods with a uniform diameter of 88 nm and a length varying from 
200 to 264 nm (Figure 3.22) although the size of the observed particles may not 
represent the bulk materials. The bigger size particle results from the agglomeration of 
the spherical nanoparticles. 
  
Figure 3.22 TEM images of the metallogel of 2.3 with 3 equivalents of AgBF4. 
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An energy dispersive X-ray (EDX) spectrum of the metallogel confirmed the presence 
of silver metal in all the metallogel samples (Figure 3.23). These findings are consistent 
with the previous report in which the silver ion serves as the gelling agent and as the 
nanoparticle growth substrate.13 
 
Figure 3.23 An EDX spectrum of metallogel of 2.3 with 0.5 equivalent of AgBF4. 
 
3.2.4 Anion addition studies 
Several reports have shown that the structural properties of supramolecular gels are 
tuneable by the interactions between anion stimuli and the gelator molecule.14,54,62 Urea 
is a common hydrogen bond donor group that can interact with anions and has found 
application in a variety anion sensors.63–65 Anions are able to form hydrogen bonds with 
the NH group of urea (Figure 3.24 a), which directly causes the disruption of the urea 
tape, responsible for the formation of a fibrous network (Figure 3.24 b).40,62   
a) 
 
b) 
 
Figure 3.24 a) urea tape hydrogen bonding motif which gives rise to long fibres b) hydrogen 
bonding motif adopted by ureas in the presence of anions resulting in breakdown of gel fibres.  
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Addition of more than one equivalent of chloride ions disrupts the silver(I) gel of ligand 
2.3 and transformed it into sols with white precipitates (Figure 3.25). When anions such 
as chloride, bromide and nitrate ion were added to the gel, the anion reacts with the 
silver metal to form AgCl, AgBr and AgNO3 that precipitates and disrupts the gel network 
that is driven by the urea tape and argentophilic interactions.66 The addition of fluoride 
ion also results in the formation of a precipitate in the gel, possibly AgF. Conversely, the 
addition of 10 equivalents of benzoate and lactate does not compromise the integrity of 
the gel probably due to the larger size that limits them from penetrating the gel network. 
 
      
Figure 3.25 Top: Silver(I) gels of 2.3 before the addition of 10 equivalents of anions as 
tetrabutylammonium salts Bottom: Silver(I) gels of 2.3 after the addition of 10 equivalents of a) 
F¯ b) Cl¯ c) Br¯ d) NO3¯ e) acetate f) benzoate  g) HSO4¯ h) H2PO4¯ i) oxalate  j) lactate in THF:H2O 
(7:3) (v/v). 
3.3 Summary 
 
To conclude, silver(I) metallogels have been obtained by the combination of silver ion 
and an organic component bearing imidazole head group containing urea derivatives. 
Both the coordination structure of the complex and the symmetrical hydrogen bonding 
between complexes as well as the van der Waals interaction of the hydrophobic alkyl 
chains are thought to be responsible for the gelation. 
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3.4 Experimental 
 
All solvents used in the synthesis and purification were of analytical reagent grade. 
Anhydrous solvents were prepared on an SPS solvent purification system. Commercial 
reagents were used as supplied, without further purification. 
 
3.4.1 Synthesis  
 
The synthesis procedure for all the ligands used in this chapter has been detailed in the 
experimental section of Chapter 2.  
 
3.4.2 Gel Preparation and Rheology 
 
Oscillatory rheometry measurements were performed at 0.1-1000 Pa using a TA 
Instruments AR 2000 on a rough Peltier plate with a 25 mm rough plate geometry and 
2.5 mm gap. Samples were prepared by dissolving 40 mg of compound 2.3 in a mixture 
of THF: H2O 7:3 (v/v) (2 mL). A stock solution of AgBF4,AgClO4, AgPF6 and AgNO3 in 0.5 
mL water was prepared so that 100 µL represents 1 equivalent of the silver salt with 
respect to the ligand. The silver solution was injected into the ligand solution and was 
thoroughly mixed by brief sonication in sealed 7 cm3 vials. The solution mixtures then 
were poured into a 25 mm cylindrical glass mould on the Peltier plate and the gels were 
allowed to form and equilibrate 45 minutes prior to analysis. The materials were left to 
cool down at 10 °C using the rheometer inbuilt temperature control to minimize the 
evaporation of the material throughout the formation and analysis. Stress sweep 
experiments were performed with a constant frequency of 1 Hz.  
 
3.4.3 Instrumentation and Analytical Measurements 
 
SEM samples were prepared on silicon wafers, dried in the dark for 3 days prior to 
imaging, and coated with 2 nm of platinum using a Cressington 328 Ultra High Resolution 
EM Coating System. Using an FEI Helios NanoLab DualBeam microscope, the images 
were obtained in immersion mode, with beam settings of 1.5 kV and 0.17 nA.  
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TEM and EDX experiments were performed on a JEOL 2100F FEG TEM instruments at 
200 kV operating voltage on samples dissolved in DMSO and applied to a copper grid. 
During the analysis, the temperature was maintained at -65 oC by cryo-cooling with 
liquid nitrogen, and monitored using a Gatan 900 SmartSet controller. UV/vis spectra 
were recorded on a Perkin Elmer UV Lambda 25 spectrometer in DMSO. Gels irradiation 
was performed using a 6 W hand held UV lamp at 365 nm. 
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Chapter 4 
 
Anion binding by pre-organised imidazole urea derivatives of 
triethylbenzene and a mesitylcalixarene  
 
4.1 Background and Project Aims 
 
The binding and sensing of biologically important anions such as citrate,1 phosphate,2,3 
lactate4–6 and chloride7–9 as well as pollutant ions namely fluoride,10,11 cyanide,12–14 
sulphate15,16 and nitrate17–19 is particularly topical. A typical anion sensor usually 
comprises an anion binding moiety such as urea,16,20,21 thiourea,16,22,23 amide or 
sulfonamide coupled to a signalling group such as a fluorophore that can transduce 
binding into a measurable signal. In order to achieve effective sensing of anions, there 
is an urge to design a more flexible receptor that can respond to a range of analytes to 
varying degree. The previous work of our research group24 has explored the induced 
fit25 concept, in which flexible receptors can bind to the analytes and result in 
conformational change that can generate a measurable output signal.25,26 
 
The mechanism of this induced fit concept is that only analytes that induce an 
appropriate conformational change will result in signal generation even though they 
may not be the strongest bound by the receptor. The Steed group has applied this 
concept to the sensing of anions using the flexible triethylbenzene and 
mesitylcalixarene scaffolds.25,27 These two versatile platforms can be used to construct 
and design small and flexible anion and cation receptors. In this chapter, 
triethylbenzene- and mesitylcalixarene-based anion hosts are synthesised and the 
binding affinity towards anions are compared to that of ligands 2.2, 2.3 and 2.4 
discussed in Chapter 2. The binding affinities of these hosts are also compared to 
previously reported anion hosts.  
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4.2 Results and Discussion  
4.2.1 Synthesis and characterisation of trialkylbenzene-based anion hosts  
 
Ligands 2.2 - 2.4 were prepared and characterised as discussed in Chapter 2. Hosts 4.1 
and 4.2 were synthesised by reacting imidazole urea arms 2.2 and 2.3 with 1,3,5-
tri(bromomethyl)-2,4,6-triethylbenzene. Reactions were carried out in dry 
tetrahydrofuran (THF), continuously stirred and heated to reflux for 24-48 hours. In 
order for this reaction to occur, the presence of a base is necessary to deprotonate the 
imidazole N-H, hence ligands 2.2 and 2.3 were used in slight excess acting as a base as 
well as being a reactant (Scheme 4.1). For both of the reactions, within four to six 
hours, light yellow precipitates began to form in the reaction flask. During the first 
attempt, the reaction between ligand 2.2 with the tripodal core was performed for 24 
hours. After 24 hours, the brown sticky oil of host 4.1 was isolated by removing the 
solvent by decanting as the oil sticks to the bottom of the flask. The solvent was 
removed while the solution was still warm to remove most of the unreacted starting 
material. The brown oil was then evaporated to dryness to give a brown solid. Upon 
exposure to air and moisture, the brown solid became sticky again, presumably due to 
absorption of atmospheric moisture. 
 
 
Scheme 4.1 Synthesis route of compound 4.1 and 4.2 using excess ligand as the base (Note: 
The structure of compound 4.1 and 4.2 drawn in this figure represents 1,3 isomer). 
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Even after 24 hours of reaction, the yield of the product was quite low, with 
unoptimised yield of approximately 25%. This could be due to the use of only a slight 
excess of ligand that was not enough to deprotonate the NH proton of all of the 
imidazole ligands to allow the reaction to take place. Nevertheless, the formation of 
host 4.1 has been confirmed by ESI-MS, 1H and 13C NMR spectroscopy. From the ESI-
MS spectrum of host 4.1, there are peaks that correspond to the mass of the molecular 
ion, particularly 1019.6 for [M+Na]+, 499.3 for [(M/2)+2H+]2+ and 333.4 for 
[(M/3)+3H+]3+. In the 1H NMR spectrum, the formation of host 4.1 is indicated by the 
appearance of a CH2 signal that connects the tripodal core with the imidazole urea 
ligands at 5.35 ppm.  
 
Due to the low yield of host 4.1, the reaction to form host 4.2 was performed for a 
longer time, up to 48 hours with a higher excess of ligand 2.3 (for example 1 mole of 
triethylbenzenetribromide was reacted with 6 moles of ligand 2.3). After 48 hours, a 
yellow sticky solid was isolated from the reaction mixture. This material was 
evaporated to dryness using rotary evaporator giving yellow solid that upon exposure 
to air begin to turn sticky again. Although the reaction time was prolonged to 48 hours, 
the yield of host 4.2 was still low at 45% unoptimised yield. With the use of a higher 
excess of the ligand, the yield can be improved somewhat, but the removal of the 
excess ligand now becomes a challenge. Nevertheless, the formation of host 4.2 has 
been confirmed by ESI-MS showing molecular ion mass peak of 1185.5 for [M+Na]+, 
583.6 for [(M/2)+2H+]2+ and 389.6 for [(M/3)+3H+]3+. The 1H NMR spectrum of host 4.2 
also confirmed the presence of CH2 signal that connects the tripodal core with the 
imidazole urea ligands at 5.19 ppm. Although the targeted product has been 
successfully synthesised, this method is not optimal due to the need to use excess 
ligand and difficulty in the separation and removal of the residual reactants since the 
reactants and products show similar solubility in a range of solvents such as alcohols.  
 
Multiple recrystallisations using different types of solvents have been performed to 
purify compound 4.1 and 4.2 as tabulated in Table 4.1. To perform the crystallisation 
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experiments, about 50 mg of host 4.1 and 4.2 were weighed into a 2 cm3 glass vials 
and the vials were filled with an appropriate amount of solvent around 1-1.5 cm3 
depending on the solubility. All samples were heated and sonicated until everything 
had dissolved. The vials were loosely sealed with lid resting on top of the vial to allow 
slow evaporation of the solvent. The samples were checked every couple of days until 
either crystal formed or non-crystalline solids formed, or a sticky oil which did not 
change over the course of a few weeks. Unfortunately, the crystallisation experiments 
only give either impure solids or impure sticky solid in which the impurities can still be 
seen in 1H NMR spectra of both hosts 4.1 and 4.2. Host 4.1 obtained after 
recrystallisation was also washed with hot acetonitrile and the solution decanted. 
Washing with hot acetonitrile caused the formation of a brown viscous liquid that was 
then dried in the oven at 60 ⁰C for two days. 
Table 4.1 Crystallisation experiments of host 4.1 and host 4.2  
(Note: P = precipitate, I = Insoluble). 
 
 Hosts 
Solvents 4.1 4.2 
Acetonitrile P P 
Nitromethane P P 
1-propanol P P 
Tetrahydrofuran  I I 
Ethyl acetate I I 
Acetone  I I 
Acetonitrile: Methanol (few drops) P P 
Nitromethane: Methanol (few drops) P P 
Acetonitrile: Ethanol (few drops) P P 
Nitromethane: Ethanol (few drops) P P 
Ethyl acetate: Ethanol (few drops) P P 
Ether diffusion into methanol solution P P 
*P = Precipitate, I = Insoluble 
On the other hand, attempts to purify host 4.2 were performed using different 
techniques such as membrane dialysis and column chromatography. Membrane 
dialysis technique was not the best solution as it decomposes the product after 
overnight stirring in methanol. Column chromatography was also employed to 
separate the residual reactants from the product using silica gel as the stationary 
phase and a mixture of ethyl acetate: iso-propyl alcohol: water (4:2:1) with 0.1% 
NH4OH as the eluent. The addition of 0.1% of NH4OH is necessary to deactivate the 
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silica gel, otherwise, host 4.2 will decompose on the column. Regardless of the high 
polarity of the eluent system being used, the residual reactants still cannot be 
separated from the product as the signal of the residual reactants can still be observed 
in the 1H NMR spectra of the product. The use of a higher amount of excess ligand also 
results in the higher percentage of impurities retained in the mixture (Figure 4.1).  
 
Figure 4.1 1H NMR spectrum of compound 4.2. 
 
For host 4.2, a 1H DOSY NMR (Diffusion Ordered Spectroscopy) experiment was 
performed to distinguish the signals of the excess reactants and product. The 1H DOSY 
NMR spectrum of 4.2 indicates the presence of two compounds proved by two distinct 
layers with the diffusion coefficient of 1.0 x 10-10 m2s-1 and 1.8 x 10-10 m2s-1, 
corresponding to the residual reactants and product, respectively (Figure 4.1 and 4.2). 
1H DOSY NMR is a very useful technique that is predominantly used for investigating 
aggregation behaviour in solution. The principle of the technique is based on the 
diffusion coefficient parameter that is highly sensitive towards changes in the 
molecular or aggregate size and the number of individual molecules, which constitutes 
an aggregate. The molecular mass of the aggregate can then be estimated using the 
Stokes-Einstein equation.28 From the DOSY spectrum, the molecular mass calculated 
from the diffusion coefficient suggest the presence of ligand 2.3 and compound 4.2 
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both in dimeric form, hence the molecular mass calculated is compared to that of 
theoretical molecular mass of the dimers. The estimated molecular weight of both 
compounds is summarised in Table 4.2. 
 
Figure 4.2 1H DOSY NMR of compound 4.2. 
 
Table 4.2 Estimated molecular mass (g/mol) of both mixtures found in the DMSO-d6 solution of 
compound 4.2.  
Entry Diffusion 
Coefficient, 
Dobs (m2s-1) 
Estimated molecular 
mass of the dimer 
(g/mol) 
 
Calculated 
molecular mass of 
the dimer (g/mol) 
 
Difference 
(%) 
 
 
Host 4.2 1.0 x 10-10 2985.8 2331.6 
 
±28.06  
Ligand 2.3  1.8 x 10-10 760.7 645 ±17.94 
 
 
From the estimated molecular mass in Table 4.2, it can also be observed that the 
residual reactants and products are prone to form dimers in the solution as the 
estimated molecular mass are closer to the calculated molecular mass for both of the 
dimers. The compound with lower molecular weight tends to diffuse more quickly in 
solution, in this case, the residual reactants, in comparison with the product that is 
heavier, having a molecular mass of at least three times of the residual reactants. From 
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this data, the peaks can be separated and assigned unambiguously, and it can be seen 
that the higher intensity peak of imidazole proton belongs to the residual reactants, 
while the lower intensity peak belongs to the product.  
Due to the difficulty in the purification step, compound 4.2 was used in its impure form 
for qualitative anion binding studies, which is discussed in the following subsection. 
Due to the lower yield and the challenge in the purification of products when excess 
ligands were used as a base in the synthesis, a different type of inorganic base was 
introduced for the reaction between the triethylbenzene core with ligand 2.4.  All of 
the synthesis attempts were monitored using LC ESI-MS in methanol for quick 
characterisation of the product obtained. The first attempt that was carried out in the 
presence of strong bases such as potassium hydroxide and sodium hydroxide, did not 
yield the desired product, most likely due to the insolubility of the base in organic 
solvent. Another alternative such as potassium carbonate also was unsuccessful in 
synthesising the desired compounds.  
To overcome the solubility problem of the inorganic base, a phase transfer catalyst, 
tetrabutylammonium bromide, was also added to the reaction mixture along with 
potassium carbonate. However, the ESI-MS spectrum does not show any molecular ion 
mass that corresponds to the desired product. The use of triethylamine as a base also 
was not successful although triethylamine readily dissolved in the solution mixture.  
The reaction of 1,3,5-tri(bromomethyl)-2,4,6-triethylbenzene with ligand 2.4 also has 
been performed in the presence of cesium carbonate. After 48 hours, the product was 
isolated and dried. The ESI-MS analysis data of the product did not show the presence 
of a peak that corresponds to the product. The 1H NMR spectrum, however, shows 
resonances that can be assigned to the desired product which are different from the 
chemical shifts of the resonances observed for both of the reactants suggesting that 
the desired product might have formed (Figure 4.3 and 4.4). The 1H NMR spectrum of 
compound 4.3 shows a downfield shift compared to the free ligand of both CH protons 
of the imidazole rings, ca Δδ 0.37 ppm and ca Δδ 0.51 ppm whereas the urea NH 
protons of NH3 and NH4 both shifted more upfield upon the formation of the product, 
ca Δδ 0.17 and ca Δδ 0.56 ppm, respectively. However, due to the impurity of the 
product obtained, the integration could not be determined accurately.  
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Table 4.3 summarises the inorganic bases used in the synthesis and the approximate 
percentage of the conversion to the targeted product. All reactions were performed in 
tetrahydrofuran and some were repeated in acetonitrile solvent. The reasons behind 
the use these two solvents in the synthesis of the host is because the products formed 
from this reaction will not dissolve in both of the solvents but the reactants used are 
soluble in this solvent at reflux temperature, hence the solution can be removed after 
the reaction leaving majority of the products in the reaction flask.  
Table 4.3 Summary of the inorganic bases and solvents used in the synthesis of 
triethylbenzene-based anion host, 4.3.  
 
Entry Inorganic base Solvents used Unoptimised Percentage of 
conversion (%) 
1 Slight excess of imidazole 
urea ligands 
 
THF and MeCN 20 - 25 
2 Sodium hydroxide (NaOH) 
 
THF and MeCN 0 
3 Potassium hydroxide (KOH) 
 
THF and MeCN 0 
4 Potassium carbonate (K2CO3) 
 
THF and MeCN 0 
5 Potassium carbonate (K2CO3) 
with tetrabutylammonium 
bromide as phase transfer 
catalyst 
 
THF 0 
6  Triethylamine  
 
THF 0 
7 Caesium carbonate (Cs2CO3) THF 41 
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Figure 4.3 1H NMR spectrum of ligand 2.4. 
 
 
Figure 4.4 1H NMR spectrum of trisurea 4.3 obtained from the reaction of 1,3,5-tribromo-
2,4,6-triethylbenzene with compound 2.4 in the presence of Cs2CO3. 
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4.2.2 Anion binding studies of host 4.2 and 4.3 
 
 
The 1H NMR spectrum of host 4.2 shows that, for 1 mole of host 4.2, there are 3 moles 
of the reactant, ligand 2.3. Therefore, in the anion binding study, the concentration of 
the guest added is based on the concentration of one mole of host 4.2 and three moles 
of ligand 2.3. The anion binding properties of fluoride, chloride, and acetate by host 
4.2 was studied by means of 1H NMR spectroscopic titrations in dimethylsulfoxide-d6. 
Although host 4.2 is fairly soluble in chloroform, the proton signals are broad and hard 
to follow, possibly due to the aggregation of the host in chloroform making the solvent 
not suitable for the titration experiment. Also, due to the free ligand impurities, it is 
not possible to calculate the binding constant for all the hosts. Hence, only qualitative 
results will be discussed in this subsection. The first titration experiment was 
performed between host 4.2 with fluoride ion (as the NBu4+ salt). Only the proton 
signals from the products (H1, H2 and urea N-H, H3 and H4) are followed in this 
titration (Figure 4.5). 
 
Figure 4.5 Proton signals (H1, H2, H3 and H4) that are followed for the anion binding 
experiments (Note: structure represent one of the binding arm of host 4.2). 
 
Addition of 0.5 to 1.0 equivalent of fluoride ion does not perturb the chemical shift of 
all four protons. However, upon the addition of 2.0 equivalent of fluoride ion, the H1 
peak corresponding to the imidazole proton became broad and shifted further upfield. 
Similarly, addition of 2.0 equivalent of fluoride also caused the broadening of the H2 
signal, attributed to another imidazole proton and the peak also shifted further upfield 
(Figure 4.6). The urea protons are not significantly affected by the fluoride ion but 
upon addition of 2.0 equivalent of fluoride ion, the urea proton peaks, H3 and H4 
starts to broaden and split forming two different signals after 5.0 equivalent of fluoride 
ions is added. Addition of 2.0 equivalent of fluoride ion also caused significant colour 
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changes to the solution from yellow to pink (Figure 4.8), indicating the deprotonation 
of imidazole proton H1 and H2 by the basic fluoride ion.  
 
Figure 4.6 Stack plot showing the 1H NMR spectrum of compound 4.2 in DMSO-d6 in the 
presence of fluoride ion as tetrabutylammonium salt. 
 
The second titration experiment was performed between host 4.2 with acetate ion (as 
NBu4+ salt). Similar to the titration with fluoride ions, only the proton signals from the 
products (H1, H2 and urea N-H, H3 and H4) are followed in this titration. Addition of 
0.5 to 1.0 equivalent of acetate ion also does not perturb the chemical shift of all three 
protons. Likewise, upon the addition of 2.0 equivalent of acetate ion, both the H1 and 
H2 signals shifted upfield (Figure 4.7). The urea protons are not significantly affected 
by the acetate ion, only showing an insignificant broadening of the peak upon the 
addition of 2.0 equivalent of acetate ions. Addition of 2.0 equivalent of acetate ion also 
induced the colour changes of the solution from yellow to pink (Figure 4.8).  
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Figure 4.7 Stack plot showing the 1H NMR spectrum of compound 4. in DMSO-d6 in the 
presence of acetate ion as tetrabutylammonium salt. 
 
 
Figure 4.8 Colour changes upon addition of 2.0 equivalent of a) tetrabutylammonium 
chloride b) tetrabutylammonium fluoride hydrate c) tetrabutylammonium 
acetate (photographs taken before solution mixing). 
 
158 
 
The chloride binding properties of host 4.2 was also examined in DMSO-d6. Suprisingly, 
host 4.2 does not interact with chloride in this medium. Addition of chloride ion does 
not result in any changes on the chemical shift changes for any of the proton signals 
examined except an insignificant broadening of the urea NH signal after the addition of 
2 equivalent of chloride (Figure 4.9). This result is in contrast with the chloride binding 
experiment on the free arm 2.3 that has been discussed in detail in Chapter 2. The 
addition of chloride to the solution of free 2.3 results in the downfield shift of the urea 
protons with chemical shift changes of Δ 1.24 ppm. The addition of the chloride ion 
also does not result in any colour change of the solution and the yellow colour is 
retained. Although the titration experiment of 2.3 were done in a less competitive 
solvent, CDCl3 and results in large chemical shift changes, the competitiveness of the 
solvent is not the only factor that determines the binding affinity of a compound to 
anions. Turner et al. reported similar titration experiment using a tripodal pyridinyl 
urea analogues having an n-octyl chain and this system binds chloride well with a 
binding constant of 7079 M-1.29 While we do not have a definite explanation for this 
effect it could be rationalized by the competitiveness of the DMSO solvent and 
possibly self-association.  
 
Figure 4.9 Stack plot showing the 1H NMR spectrum of compound 4.2 in DMSO-d6 in the 
presence of chloride ion as tetrabutylammonium salt. 
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For host 4.3, the anion binding titration experiment was performed on chloride, 
fluoride and acetate as the tetrabutylammonium salts in DMSO-d6. Upon the addition 
of these three anions, there are no changes observed in the chemical shifts of the 
designated protons; H1 and H2 protons of imidazole and urea NH (Figure 4.10 - 4.12).  
 
Figure 4.10 Stack plot showing the 1H NMR spectrum of compound 4.3 in DMSO-d6 in the 
presence of chloride ion as tetrabutylammonium salt. 
 
Figure 4.11 Stack plot showing the 1H NMR spectrum of compound 4.3 in DMSO-d6 in the 
presence of fluoride ion as tetrabutylammonium salt. 
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Figure 4.12 Stack plot showing the 1H NMR spectrum of compound 4.3 in DMSO-d6 in 
the presence acetate ion as tetrabutylammonium salt. 
 
From the titration data, there could be a few possible reasons why the imidazole CH, 
H1 and H2 as well as urea NH3 and NH4 of compound 4.3 are not affected by the 
addition of Cl¯, F¯ and OAc¯ ions. One of the plausible reason might be that compound 
4.3, may form a carbonate complex, in which the carbonate ion from cesium carbonate 
hydrogen bonds with the urea moieties of compound 4.3. The presence of the carbon 
signal of a carbonate can be seen in the 13C NMR spectrum of compound 4.3 at 206.9 
ppm. Similar hydrogen bonds between urea NH and carbonate ion have been reported 
previously,30 in which the carbonate ion was encapsulated tightly in a cavity of tripodal 
hexaurea receptor by strong 12 NH···O bonds (dNH···O = 2.703(3) – 2.989(3) Å) from 12 
NH groups of urea units (Figure 4.13). The use of competitive solvent DMSO for the 
titration also could contribute to the low binding affinity of the host towards Cl¯, F¯ 
and OAc¯ ions. 
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Figure 4.13 Single-crystal X-ray structure of the carbonate complex of tripodal hexaurea  
                  receptor (countercations and hydrogen atoms on carbons are omitted for clarity). 
Reproduced with permission from reference 31. 
 
Another reason that could contribute to the non-interaction between compound 4.3 
with all of the aforementioned anions is compound 4.3 might self-assemble and form a 
dimer that is interconnected by hydrogen bonds between the urea NH with the 
carbonyl group that subsequently leads to the formation of a molecular capsule or belt 
as reported previously by Shimazu and Yamanaka (Figure 4.14).31 
 
 
Figure 4.14 Formation of a discrete dimer of C3-Symmetric tris-urea in less polar solvent, 
chloroform through self-assembly, whereas in the more polar acetonitrile and acetone a 
supramolecular gel was obtained. Reproduced with permission from reference 32. 
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4.2.3 Synthesis and characterisation of mesitylcalixarene-based compounds  
 
Flexible receptors using a mesitylcalixarene core have also been synthesised. Firstly, the 
precursor, mesityl calix[4]arene (4.4) was prepared in good yield by self-condensation of 
-chloro isodurene in the presence of SnCl4 as the catalyst. Next, bromomethylation of 
4.4 to afford tetrakis-p-bromomethylated mesityl calix[4]arene (4.5) scaffold was 
achieved in a single step using a simplified version of the literature procedure32,33 as 
depicted in Scheme 4.2. 
 
Scheme 4.2  Bromomethylation of mesityl calix[4]arene. 
 
 
In order to synthesise the ditopic anion receptor compounds, the scaffold, 4.5 was 
reacted with a slight excess of imidazole urea ligands with butyl chain (2.1) by adapting 
the procedure described by Willans and co-workers32 with some modification on the 
reaction temperature and solvent used (Scheme 4.3). 
 
 
Scheme 4.3 Synthesis route of compound 4.6 using excess ligand as the base. 
 
ESI-MS confirmed the formation of compound 4.6, from molecular ion peaks of 473.47 
that corresponds to ((M/3)+3H+)3+. The reaction was monitored using ESI-MS and even 
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after 24 hours of reaction, the conversion of the reactants to the product was very low, 
<20%. This low conversion could be due to the use of only a slight excess of ligands 
that was not enough to deprotonate the NH proton of imidazole to allow the reaction 
to take place. This method is problematic due to the need of using a very large excess 
of ligands to afford higher yield, which is not cost effective. In addition, the product, 
4.6 was only soluble in polar solvents such as methanol, DMSO and DMF. Attempts to 
purify the compound have been performed by recrystallisation from nitromethane, 
acetonitrile and a range of solvents, but a pure compound still could not be obtained. 
Attempts to purify the compound using membrane dialysis were also were 
unsuccessful due to decomposition after overnight stirring in the dialysis membrane. 
Therefore, another compound 4.7 with a longer alkyl chain, was synthesised in order 
to improve the solubility of the product and for this purpose, instead of using excess 
ligands, another base, caesium carbonate was introduced to aid in the deprotonation 
of the NH group of the imidazole (Scheme 4.4). However, due to the insolubility of the 
caesium carbonate in the organic solvent, the reaction time was prolonged to 48 hours 
with constant stirring at 60 ⁰C. 
 
Scheme 4.4 Synthesis route of compound 4.7 using caesium carbonate as base. 
 
A beige-coloured precipitate formed after the reaction at reasonable yield (52 %), but 
unfortunately, the product obtained cannot be characterised by solution NMR 
spectroscopy due to the insolubility of the product in most organic solvents including 
DMSO and DMF. A solid state NMR experiment was carried out to attempt to identify 
the target compound, but unfortunately the CH2 signal that connects the tripodal core 
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with ligand 2.2 was not observed thus we cannot confirm the formation of compound 
4.7. In order to improve the solubility of compound 4.7, an attempt to modify the 
structure was performed by reacting compound 4.7 with excess methyl iodide to give 
the methylated imidazolium derivative. Methyl iodide was added to a methanol 
solution containing compound 4.7 at 0 ⁰C, and then solution was stirred and heated to 
40 °C for 2 hours to afford compound 4.8 (Scheme 4.5). After compound 4.8 was 
isolated, a metathesis reaction with potassium hexafluorophosphate (KPF6) was 
carried out to exchange the iodide ion with less coordinating hexafluorophosphate ion 
to obtain compound 4.9 (Scheme 4.5). 
 
Scheme 4.5 Reaction of compound 4.7 with excess CH3I and subsequent metathesis reaction 
with KPF6 in methanol. 
 
Although the final product, 4.9, shows better solubility in DMSO and DMF, it remains 
insoluble in less polar solvents such as acetone and acetonitrile. However, ESI-MS 
analysis does not prove the formation of this compound as there are no molecular ion 
peaks that correspond to compound 4.9. The 1H NMR spectrum of compound 4.9 also 
show a mixture of broad signals that makes the characterisation difficult. Hence, it is 
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concluded that the attempt to modify the structure of compound 4.7 was unsuccessful 
and further work on these series was not carried out. 
 
4.2.4 Anion binding studies of host 4.6 
 
Host 4.6 is only soluble in polar solvents such as alcohols, DMF and DMSO, therefore 
for host 4.6, anion binding titration experiments were performed with fluoride, nitrate, 
chloride and acetate ion as tetrabutylammonium salts in dimethylsulfoxide. From the 
1H NMR titration spectra of host 4.6 with chloride, it is observed that there were no 
significant changes on the chemical shift of Imidazole protons, H1 and H2 as well as 
urea protons, H3 and H4 (Figure 4.15 and 4.16). The possible explanation might be due 
to the competitiveness of DMSO solvent. 
 
Figure 4.15 Stack plot showing the 1H NMR spectrum of compound 4.6 in DMSO-d6 in the 
presence of chloride ion as tetrabutylammonium salt. 
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Figure 4.16 Stack plot showing the 1H NMR spectrum of compound 4.6 in DMSO-d6 in the 
presence of nitrate ion as tetrabutylammonium salt. 
 
In contrast, the addition of 0.2 equivalent of acetate ion (as NBu4+ salt) results in the 
splitting of H1 and H2 signal at almost the same ratio (Figure 4.17), possibly due to the 
interaction of acetate with only one out of the two binding pockets. 
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Figure 4.17 Stack plot showing the 1H NMR spectrum of compound 4.6 in DMSO-d6 in 
the presence of acetate ion as tetrabutylammonium salt. 
 
From the X-ray crystal structure of ligand 2.1 discussed in Chapter 2, it is shown that 
the imidazole nitrogen can form self-complementary hydrogen bonding with NH of the 
other imidazole. There is a possibility that the presence of imidazole moiety in this 
compound might result in the formation of an array of self-complementary hydrogen 
bonds that is strong enough and resistant to anion binding. In order to probe the role 
of self-complementarity in host 4.6, titration of host 4.6 with zinc(II) nitrate, zinc(II) 
chloride and zinc(II) acetate was undertaken. The presence of zinc ions will disrupt the 
NH…N hydrogen bond and leave the imidazole protons free to interact with the anion 
guest. The first titration was performed using zinc(II) nitrate in dimethylsulfoxide. The 
addition of 0.6 equivalent of zinc(II) nitrate results in small changes in the chemical 
shift of imidazole protons, H1 (Δ 0.14 ppm) and H2 (Δ 0.06 ppm). The downfield 
shift of H1 signal is due to the hydrogen bonding interaction with the oxygen atom of 
the nitrate ion, decreasing the electron density around the H1 proton (Figure 4.18).34  
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Figure 4.18 Stack plot showing the 1H NMR spectrum of compound 4.6 in DMSO-d6 in the 
presence of increasing equivalents of zinc(II) nitrate. 
 
On the other hand, the titration experiment of host 4.6 with zinc(II) chloride and 
zinc(II) acetate was performed in a less competitive solvent, DMF-d7. From the 1H NMR 
spectrum (Figure 4.19), the addition of up to 1.0 equivalent of zinc(II) chloride results 
in the downfield shift of imidazole proton H1 and H2 from 8.98 and 7.61 ppm to 9.31 
and 7.76 ppm, respectively. This result is in contrast to the titration experiment of host 
4.6 with tetrabutylammonium chloride. The pronounced changes in the chemical shifts 
suggest that the zinc might coordinate to the imidazole nitrogen atom and the counter 
chloride ion of the zinc salt is forming hydrogen bonding with the H1 proton of the 
imidazole.  
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Figure 4.19 Stack plot showing the 1H NMR spectrum of compound 4.6 in DMF-d7 in 
the presence of zinc(II) chloride 
 
Titration of host 4.6 with zinc(II) acetate has also been performed in DMF-d7. This 
titration experiment shows a more complex binding pattern in comparison to the 
titration with zinc(II) nitrate and zinc(II) chloride (Figure 4.20). The addition of 0.2 
equivalent of zinc(II) acetate results in the upfield shift of the imidazole proton H1 and 
H2 as well as urea NH, H3 and H4. Subsequent addition of 0.8 equivalent of zinc(II) 
acetate results in the disappearance of H1 and H3 signals. On the other hand, addition 
of 0.8 equivalent of zinc(II) acetate cause the broadening of H2 signal that eventually 
emerges as a sharp peak after the addition of more than 1.0 equivalent of zinc(II) 
acetate. It is suggested that the disappearance of the H1 and H3 proton signals may be 
due to deprotonation or slow kinetics of anion exchange on the NMR timescale.11 The 
titration data with zinc(II) acetate is atypical and clearly indicative of more than one 
binding process. 
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Figure 4.20 Stack plot showing the 1H NMR spectrum of compound 4.6 in DMF-d7 in 
the presence of zinc(II) acetate. 
 
4.3 Summary 
 
A series of tripodal hosts, 4.1 – 4.3 have been synthesised from the reaction of 
tribromotriethylbenzene with respective imidazole urea ligands, 2.2, 2.3 and 2.4. 1H 
NMR titration experiment of host 4.2 with fluoride, chloride and acetate ion (as NBu4+ 
salt) has been performed. The addition of fluoride and acetate induced colour changes 
of the solution from yellow to pink, suggesting the deprotonation of imidazole protons, 
H1 and H2 by these strong basic anions. These findings are in contrast to the anion 
titration experiment performed on the free ligand 2.3 in chloroform in which upon the 
addition of the anions, the signals that are perturbed are urea N-H, H3 and H4. The 
addition of chloride ion to the solution of host 4.2 in DMSO does not impart any effect 
on the chemical shifts of all the designated proton signals, H1, H2 as well as urea N-H. 
Similar results were obtained in the titration experiment of host 4.3 on 
tetrabutylammonium chloride and tetrabutylammonium acetate. These findings 
suggest that this system might not be a suitable system for anion sensing, at least not 
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in a competitive solvent. It is envisaged that the presence of imidazole moiety, which 
can form a hydrogen-bonded network might inhibit the interaction of anions with the 
urea group. However, without more structural information, it is not possible to 
accurately assign the mechanism of this interaction. A mesitylcalixarene-based host 
4.6, has also been synthesised and its interaction with chloride, acetate and nitrate 
ions has been investigated. The 1H NMR titration experiment was carried out using two 
different conditions; the first condition is the titration experiment is performed using 
tetrabutylammonium salts of chloride, acetate and nitrate whereas, in the second 
condition, the tetrabutylammonium salts were replaced with zinc(II) chloride, zinc(II) 
acetate and zinc(II) nitrate. It is found that, without the presence of zinc metal, no 
interaction was observed between the designated protons with the anions. However, 
when zinc(II) salts were used, there are some changes in the chemical shift of 
imidazole and urea protons. The plausible explanation for this result could be due to 
the coordination of zinc to the imidazole nitrogen atom, hence disrupting the 
hydrogen-bonding network form by the imidazole moiety.    
 
4.4 Experimental 
 
All solvents used in the synthesis and purification were of analytical reagent grade. 
Anhydrous solvents were prepared on an SPS solvent purification system. Commercial 
reagents were used as supplied, without further purification.  
 
4.4.1 General Procedure for 1H NMR spectroscopic experiments 
 
1H-NMR spectroscopic titration experiments were carried out using Varian Mercury 
400 spectrometer running at 400 MHz, at room temperature. All chemical shifts are 
reported in ppm. A specific concentration of host was made up in a single NMR tube in 
the desired deuterated solvent (0.5 mL). The anions, as their tetrabutylammonium 
salts, were made up to 1 mL, 5 times the concentration of the host, with the desired 
deuterated solvent. 10 μL aliquots of the guest were added to the NMR tube and the 
spectra were recorded after each addition.  
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4.4.2 Instrumentation 
 
All NMR spectra were obtained from a Bruker Avance 400 at a frequency of 400 MHz 
for 1H and 100 MHz for 13C, while 1H-1H COSY, 1H-13C HSQC and 1H-13C HMBC spectra 
were obtained from a Varian INOVA 500 spectrometer at a frequency of 500 MHz for 
1H and 125 MHz for 13C. All chemical shifts are reported in parts per million (δ) relative 
to tetramethylsilane as an internal reference. Electrospray ionisation (ESI) mass 
spectrometry was recorded on a TQD mass spectrometer instrument. Fourier 
transform infrared spectra were recorded with a Perkin Elmer Spectrum 100 FT-IR 
spectrometer in which for each spectrum, 64 scans were conducted over a spectral 
range of 4000 to 600 cm-1 with a resolution of 4 cm-1. Elemental analysis was 
performed using an Exeter Analytical CE-400 Elemental Analyser.  
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4.4.3 Synthesis of compounds 
 
4.4.3.1 Synthesis of compound 4.1 
 
 
1,3,5-tribromo-2,4,6-triethylbenzene (0.66 g, 1 mmol) and 1-[2-(1H-imidazol-4-
yl)ethyl]-3-(octyl)urea, 2.2 (1.0655 g, 4 mmol) were added to a flask and dissolved in 
dry tetrahydrofuran (50 mL). The solution was stirred and heated to reflux at 60 °C for 
24 hours resulting in a brown sticky oil. The solvent was removed while it is still warm 
and the sticky oil was evaporated to dryness. Unoptimised yield = 0.28 g, 0.24 mmol, 
25 %.1H NMR: δH (400 MHz; CDCl3; Me4Si) 8.94 (3 H, s, H4), 7.38 (3 H, s, H5), 6.00 (3 H, 
t, J 5.6, H8), 5.92 (3 H, t, J 5.6, H9), 5.35 (6 H, s, H3), 3.26 (6 H, m, H6), 3.21 (6 H, q, H7), 
2.70 (6 H, t, J 7.1 H10), 2.47 (6 H, t, J 5.6, H2), 1.20 (36 H, m, H11-H16), 0.81 (18 H, t, J 
8.0, H1 & H17). 13C NMR: δC {1H} (101 MHz; CDCl3) 158.44 (Ck), 147.01 (Cf), 135.28 (Cg), 
134.11 (Ch), 131.83 (Cd), 116.46 (Cc), 47.26 (Ce), 39.80 (Cj), 31.68 (Ci), 30.39 (Cb), 
29.12 (Cl), 26.85 (Cm), 26.05 (Co), 23.47 (Cp), 22.52 (Cq), 22.56 (Cr), 15.58 (Ca), 14.42 
(Cs). FTIR: νmax/cm-1 3102 (N-H), 1611 (C=O), 1560 (C=C imidazole ring), 1483 (C=N-C=C 
imidazole). m/z (ESI-MS) 499 [M+2H+]2+ and 1019 [M+NH4+]+. Due to the impurity of 
the sample, elemental analysis did not give usable information. 
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4.4.3.2 Synthesis of compound 4.2 
 
 
 
1,3,5-tribromo-2,4,6-triethylbenzene (0.66 g, 1 mmol) and 1-[2-(1H-imidazol-4-
yl)ethyl]-3-(dodecyl)urea, 2.3 (1.935 g, 6 mmol) were added to a flask and dissolved in 
dry tetrahydrofuran (50 mL). The solution was stirred and heated to reflux at 60 °C for 
48 hours resulting in a yellow sticky oil. The solvent was removed while it is still warm 
and the sticky yellow oil was evaporated to dryness. Unoptimised yield = 0.52 g, 0.45 
mmol, 45 %. 
1H NMR: δH (400 MHz; CDCl3; Me4Si) 7.60 (3 H, s, H4), 6.82 (3 H, s, H5), 5.86 (3 H, t, J 
5.6, H8), 5.85 (3 H, t, J 5.6, H9), 5.19 (6 H, s, H3), 3.23 (6 H, m, H6), 3.14 (6 H, q, H7), 
2.91 (6 H, t, J 7.1 H10), 2.65 (6 H, t, J 5.6, H2), 1.22 (36 H, m, H11-H20), 0.83 (18 H, t, J 
8.0, H1 & H21). 
13C NMR: δC {1H} (101 MHz; CDCl3) 158.41 (Ck), 146.82 (Cf), 136.08 (Cg), 134.46 (Ch), 
133.02 (Cd), 116.87 (Cc), 45.20 (Ce), 39.01 (Cj), 31.74 (Ci), 30.43 (Cb), 29.50 (Cl), 29.46 – 
22.52 (Cm-Cv), 15.55 (Ca), 14.38 (Cw). FTIR: νmax/cm-1 3104 (N-H), 1670 (C=O), 1600 
(C=C imidazole ring), 1448 (C=N-C=C imidazole). m/z (ESI-MS) 583 [M+2H+]2+ and 1187 
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[M+Na+]+. Due to the impurity of the sample, elemental analysis did not give usable 
information. 
4.4.3.3 Synthesis of compound 4.3 
 
 
1-[2-(1H-imidazol-4-yl)ethyl]-3-(p-tolyl)urea, 2.4 (1.935 g, 3 mmol) and cesium 
carbonate ( 0.977 g, 3 mmol) were mixed and stirred for 2 hours at 40°C in dry 
tetrahydrofuran (50 mL). Then, a THF solution of 1,3,5-tribromo-2,4,6-triethylbenzene 
(0.66 g, 1 mmol) were added to the reaction mixture. The solution was stirred and 
heated to reflux at 60 °C for 48 hours resulting in a white solid. After 48 hours reaction, 
the solvent was removed and the white precipitate was washed with water (20ml x 3) 
and acetone (20ml x 3) to remove excess caesium carbonate. The white precipitate 
was then dried in the desiccator. Unoptimised yield = 0.38 g, 0.41 mmol, 41 %. 
1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 8.78 (3 H, s, H4), 8.06 (3 H, d, J 1.1, H5), 7.25 
(6 H, m, H10), 6.96 (6 H, m, H11), 6.66 (3 H, d, J 1.1, H9), 5.53 (3 H, t, J 5.7, H8), 5.36 (6 
H, s, H3), 3.09 (6 H, s, H6), 2.48 (6 H, s, H7), 2.06 (6 H, s, H2), 0.94 (18 H, t, J 5.7, H1 & 
H12).  
13C NMR: δC {1H} (101 MHz; DMSO) 156.03 (Ck), 138.24 (Cf), 130.28 (Cd, Ch and Cc), 
129.37 (Cl), 118.08 (Cm), 37.37 (Ce), 31.13 (Ci), 25.17 (Cj), 20.71 (Cb), 15.96 (Cn & Ca). 
FTIR: νmax/cm-1 3120 (N-H), 1610 (C=O), 1570 (C=C imidazole ring), 1458 (C=N-C=C 
imidazole). Due to the impurity of the sample, elemental analysis did not give usable 
information. 
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4.4.3.4 Synthesis of Mesityl calix[4]arene 4.4 
 
 
Under a constant stream of N2, SnCl4  (0.7 mL, 2.69 mmol) was added to a solution of α-
chloroisodurene (5.0g, 39 mmol) in dry CH2Cl2 (50 mL). The mixture was stirred and 
heated under reflux at 62 °C for 2h, resulting in a colour change from colourless to red 
and subsequent formation of white precipitate. The solution mixture was then 
hydrolysed and extracted with two portions of CH2Cl2 (25mL each). Both layers were 
separated using separatory funnel and the white precipitate obtained was filtered and 
dried under vacuum. The pure product was recrystallised from CH2Cl2 and ethyl 
acetate. Yield = 4.67 g, 31.9 mmol, 82 %. 1H NMR: δH (400 MHz; CDCl3; Me4Si) 6.84 (4 
H, s, H4), 3.93 (8 H, s, H1), 2.38 (24 H, s, H2), 1.23 (12 H, s, H3) 13C NMR: δC {1H} (101 
MHz; CDCl3) 137.63 (Cc), 135.91 (Cd), 133.24 (Ca), 130.33 (Cb), 31.93 (Ce), 21.43 (Cf), 
17.96 (Cg). FTIR: νmax/cm-1 2967 (CH aromatic ring), 1471 (C=C aromatic ring), m/z (ESI-
MS) 551.35 [M+Na]+. Elem. Anal. Calc. (%) (C40H48) C, 90.89; H, 9.10; Found (%): C, 
90.08, H, 9.01%. 
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4.4.3.5 Synthesis of Tetrakis-p-bromomethylated mesityl calix[4]arene 4.5 
 
 
A mixture of 0.5 molar equivalent (to calixarene) of zinc and HBr (33% in acetic acid) 
(2mL) was stirred and heated in glacial acetic acid (20 mL) until the zinc was fully 
dissolved. To this solution mixture, mesityl calix[4]arene (4.4) (0.53g, 1.00 mmol), 
paraformaldehyde (1.5 g, 51.7 mmol), and HBr (33% in acetic acid) (10 mL) was added 
slowly and heated to reflux for 48 h at 90 ºC. White precipitate formed was filtered and 
washed thoroughly with water (25 mL), diethyl ether (25 mL) and again with water (25 
mL) then dried under vacuum. Yield = 0.76 g, 0.85 mmol, 85 %.1H NMR: δH (400 MHz; 
CDCl3; Me4Si) 4.66 (8 H, s, H3), 4.04 (8 H, s, H1), 2.47 (24 H, s, H2), 1.11 (12 H, s, H4)  13C 
NMR: δC {1H} (101 MHz; CDCl3) δC {1H} (101 MHz; CDCl3) 138.06 (8 C, Cc), 136.61 (4 C, 
Cd), 133.25 (8 C, Ca), 131.88 (4 C, Cb), 32.94 (4 C, Ce), 20.65 (4 C, Ch), 18.73 (4 C, Cg), 
16.70 (4 C, Cf). FTIR: νmax/cm-1 2938 (CH aromatic ring), 1448 (C=C aromatic ring). m/z 
(ESI-MS) 923.3 [M+Na]+. Elem. Anal. Calc. (%) (C44H52Br4) C, 58.69; H, 5.82; Found (%): 
C, 57.9, H, 5.83%. 
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4.4.3.6 Synthesis of compound 4.6 
 
 
 
Compound 4.5 (0.50 g, 0.55 mmol) and 1-[2-(1H-imidazol-4-yl)ethyl]-3-(butyl)urea, 2.1 
(0.53 g, 2.55 mmol) were added to a flask and dissolved in dry tetrahydrofuran (50 
mL). The solution was stirred and heated to reflux at 60 °C for 24 hours resulting in a 
yellow sticky precipitate. The precipitate was filtered, washed with tetrahydrofuran (3 
x 25 mL) and and dried under vacuum to give the imidazole tetrapod. Unoptimised 
yield = 1.92 g, 1.35 mmol, 61%. 
1H NMR: 8.88 (4 H, s, H1), 7.38 (4 H, s, H3), 5.97 (4 H, t, J 5.9,  H6), 5.90 (4 H, t, J 5.7, 
H7), 3.60 (8 H, m, H2), 3.29 (8 H, dt, H5), 2.96 (8 H, dt, H8), 2.73 (8 H, t, J 6.8,  H4), 2.33 
(24 H, s, H12), 1.76 (8 H, m, H13), 1.32 (8 H, m, H9), 1.25 (8 H, m, H10), 0.84 (12 H, t, J 
7.1, H11)  13C NMR: δC {1H} (101 MHz; DMSO-d6) 163.85 (4 C, Cf), 136.98 (4 C, Ca), 
120.96 (4 C, Ck), 72.48 (4 C, Cc), 43.31 (4 C, Cd), 37.16 (8 C, Ce and Cg), 31.10 (4 C, Cl), 
30.30 (4 C, Cj), 24.75 (8 C, Ch and Ci), 18.69 (4 C, Cm) FTIR: νmax/cm-1 3302 and 2956 
(NH), 1632 (CO), 1555 (imid. ring). m/z (ESI-MS) 1439.9 [M+Na]+, 731.7 [(M/2)+2Na+]2+, 
473.6 [(M/3)+3H+]3+. Due to the impurity of the sample, elemental analysis did not give 
usable information. 
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Chapter 5  
Ruthenium-based tripodal anion hosts 
 
5.1 Background and Project Aims 
 
In recent years, there has been an increasing interest in the use of transition metal ions 
as sensing and structural elements in the design of supramolecular hosts for anions.1–5 
The main reason is due to the diversity of their geometries, redox activities, 
photophysical activities and their ability to act as Lewis acids.6 Metal-based receptors 
can offer a combination of electrostatic attraction coordination and hydrogen bonds to 
interact with guest molecules or ions. Hydrogen bond donor unit such as O-H and N-H 
group are often incorporated into the metal-based receptors to permit the sensing of 
the anions. The presence of metal as a core unit can enhance hydrogen bond donor 
ability owing to its electron withdrawing characteristics, hence increase the strength of 
host-guest interaction.7  
 
The use of capping ligands has been extensively studied in the design of bipodal and 
tripodal anion sensors incorporating a metal scaffold. For instance, anion receptors 
having an (arene)ruthenium(II) core, 1.80 reported by Mishra and co-workers, also 
comprises a bis-pyridine amide ligand as a hydrogen-bonding unit.8 This ruthenium-
based metallabowl shows high selectivity and sensitivity for carboxylates such as 
oxalate, tartrate and citrate in methanol with binding constants of 4 x 104 M-1, 5 x 104 
M-1 and 5.5 x 104 M-1, respectively. In other work, Dickson and co-workers have prepared 
semilabile (arene)ruthenium(II) piano stool type complexes (1.62a - 1.62c), consisting of 
pyridine amine as the anion recognition unit.9 These coordination compounds are able 
to coordinate to selected anions and can potentially be explored as fluorescent anion 
sensors. However, the use of aromatic p-cymene group as the capping ligand can lead 
to the formation of [ML2X]+ dipodal complex instead of forming fully tri-substituted 
[ML3]2+ as desired and the ruthenium arene bond can be subject to solvolysis. 
 
Hence, the limitation of p-cymene group has directed further research work on the use 
of another capping ligand, for instance, 1,4,7-trithiacyclononane ([9]ane-S3) which was 
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used extensively in this study. This capping ligand is a better choice than p-cymene as it 
can retain the octahedral nature of the Ru(II) core, with 90° angle between the ligands, 
which has been demonstrated by Todd and co-workers in their work.10 The ruthenium(II) 
complexes reported, 5.1-5.5 function as supramolecular receptors for anions via three 
tripodally arranged 3-aminopyridine ligands. Of all the receptors synthesised, receptor 
5.5 shows the highest affinity for anions as 5.5 contains a urea moiety that can form two 
hydrogen bonds with anions. Overall, all the tripodal receptors show a better affinity 
towards anions in comparison with metal complex with single pyridyl ligand 5.6,11 a 
reflection of the multiple binding groups and positive charge. 
  
 
The use of this ([9]ane-S3)Ru(II) core to allow the synthesis of tripodal receptors of well-
defined geometry has been proved successful in previous work.10,12,13 Hence, our aim is 
to synthesise tripodal receptors incorporating ([9]ane-S3)Ru(II) as the core unit and 
imidazole urea as the anion binding functionality, investigate their interaction with 
various anions and compare their anion binding interaction with the free ligands (as 
discussed in Chapter 2) and previously reported tripodal receptors.  
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5.2 Results and discussion 
 
5.2.1 Synthesis of the ruthenium complexes of imidazole urea  
 
The [9]ane-S3-capped ruthenium precursor was successfully synthesised by reacting 
[RuCl2(DMSO)4] with the thioether ring, in which the former was obtained from the 
reaction between RuCl3 and DMSO as described in the literature.10 Metathesis of the 
counter anions from chloride to hexafluorophosphate or triflate was achieved through 
the addition of silver salts (e.g AgPF6 or AgCF3SO3) and subsequent removal of the 
precipitated AgCl, and was carried out prior the addition of the receptor ligands 2.1, 2.3 
and 2.4 (Scheme 5.1).  
 
Scheme 5.1 Synthesis route of ruthenium(II) complexes of imidazole urea. 
 
The first attempt to synthesise these Ru(II) complexes was carried out by the addition 
of ligand 2.1 to the solution of the precursor under continuous nitrogen stream with the 
metal core to ligand ratio of 1:3. The solution mixture was then constantly stirred and 
heated under reflux in ethanol:water (4:1) for 18 hours. However, the attempt was not 
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successful as the resulting complex was not fully (triply) substituted by the imidazole 
urea ligands as proven by 1H NMR spectroscopy. The second attempt to synthesise 
complex 5.1 was made by extending the reaction time to 6 days with other conditions 
such as metal to ligand ratio and reaction temperature remaining the same. Complex 
5.1 was obtained as a brown viscous oil after multiple recrystallisations with different 
solvents. ESI-MS analysis of complex 5.1 shows a molecular ion peak of 456.6 m/z due 
to the loss of two moles of hexafluorophosphate ions, [(M-2PF6)]2+. The formation of 
complex 5.1 has also been confirmed by High Resolution Mass Spectrometry in which 
the data obtained is in agreement with the expected positive ion mass of complex 5.1, 
[(M-2PF6)+ H+]+2   (Figure 5.1). 
 
 
Figure 5.1 High Resolution Mass Spectrometry data for complex 5.1. 
 
The brown viscous oil was then subjected to Preparative HPLC to obtain the pure triply 
substituted ruthenium(II) complex. The 1H NMR spectrum of complex 5.1 obtained after 
HPLC shows a mixture of doubly and triply substituted ruthenium(II) complex. Even after 
the longer reaction time and purification steps, the pure, fully tri-substituted complex 
was not successfully obtained. Complex 5.1 dissolves in polar solvents such as alcohols, 
DMSO and DMF but not soluble in less polar solvents such as acetonitrile and acetone.  
Therefore, to address the solubility problem of this receptor, we introduced a urea unit 
with a longer chain, in the form of ligand 2.3. The synthesis of complex 5.2 using ligand 
2.3, was carried out in the same manner as complex 5.1, except that ligand 2.3 is used 
in slight excess, with metal to ligand ratio of 1:4 to ensure the complete substitution by 
ligand 2.3. The use of the slight excess of the ligands has directed the reaction in 
producing only tri-substituted complex as proved by 1H NMR spectroscopy. However, as 
excess ligands were introduced, the product formed, complex 5.2 was not easily 
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separated from the excess ligands as both the products and the reactants show similar 
solubility. Nevertheless, complex 5.2 was purified through column chromatography 
using alumina as the stationary phase and gradient eluent system starting from diethyl 
ether: methanol (9:1) up to 100% methanol to afford light yellow solid with an 
unoptimised yield of 62%. Despite the introduction of ligand 2.3 with a longer chain, the 
solubility of complex 5.2 was similar to complex 5.1; insoluble in less polar solvents such 
as acetonitrile and acetone but soluble in highly polar solvents such as alcohols, DMSO 
and DMF. The formation of complex 5.2 has been confirmed by two characteristic mass 
peaks of 625.5 correspond to [(M-2PF6) + H+]+3. The formation of compound 5.2 has also 
been confirmed using High Resolution Mass Spectrometry as in Figure 5.2. 
 
Figure 5.2 High Resolution Mass Spectrometry data for complex 5.2. 
 
Another ruthenium(II) complex (5.3) with aromatic substituents, using ligand 2.4 has 
also been prepared. This complex was synthesised for the purpose of comparison with 
complex 5.2 in terms of the anion binding properties. The synthesis of complex 5.3 was 
carried out using the same procedure as in the synthesis of complex 5.2, except that 
complex 5.3 bears triflate ions as counter ions. Complex 5.3 was obtained as a brown 
solid with an unoptimised yield of 68%. Complex 5.3 has been purified from fractional 
crystallisation from acetonitrile and nitromethane. Similarly, complex 5.3 shows a 
characteristic mass peak of 507.15 m/z which corresponds to the loss of two moles of 
triflate ions, [(M-2CF3SO3)]2+. The formation of complex 5.3 has also been confirmed by 
High Resolution Mass Spectrometry in which the data obtained is in agreement with the 
expected positive ion mass of complex 5.3, [(M-2 CF3SO3)+ H+]+2 (Figure 5.3). 
186 
 
 
Figure 5.3 High Resolution Mass Spectrometry data for complex 5.3. 
 
The complexes 5.1 – 5.3 show many similarities in the 1H NMR spectra to that of the 
ligands 2.1, 2.3 and 2.4, respectively. Coordination of the imidazole urea ligand 2.3 and 
2.4 to the ruthenium center causes an upfield shift of proton H1 (Δ 0.26 ppm for 
complex 5.2 and Δ 0.15 ppm for complex 5.3) and H3 (Δ 0.35 ppm for complex 5.2 and 
Δ 0.15 ppm for complex 5.3) of the imidazole region in both complexes, compared to 
the free uncoordinated ligand. However, in complex 5.1, the shift in the resonance of 
proton H1 and H3 cannot be determined accurately due to the presence of impurities in 
the sample. Additionally, the 13C NMR spectra of complexes 5.1 and 5.2 show a general 
downfield shift for the imidazole carbon indicating coordination occurs via the nitrogen 
atom of the imidazole moiety. The shift in the signals of the designated protons and 
carbon possibly indicating that the face-capping ligand has an impact on the 
spectroscopic properties of the complexes.  
 
On the other hand, the chemical shifts for the [9]aneS3 ligand in all complexes observed 
between δ = 2.55 and 2.71 ppm are in agreement with previous work.10 However, it is 
difficult to determine whether there are multiple sets of peaks for the thioether group 
as the peaks for the [9]aneS3 macrocyclic ring of all the complexes are of second order 
which overlapping with each other resulting in lower value of J-coupling. 
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In addition, the FTIR data of all the complexes also provides some valuable information 
on the changes after the complexation reaction. For instance, the hydrogen bonding in 
the ligands and complexes can be compared by observing the v(NH) stretch. For all the 
complexes, the v(NH) stretch is shifted towards higher energy upon complexation with 
ruthenium(II) in comparison to the respective ligand. This indicates that the hydrogen 
bonding between the urea moieties and imidazole groups is weakened upon 
coordination to the ruthenium(II) as the coordination inhibits inter-ligand interactions.  
Table 5.1 shows some of the important stretching vibrations observed for free ligands, 
2.1, 2.3 and 2.4 in comparison to their respective ruthenium(II) complexes.  
 
Table 5.1 Selected FTIR stretching vibrations of free imidazole urea ligands (2.1, 2.3 and 2.4) in 
comparison to their ruthenium(II) complexes. 
 
Entry Compounds Selected FTIR stretching vibrations 
ν (N-H) ν (C=O) ν (C-H 
imidazole ring) 
ν (C=N-C=C) 
imidazole 
1 Free ligand 2.1 3290 1650 1564      1454 
2 Complex 5.1 3376 1644 1568 1464 
3 Free ligand 2.3 3309 1611 1570     1450 
4 Complex 5.2 3332 1621 1573 1462 
5 Free ligand 2.4 3304  1633 1558 1448 
6 Complex 5.3 3337 1637 1559 1451 
 
For all complexes 5.1 – 5.3, purification was problematic due to the similar solubilities 
of the complexes and the unbound ligand. While complex 5.1 has been purified using 
preparative HPLC, complex 5.2 was only purified through column chromatography using 
alumina as the stationary phase and gradient eluent system starting from diethyl ether: 
methanol (9:1) up to 100% methanol. On the other hand, complex 5.3 has been purified 
by fractional crystallisation from acetonitrile and nitromethane. However, traces of 
impurities can still be found by elemental analysis and NMR spectroscopy even after 
188 
 
column chromatography and multiple recrystallisations have been carried out. None of 
the complexes is soluble in less polar solvent such as acetone and acetonitrile although, 
in the case of complex 5.3, a dodecyl chain has been introduced to enhance the solubility 
in less polar solvent. Due to the insolubility of the complexes in acetonitrile, the anion 
binding studies have been carried out in a more competitive solvent, DMSO-d6. 
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5.2.2 Anion binding properties of the ruthenium(II) complexes of imidazole urea 
 
In order to assess the anion-binding properties of this family of metal-based receptors 
(5.2 and 5.3), binding studies were conducted using 1H-NMR spectroscopic titration 
experiments in a more competitive solvent, DMSO-d6 due to the insolubility of these 
two complexes in a less competitive solvent, acetonitrile. An anion binding study was 
not performed on complex 5.1 as it occurs as a viscous solid and contains a mixture of 
at least two different compounds, that cannot be separated even with the use of 
preparative HPLC. However, for complex 5.2 and 5.3, the presence of impurities in both 
of the complexes deters the accurate determination of the binding constant.  
 
For complex 5.2, the addition of up to 1.5 equivalent of chloride ion (as NBu4+ salts) to 
the complex solution did not result in any significant changes to the chemical shifts of 
the H1 and H2 protons of the imidazole group and the urea protons NH3 and NH4. Only 
after the addition of 2 equivalent of chloride ion, the urea protons peaks start to 
broadening (Figure 5.4) possibly due to the rapid exchange upon addition of anions 
caused by rotation of the urea group about the C-N bond. This is also due to the use of 
a more competitive solvent, DMSO-d6 that competes in the hydrogen bonding formation 
of the anions to the hosts. In comparison, as detailed in the previous Chapter 2, it has 
been shown that the free ligand 2.3 forms a hydrogen bond upon titration with chloride 
ion in chloroform solvent although the binding constant was not accurately determined 
due to the large error.  
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Figure 5.4 Stack plot showing the 1H NMR spectrum of complex 5.2 in DMSO-d6 in the  
presence of chloride ion as tetrabutylammonium salt. 
 
On the other hand, there was also a large degree of peak broadening observed for H1, 
H2 and urea protons, H3 and H4 in the presence of fluoride ion (as NBu4+ salt) which 
indicates that host 5.2 showed possible acid-base interactions with the highly basic 
fluoride anion (Figure 5.5). To further confirm the acid-base interaction pattern of host 
5.2, a control experiment was performed in which complex 5.2 was titrated with sodium 
hydroxide solution as illustrated in Figure 5.6. The addition of sodium hydroxide results 
in severe broadening and subsequent disappearances of the imidazole protons, H1 and 
H2 as well as resonances assigned to the urea protons, NH3 and NH4. In this case, the 
disappearance of the resonances could possibly be due to the precipitation of the 
complex from the solution and also the dissociation of H+ from the urea. Since the 
titration of complex 5.2 with the fluoride ions and sodium hydroxide show the same 
pattern, it can be concluded that complex 5.2 underwent acid-base interaction with 
fluoride ions.  
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Figure 5.5 Stack plot showing the 1H NMR spectrum of compound 5.2 in DMSO-d6 in the 
presence of fluoride ion as tetrabutylammonium salt. 
 
Figure 5.6 Stack plot showing the 1H NMR spectrum of compound 5.2 in DMSO-d6 in the 
presence of NaOH. 
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Similarly, titration of complex 5.2 with acetate ion (as NBu4+ salt) shows a similar pattern 
with fluoride and hydroxide ions although the deprotonation started to be observed 
upon addition of 3 equivalent of acetate ion. The addition of 1 equivalent of acetate ion 
to the solution of complex 5.2 results in the splitting of the peaks of H1, H2, NH3 and 
NH4 signals (Figure 5.7 and 5.8). Further addition of up to 1.5 equivalent of acetate ion 
to the complex solution results in the presence of two different species at the same ratio 
as illustrated in Figure 5.9. This result is similar to the anion binding titration experiment 
of ligand 2.4 in DMSO-d6, in which the addition of basic anions like fluoride cause the 
splitting of the signals giving two different species in the solution. The species that 
respond to the acetate ion shows similar interaction pattern with free ligand 2.3 in 
DMSO-d6 as shown in Figure 5.10. Upon the addition of the acetate ion, the urea proton 
signal H3 and H4 started to move downfield and at some point merge and disappear. 
The disappearances of the H3 and H4 signal is caused by acid-base interaction between 
the NH group and acetate ions. 
 
Figure 5.7 Stack plot showing the1H NMR spectrum of compound 5.2 in DMSO-d6 in the 
presence of acetate ion as tetrabutylammonium salt. 
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Figure 5.8 The 1H NMR spectrum of compound 5.2 in DMSO-d6 in the presence of 1 equivalent 
of acetate ion as tetrabutylammonium salt. 
 
 
Figure 5.9 The 1H NMR spectrum of compound 5.2 in DMSO-d6 in the presence of 1.5 
equivalent of acetate ion as tetrabutylammonium salt. 
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Figure 5.10 Stack plot showing the 1H NMR spectrum of compound 2.3 in DMSO-d6 in the  
presence of acetate ion as tetrabutylammonium salt. 
 
A similar observation was found in the titration experiment of complex 5.2 with 
benzoate ion. Likewise, benzoate ion is basic in nature and could lead to the possible 
acid-base interaction with complex 5.2 as shown in Figure 5.11. On the other hand, the 
addition of hydrogen sulphate ion did not perturb any of the proton signals, H1-H4 of 
complex 5.2 (Figure 5.12).  
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Figure 5.11 Stack plot showing the 1H NMR spectrum of compound 5.2 in DMSO-d6 in 
the 
presence of benzoate ion as tetrabutylammonium salt. 
 
Figure 5.12 Stack plot showing the 1H NMR spectrum of compound 5.2 in DMSO-d6 in the    
presence of hydrogen sulphate ion as tetrabutylammonium salt. 
 
196 
 
 
On the other hand, the anion binding experiment also has been performed on the 
ruthenium(II) complexes (5.3) containing imidazole with an aromatic ring (ligand 2.4) to 
assess the influence of the aromatic group towards the anion binding. The titration 
experiment has been performed in DMSO-d6 due to the limitation on the solubility of 
the complex.  Similar to complex 5.2, imidazole protons, H1 and H2 as well as urea 
protons H3 and H4 were followed during the titration. For the first titration with chloride 
ion, the addition of 0.25 equivalent of chloride ion (as tetrabutylammonium salts) has 
caused the splitting of imidazole H1 and urea H3 proton signals, while the chemical shift 
of imidazole H2 and urea H4 proton signals remained unchanged (Figure 5.13). 
 
Figure 5.13 Stack plot showing the 1H NMR spectrum of complex 5.3 in DMSO-d6 in the 
presence of chloride as tetrabutylammonium salt. 
 
On the other hand, titration experiment of complex 5.3 with larger halide anions such 
as bromide and iodide (as tetrabutylammonium salt), did not result in any significant 
changes on the chemical shift of all the designated protons, H1 and H2 of imidazole 
197 
 
protons and H3 and H4 protons of urea although with the addition of excess anions, 
which were added up to three equivalents (Figure 5.14 and 5.15). 
 
Figure 5.14 Stack plot showing the 1H NMR spectrum of compound 5.3 in DMSO-d6 in the 
presence of bromide ion as tetrabutylammonium salt. 
 
Figure 5.15 Stack plot showing the 1H NMR spectrum of compound 5.3 in DMSO-d6 in the  
                        presence of iodide ion as tetrabutylammonium salt. 
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Titration experiments of complex 5.3 with different types of basic anions such as 
fluoride, acetate, benzoate and hydrogen phosphate have also been performed in 
DMSO-d6. Figure 5.16 shows that the addition of 0.50 equivalent of fluoride ion results 
in the broadening of H1 and H3 protons while there is no change on the chemical shift 
of H2 proton. It is also observed that H4 proton has completely disappeared from the 
spectrum due to the deprotonation. 
 
Figure 5.16 Stack plot showing the 1H NMR spectrum of compound 5.3 in DMSO-d6 in the  
                        presence of fluoride ion as tetrabutylammonium salt.   
 
Likewise, the addition of acetate ion results in the downfield shift of H1 and H3 proton 
resonances (Δ 0.10 ppm) up to 3 equivalent of acetate ion. The excess amount of 
acetate ion does not cause any significant changes to the designated proton signal. In 
contrast to fluoride ion, the addition of acetate ion does not cause the disappearance of 
H4 proton signal, but instead, the peak broadened (Figure 5.17). Titration of complex 
5.3 with benzoate ion also results in the similar pattern with acetate, in which both H1 
and H3 protons shifted downfield (Δ 0.09 ppm), while H2 proton unaffected and the 
H3 proton peak broadened (Figure 5.18). The downfield shift induced by acetate and 
benzoate ions is common for urea-based receptors due to the high basicity and 
complementary Y shape of these anions with the urea group.14,15 
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Figure 5.17 Stack plot showing the 1H NMR spectrum of compound 5.3 in DMSO-d6 in the  
                        presence of acetate ion as tetrabutylammonium salt. 
 
Figure 5.18 Stack plot showing the 1H NMR spectrum of compound 5.3 in DMSO-d6 in the 
presence of benzoate ion as tetrabutylammonium salt. 
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Likewise, the addition of hydrogen phosphate ion also results in the slight downfield of 
H1 and H3 proton signals but there are no changes on the H2 and H4 signals (Figure 
5.19).  
 
 
Figure 5.19 Stack plot showing the 1H NMR spectrum of compound 5.3 in DMSO-d6 in the  
                        presence of hydrogen phosphate ion as tetrabutylammonium salt. 
 
The response of complex 5.3 towards chloride fluoride, acetate, benzoate and hydrogen 
phosphate ion is in agreement with the Hofmeister series (Table 5.2), in which weakly 
hydrated anions show more significant changes on the proton signals of the complex.16 
 
Table 5.2 The Hofmeister Series. 
 
Weakly hydrated (hydrophobic)                      Strongly hydrated(hydrophilic) 
Anions: organic anions > ClO4– > I– > SCN– > NO3– > ClO3– > Br– > Cl– >> F–, IO3– > CH3CO2–, 
CO32– > HPO42–, SO42– > citrate3– 
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5.3 Summary 
 
A series of Ruthenium(II) based tripodal hosts, 5.1 – 5.3 have been synthesised from the 
reaction of [9]ane-S3-capped ruthenium precursor with respective imidazole urea 
ligands, 2.1, 2.3 and 2.4. 1H NMR titration experiment of complex 5.2 with chloride 
fluoride, acetate, benzoate and hydrogen sulphate ions (as NBu4+ salt) has been 
performed in DMSO-d6 and host 5.2 only responds to fluoride, acetate and benzoate 
ions. In the case of fluoride, deprotonation reaction occurred after the addition of one 
equivalent of fluoride ion which later causes the disappearances of all the designated 
proton signals, H1-H4. However, in the case of the titration of complex 5.2 with acetate 
and benzoate ions, similar patterns have been observed. The addition of both anions at 
1.5 equivalent caused the splitting of all proton (H1-H4) signals into two different set at 
1:1 ratio suggesting that there might be two different species in the solution, one that 
responds to the anions, while the other does not. After 2.0 equivalent, the new set of 
the peak gradually disappeared suggesting deprotonation reaction has taken place.  
 
On the other hand, for complex 5.3, chloride is the only ion that can cause the splitting 
of the H1-H4 protons signals after the addition of 0.25 equivalents. The addition of larger 
anions such as bromide and iodide does not affect the chemical shift of complex 5.3. In 
the case of basic anions, only fluoride ion caused the disappearance of H2 proton signal 
after 0.5 equivalent of fluoride ion added. Titration with other basic anions such as 
acetate, benzoate and hydrogen phosphate does not result in any significant changes in 
the proton signals. These findings suggest that this system might not be a suitable 
system for anion sensing, at least not in a competitive solvent.  
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5.4 Experimental 
 
All solvents used in the synthesis and purification were of analytical reagent grade. 
Anhydrous solvents were prepared on an SPS solvent purification system. Commercial 
reagents were used as supplied, without further purification. 
 
5.5.1 Instrumentation and Analytical Measurements 
 
All NMR spectra were obtained from a Bruker Avance 400 at a frequency of 400 MHz for 
1H and 100 MHz for 13C, while 1H, 13C, 1 H-1 H COSY, 1H-1 C HSQC and 1H-13C HMBC 
spectra were obtained from a Varian INOVA 500 spectrometer at a frequency of 500 
MHz for 1H and 125 MHz for 13C. All chemical shifts are reported in parts per million (δ) 
relative to tetramethylsilane as an internal reference. Electrospray ionisation (ESI) mass 
spectrometry was recorded on a TQD mass spectrometer instrument. Fourier 
transforms infrared spectra were recorded with a Perkin-Elmer Spectrum 100 FT-IR 
spectrometer in which for each spectrum, 64 scans were conducted over a spectral 
range of 4000 to 600 cm-1 with a resolution of 4 cm-1. Elemental analysis was performed 
using an Exeter Analytical CE-400 Elemental Analyser.  
 
5.5.2 General Procedure for 1H NMR Spectroscopic Titrations 
All chemical shifts are reported in ppm relative to residual solvent, DMSO-d6.  A solution 
of the host species of known concentration typically 0.5-1.5mM, was made up in an NMR 
tube using the appropriate deuterated DMSO (0.5 ml).  Solutions of the anions, as TBA 
salts (1 ml) were made ten times the concentration of the host solution.  The guest 
solution was typically added in 10 μl aliquots, representing 0.25 equivalents of the guest 
with respect to the host.  Larger aliquots were used in some cases where no inflection 
of the trace was evident.  Spectra were recorded after each addition and the trace was 
followed simultaneously.   
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5.5.3 Synthesis of the ruthenium complexes 
 
Synthesis of ([9]ane-S3)RuCl2.DMSO 
In 2 ml of DMSO, RuCl3·3H2O (1.0 g, 3.8 mmol) was dissolved and heated to boiling to 
remove any water from the solution.  After the DMSO solution cooled to room 
temperature, acetone (25 ml) was added, leading to precipitation of a dark orange 
material. Filtration of this material left an orange solution which gave the desired 
RuCl2(DMSO)4 as yellow crystals upon drying.  Repeated dissolution of the dark orange 
precipitate with more DMSO/acetone with heating produced more of the yellow 
product.10  Yield 1.5 g, 3.1 mmol, 82%.  Anal. Calc. for C8H24S4O4RuCl2: C, 19.83; H, 4.99.  
Found: C, 19.84; H, 4.90. 
This RuCl2(DMSO)4 (0.48 g, 1 mmol) was then dissolved in CHCl3 (25 ml) in a round-
bottomed flask fitted with a reflux condenser.  1,4,7-trithiacyclononane ([9]ane-S3) (0.2 
g, 1.1 mmol) was added and the solution heated to reflux for 90 mins with stirring, 
leading to the precipitation of the capped ([9]ane-S3)RuCl2.DMSO as a yellow-orange 
solid.  Yield 0.36 g, 0.84 mmol, 84%.  Anal. Calc. for C8H18S4ORuCl2: C, 22.32; H, 4.21.  
Found: C, 22.05; H, 4.08. 
 
 
Synthesis of  ([9]ane-S3)Ru(1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐butyl)urea)3.2PF6¯ (5.1)  
Formation of the ([9]ane-S3)Ru(PF6)2.DMSO 
intermediate was achieved via by stirring ([9]ane-
S3)RuCl2.DMSO (0.22 g, 0.5 mmol) with silver 
hexafluorphosphate (0.25 g, 1 mmol) for 2 hours in 
methanol (100 mL) in the dark at room temperature. 
AgCl precipitate formed was removed by filtration 
through celite. The yellow filtrate was then degassed for 
2 hours before subsequent addition of 1‐[2‐(1H‐
imidazol‐4‐yl)ethyl]‐3‐(4‐butyl)urea (0.3 g, 1.5 mmol). 
The mixture was then stirred and heated to 75 ⁰C for 6 
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days. Cooling and removal of the solvent led to the formation of the crude product as 
an orange viscous liquid.   
Purification was achieved by column chromatography using alumina as the stationary 
phase and gradient eluent system starting from diethyl ether:methanol (9:1) up to 100% 
methanol. Removal of the solvent from the desired fraction resulted in the formation of 
final product as orange viscous liquid (0.39 g, 0.33 mmol, 65%).  1H NMR: δH (400 MHz; 
DMSO-d6; Me4Si) 12.64 (1 H, br s, H2), 8.47 (1 H, d, J 1.1, H1), 6.40 (1 H, s, H3), 5.84 (1 
H, t, J 5.6, H6), 5.74 (1 H, t, J 5.6, H7), 3.17 (2 H, m, H5), 3.02 ( 2 H, m, H8), 2.66-2.71 (m, 
H thioether), 2.52 (2 H, t, J 7.1 H4), 1.12 (2 H, m, H9), 1.06 (2 H, m, H10) , 0.65 (3 H, t, J 
8.0, H11). 13C {1H} NMR: δC {1H} (101 MHz; DMSO) 158.50 (Cf), 138.37 (Ca), 38.76 (Cc), 
39.36 (Cb), 32.59 (Ce and Cg), 32.53 (Cd), 26.47 – 26.24 (Thioether C), 19.95 (Ch and Ci), 
14.18 (Cj). FTIR: νmax/cm-1 3376 (NH), 1644 (CO), 1568 and 1464 (imid. ring), m/z (ESI-
MS) 456.6 [(M-2PF6)/2]2+, m/z (HRMS) 456.1 [(M-2PF6)/2]2+.   Due to the impurity of the 
sample, elemental analysis did not give usable information. 
 
Synthesis of ([9]ane-S3)Ru(1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐
dodecyl)urea)3.2PF6¯ (5.2):  
 
Formation of the ([9]ane-S3)Ru(PF6)2.DMSO intermediate was 
achieved by stirring ([9]ane-S3)RuCl2.DMSO (0.22 g, 0.5 mmol) 
with silver hexafluorophosphate (0.25 g, 1 mmol) for 2 hours in 
methanol (100 mL) in the dark at room temperature. AgCl 
precipitate formed was removed by filtration over celite. The 
yellow filtrate was then degassed for 2 hours before subsequent 
addition of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐butyl)urea ( 0.64 g, 
2 mmol). The mixture was then stirred and heated to 75 ⁰C for 6 
days. Cooling and removal of the solvent led to the formation of 
the crude product as yellow powder.  Purification was achieved 
by column chromatography using alumina as the stationary phase and gradient eluent 
system starting from diethyl ether: methanol (9:1) up to 100% methanol.  
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Removal of the solvent from the desired fraction resulted in the formation of final 
product as light yellow solid (0.48 g, 0.31 mmol, 62%). 1H NMR: δH (400 MHz; DMSO-d6; 
Me4Si) 12.77 (1 H, s, H2), 7.32 (1 H, s, H1), 6.44 (1 H, s, H3), 5.96 (1 H, t, J 5.6, H6), 5.85 
(1 H, t, J 5.6, H7), 3.06 (2 H, dt, H5), 2.79 ( 2 H, q, H8), 2.55 (m, H thioether), 2.37 (2 H, t, 
J 7.1 H4), 1.09 (20 H, m, H9-H18), 0.70 (3 H, t, J 8.0, H19). 13C {1H} NMR: δC {1H} (101 
MHz; DMSO) 158.52 (Cf), 138.37 (Ca), 130.87 (Cb), 39.78 (Cd), 32.99 (Ce), 31.73 (Cg), 
30.50 (Ch-l), 29.51 (Cm), 29.30 (Cn), 28.15 (Co), 26.87 (thioether C), 26.22 (Cp), 22.53 
(Cq), 14.37 (Cr). FTIR: νmax/cm-1 3332 (NH), 1621 (CO), 1570 and 1462(imid. ring). m/z 
(ESI-MS) 625.5 [(M-2PF6)/2]2+, m/z (HRMS) 625.2 [(M-2PF6)/2]2+. Due to the impurity of 
the sample, elemental analysis did not give usable information. 
 
Synthesis of  ([9]ane-S3)Ru(1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐methylphenyl) 
urea)3.2CF3SO3¯ (5.3):  
Formation of the ([9]ane-S3)Ru(PF6)2.DMSO 
intermediate was achieved by stirring ([9]ane-
S3)RuCl2.DMSO (0.22 g, 0.5 mmol) with silver 
trifluoromethanesulphonate ( 0.26 g, 1 mmol) for 2 
hours in methanol (100 mL) in the dark at room 
temperature. AgCl precipitate formed was removed 
by filtration over celite. The yellow filtrate was then 
degassed for 2 hours before subsequent addition of 
1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐
methylphenyl)urea (0.98 g, 4 mmol). The mixture was 
then stirred and heated to 75 ⁰C for 6 days. Cooling 
and removal of the solvent led to the formation of the 
crude product as a brown powder.   
Purification was achieved by fractional recrystallisation of this brown powder with 
acetonitrile to remove the remaining reactants.  The final product was a lighter shade of 
brown than the crude (0.45 g, 0.34 mmol, 68%). 1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 
8.26 (1 H, s, H1), 7.40 (1 H, d, J 1.1, H3), 7.10 (2 H, m, H8), 6.85 (2 H, m, H9), 6.67 (1 H, 
br s, H7), 5.95 (1 H, t, J 5.7, H6), 1.13 (2 H, dt, H5), 2.55 (m, H thioether), 2.36 (2 H, t, J 
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6.9, H4), 2.05 (3 H, s, H10). 13C {1H} NMR: δC {1H} (101 MHz; DMSO) 155.68 (Cf), 138.43 
(Cb), 135.12 (Ce), 130.07 (Cg), 129.44 (Ch), 118.74 (Cj), 118.13 (Ci), 39.67 (Cd), 28.04 
(thioether C), 20.71 (Ck). FTIR: νmax/cm-1 3337 (NH), 1637 (CO), 1559 and 1451 (imid. 
ring). m/z (ESI-MS) 507.15 [(M-2CF3SO3)/2]2+, m/z (HRMS) 507.15 [(M-2 CF3SO3)/2]2+. 
Due to the impurity of the sample, elemental analysis did not give usable information. 
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Chapter 6 
Self-assembly of Platinum(II) and Palladium(II) complexes of imidazole 
compounds containing urea derivatives and their interaction with anions 
 
6.1 Background and Project Aims 
 
Platinum and Palladium are both d-block metals which are commonly found in 
oxidation states of +2 or +4. Platinum(II) and palladium(II) complexes are typically four 
coordinate while platinum(IV) and palladium(IV) are typically 6-coordinate.1 
Theoretically, 4-coordinate d8 platinum(II) and palladium(II) complexes could show 
either a tetrahedral or square planar geometry, but in reality, they are almost always 
square planar which can be explained in detail by crystal field theory.1 The Yam group 
has reported the anion binding behaviour of platinum-based host due to the hosts’ 
useful spectroscopic and luminescence properties.2 This work has been reviewed in 
detailed in Chapter 1 section 1.3.3. 
 
Recently, several square planar complexes based on Pt(II) and Au(III) have been 
extensively studied as supramolecular polymer precursors due to their ability to 
aggregate into discrete nanostructure linked by various non-covalent interactions.3–6 
Such aggregation has been reported by the Manners’ group, in which the platinum(II) 
complexes of polyethylene glycol-based ligands, 6.1 self-assemble forming functional 
(1D) supramolecular architectures.7 This assembly was facilitated by several 
interactions including metallophilic, hydrogen bonding and π-π interactions. In order to 
determine the Pt…Pt and π-π overlap in the complexes, various characterisation 
techniques including AFM microscopy, small-angle X-ray Scattering (SAXS), wide-
angled X-ray scattering (WAXS) and selected area diffraction (SAED) techniques have 
been employed. The characterisation techniques revealed the presence of narrow 
diameter fibers and the Pt…Pt stacking in the complexes has been confirmed by SAED, 
that showed a distinct reflection with a spacing of 0.323 nm, attributed to the known 
range of spacing for Pt…Pt stacking.8,9 These self-assembled materials possess 
interesting properties including electronic and emissive properties,3 resistance to 
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photobleaching10 and near IR excitation properties,4 which could be very useful in 
various applications particularly in the development of artificial photosynthesis,11,12 
solar cell applications13,14 and organic light-emitting diodes (OLEDs).15,16 
 
6.1 
 
Single-crystal X-ray diffraction analysis provides the most reliable structural 
information in the solid-state but, unfortunately, suitable crystals of supramolecular 
assemblies are often not easily obtained. Moreover, packing-forces may result in solid-
state structures different from those existing in solution, where, additionally, equilibria 
between different stoichiometries may occur. Thus, in the absence of good single 
crystals suitable for X-ray crystallography, the self-assembly properties of metal 
complexes can also be studied using Diffusion-ordered Spectroscopy (DOSY), a well-
established NMR technique that permits the separation of the NMR signals in a 
multicomponent mixture based on based on the translational diffusion of each 
chemical species in solution.17  
 
Since the 1990s, the dramatic development of the diffusion-ordered NMR 
spectroscopy (DOSY) technique, has made the investigation of aggregates in solution 
became much more accessible. This method enables the resolution of NMR spectra 
along a diffusion axis, thereby arraying resonances of aggregates by weight, as larger, 
higher molecular mass complexes diffuse more slowly than lower mass complexes thus 
giving a lower diffusion coefficient value. This technique is highly dependent on the 
size and shape of the molecule, as well as the physical properties of the surrounding 
environment such as viscosity, temperature, etc. There is a large volume of published 
studies utilising DOSY NMR techniques to characterise the aggregates that form in the 
solution mixture.18–21  
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For instance, Zheng and co-workers has developed a drug delivery supramolecular 
complex using coordination-driven self-assembly concept, in which a hexanuclear Pt(II) 
cage acts as the delivery vehicle with Pt(IV) prodrugs as the cargo.22 In this work, DOSY 
NMR was used to measure the size of the resulting supramolecular complex. Using the 
equation developed by Stang group,23 the diffusion coeffiecient (D) obtained from the 
DOSY was used to estimate the size of the structure. Results from DOSY NMR analysis 
has confirmed the encapsulation of the Pt(IV) drugs within the cage by comparing the 
diffusion coefficient (D) values of the cage alone (1.30 x 10-10 m2s-1) and the cage with 
the drugs (1.60 x 10-10 m2s-1).    
 
Figure 6.1 Representation of the host–guest complex (6.4) assembled from the Pt(IV) prodrug 
(6.2) and the Pt(II) cage (6.3). Reproduced with permission from reference 22. 
 
Undoubtedly, for coordination complexes, an appropriate NMR technique such as 
DOSY is of vital importance to monitor and distinguish mononuclear and polynuclear 
derivatives that form in the solution in situ as exemplified in the work of Ananikov and 
co-workers.24 With the advent of DOSY NMR, the identification of intermediate 
complexes in the catalytic carbon-sulfur bond formation reaction, [Pd(SPh)2(PPh3)2] 
and [Pd2(SPh)4(PPh3)2]  as mononuclear and polynuclear derivatives, respectively has 
been made possible. Other techniques such as 1H NMR and 31P NMR cannot be used to 
distinguish the nature of the palladium complexes in the mixture. Similarly, X-Ray 
crystallography analysis, while a powerful technique for structural characterisation of 
metal complexes, requires very high quality crystals that might only represent the 
most stable complexes, not the intermediates that form in the solution.  
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In another example, the DOSY NMR technique was employed to investigate the self-
association of [PtII(phen)(L1-S,O)]+ cations that form dimer aggregates in acetonitrile 
solution and water–acetonitrile mixtures of up to 30% (v/v) D2O–CD3CN.18 This self-
association was driven by cation–π stacking interactions as illustrated in Figure 6.2. It 
was found that by increasing the water content from >30% to 100% (v/v) D2O–CD3CN, 
the extent of aggregation also increased as a function of [PtII(phen)(L1-S,O)]Cl 
concentration. These aggregations result in the formation of nano-sized structures 
consisting of up to ca. 735 mononuclear as determined by diffusion coefficients 
obtained from DOSY NMR.   
 
Figure 6.2 Postulated ‘average’ structure of a {[PtII(phen)(L1 -S,O)]+ }2 dimer aggregate in 
solution based on 1H NMR shielding trends as a function of concentration. 
 
In this chapter we aim to produce platinum(II) and palladium(II) complexes of 
imidazole urea ligands and investigate their interaction with various anions. To study 
the interaction with the anions, the pincer-type complexes are required to form in cis-
configuration so that the urea groups can converge and hydrogen bond with the 
incoming anions. This can be achieved by using a combination of different types of cis-
blocking ligands such ethylenediamine (en), cyclohexanediamine (cyen) and 1,2-
bis(diphenylphosphino)ethane (dppe) with imidazole urea ligands to pre-organise the 
complex into a cis configuration. The use of chelating cis-blocked ligands has been 
exemplified in the work of many researchers.25,26 
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6.2 Results and Discussion 
 
6.2.1 Synthesis and characterisation of Platinum(II) and Palladium(II) complexes 
 
Cis-[Pt(en)Cl2] 6.5, prepared from K2PtCl4 and ethylenediamine, was converted to 
[Pt(en)(CF3SO3)2] in methanol solution (20 °C, 2 hours, in the dark) by using two 
equivalent of AgCF3SO3. After the removal of the greyish precipitate by filtration over 
celite, the yellow solution obtained was bubbled under a continuous nitrogen stream 
for 2 hours. Two equivalent of ligand 2.1 was then added to the solution and heated at 
75 °C for three days in 2-propanol to afford complex 6.9 (Scheme 6.1).   
 
 
Scheme 6.1 Synthesis pathway of the preparation of mixed-ligands Platinum(II) complexes. 
 
Complex 6.9 was obtained as a brown viscous solid or gum after multiple 
recrystallisations with different solvents and is soluble in acetone, acetonitrile, 
methanol, ethanol as well as dimethylsulfoxide. Complex 6.9 has been characterised 
by ESI-mass spectrometry as a doubly charged ion, [M-2(CF3SO3)¯]2+, m/zexptl 337.88 
due to the loss of the two CF3SO3 counter ions. Complex 6.9 also has been identified 
using High-Resolution Mass Spectrometry, in which the experimental value of m/z is 
consistent with the simulated m/z (Figure 6.3).  
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Figure 6.3 High-Resolution Mass Spectrometry data of complex 6.9. 
 
To our surprise, characterisation of complex 6.9 using 1H NMR spectroscopy in three 
different deuterated solvents namely MeOH-d4, DMSO-d6 and CD3CN revealed the 
presence of more than one species in solution. Initially, the first attempt of this 
reaction was carried out without the presence of nitrogen gas which suggested that 
the platinum(II) metal ion might have been oxidised to platinum(IV) ion resulting in the 
octahedral complexes, that could explain the presence of multiple products. Therefore, 
to eliminate the possibility in the formation of Pt(IV) complexes, for the second 
attempt, the reaction was performed under continuous nitrogen stream to eliminate 
the presence of oxygen that might contribute to the oxidation. Nevertheless, even 
with the absence of oxygen, the reaction still produced an apparent mixture of 
compounds which was confirmed by 1H NMR spectroscopy, showing ten proton signals 
assigned to the imidazole CH protons (in the 6.5 to 8.5 ppm region), very different 
from our expectation of only two resonances attributed to imidazole CH protons 
(Figure 6.4). The assignment of the signals is also challenging particularly in the 
methylene proton regions as most of the signals are overlapping with each other. 
While it is clear from the 1H NMR spectrum of complex 6.9 that there are several 
species present, their assignment cannot be made on the basis of this one-dimensional 
data alone.  
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Figure 6.4 1H NMR spectrum of complex 6.9 comparable to its free ligand 2.1 (inset picture). 
 
The 1H DOSY NMR experiment in CD3CN established the coexistence of four different 
compounds present in the solution mixture of complex 6.9, evident from four distinct 
layers of imidazole CH proton signals that are well-separated from each other (Figure 
6.5). In contrast, the rest of the proton signals are not well resolved as they are 
exchanging with one another. Using the diffusion coefficient equation developed by 
Morris group,27 the molecular weight of each species have been estimated (Table 6.1).  
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Figure 6.5 1H DOSY NMR spectrum of complex 6.9 in CD3CN.. 
 
The CD3CN was chosen as the solvent for DOSY NMR because there is no appreciable 
proton exchange of the imidazole protons with residual solvents, unlike the exchange 
that has been observed in the DOSY spectra of complex 6.9 in MeOH-d4 and DMSO-d6,. 
From the DOSY spectra of complex 6.9 in MeOH-d4, the CH1 and CH2 proton signals of 
the monomer show higher diffusion coefficients, 7.84 x 10-10 compared to the value in 
CD3CN most likely due to the exchange with the residual solvents. The higher diffusion 
coefficient value results from the average diffusion coefficients between those of the 
exchanging sites (Figure 6.6). 
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Figure 6.6 1H DOSY NMR spectrum of complex 6.9 in MeOH-d4. 
Table 6.1 Estimated molecular mass (g/mol) of the components of the mixtures found in the 
CD3CN solution of complex 6.9.  
Layer Diffusion 
Coefficient, Dobs 
(m2s-1) 
Estimated 
molecular mass 
(g/mol) 
 
Expected/theoretical 
molecular mass 
(g/mol) 
 
Difference 
(%) 
 
 
1 9.15 x10-10 1040.8 973.23 6.86 
2 7.13 x10-10 1912.6 1946.46 1.74 
3 6.39 x10-10 2517.9 2919.69 13.76 
4 5.80 x10-10 3222.7 3892.92 17.21 
 
Based on the estimated molecular mass (g/mol) obtained from the calculation, it is 
suggested that four different oligomers of Platinum(II) complexes have been formed. 
Layer 1 (the bottom layer) represents the monomer as it has smaller molecular weight 
and diffuses the fastest among all the oligomers. The subsequent layers represent the 
dimer, followed by the trimer and tetramer, respectively. From the ESI-MS spectrum of 
complex 6.9 in acetonitrile, several sets of peaks centred around m/z 339, 674, 1012 
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and 1347 are observed that are assigned to doubly charged ions of the monomer, 
dimer, trimer and tetramer, respectively (Figure 6.7).  
 
Figure 6.7 ESI-MS spectrum of complex 6.9 showing the presence of oligomers in the 
acetonitrile solution. 
 
The formation of these oligomers is possibly driven by Pt…Pt interactions and π-π 
stacking of the imidazole group as shown in previous reports.26,28 Variable temperature 
(VT) NMR spectroscopy was also performed to observe or rule out possible 
conformational changes within the complex or exchange between the different 
species. The NMR spectrum was recorded at 25°C, 50°C and 80°C (Figure 6.8). 
However, no appreciable change was observed on the chemical shifts of all protons of 
complex 6.9 nor in the overall appearance of the spectrum suggesting that the 
observation of multiple peaks does not arise from the presence of conformers able to 
exchange on the NMR timescale.  
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Figure 6.8 VT-NMR spectra of complex 6.9. 
 
We sought insight the role of ethylenediamine in the self-assembly of the complex by 
replacing the ethylenediamine ligand with R,R-1,2-cyclohexanediamine, to give 
complex 6.10. The precursor, cis-[Pt(cyclohexanediamine)Cl2] 6.6, prepared from 
K2PtCl4 and cyclohexanediamine, was converted to [Pt(cyclohexanediamine) (CF3SO3)2] 
in methanol solution (20 °C, 2 hours, in the dark) using two equivalent of AgCF3SO3. 
After the removal of the light grey precipitate by filtration over celite, the yellow 
solution obtained was bubbled under a continuous nitrogen stream for 2 hours. Two 
equivalents of ligand 2.1 was then added to the solution and the mixture heated at 75 
°C for three days to afford complex 6.10. Similar to complex 6.9, this compound also 
soluble in the same solvents, namely acetone, acetonitrile, methanol, ethanol as well 
as dimethylsulfoxide. Characterisation by ESI-mass spectrometry has confirmed the 
formation of complex 6.10 as doubly charged ion, [(M-2(CF3SO3¯)]2+, m/zexptl 364.68 
due to the loss of the two CF3SO3 counter ions. Complex 6.10 also has been identified 
using High-Resolution Mass Spectrometry, in which the experimental profile is 
consistent with the simulated spectrum (Figure 6.9).  
219 
 
 
Figure 6.9 High-Resolution Mass Spectrometry data for complex 6.10. 
 
Characterisation of complex 6.10 using 1H NMR spectroscopy was carried out in CD3CN 
similar with complex 6.9. 1H NMR spectrum of complex 6.10 also shows the presence 
of more than one species in the solution, similar to complex 6.9 (Figure 6.10). 
 
Figure 6.10 1H NMR spectrum of complex 6.10 comparable to its free ligand 2.1 (inset picture). 
Simulation 
Experimental 
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A 1H DOSY NMR experiment established the presence of three different species in the 
solution mixture of complex 6.10 evident from three distinct layers of imidazole CH 
proton signals that are well-separated from each other (Figure 6.11). The lowest layer 
is labelled as layer 1 while the rest of the layers are labelled accordingly. Based on the 
molecular mass calculated from the diffusion coefficient, the first layer corresponds to 
the trimer of complex 6.10, followed by pentamer and heptamer for the other two 
respective layers. While there are distinct signals observed in the imidazole region, the 
urea protons and methylene protons are not well resolved as they are exchanging with 
each other. Using the same equation as complex 6.9, an estimate of the molecular 
weight of each of the species has been calculated (Table 6.2).  
 
Figure 6.11 1H DOSY spectrum of complex 6.6 in CD3CN. 
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Table 6.2 Estimated molecular mass (g/mol) of both mixtures found in the CD3CN  solution of 
complex 6.10.  
Layer Diffusion 
Coefficient, 
Dobs (m2s-1) 
Estimated 
molecular mass 
(g/mol) 
 
Expected molecular 
mass (g/mol) 
 
Difference 
(%) 
 
 
1 5.6 x10-10 3527.0 1027.28*3 = 3081.84 14.4 
2 5.0 x10-10 5269.2 1027.28*5 = 5136.40 2.6 
3 4.4 x10-10 7050.5 1027.28*7 = 7190.96 1.9 
Note: Expected molecular mass for layer 1, 2 and 3 correspond to the molecular mass 
of trimer, pentamer and heptamer. 
 
From the ESI-MS spectrum of complex 6.10 in acetonitrile, several sets of peaks 
centred around m/z 366, 728, 1092 and 1455 are observed that might correspond to 
doubly charged ions of the monomer, dimer, trimer and tetramer, respectively. 
However, there is no ion mass related to the pentamer and heptamer suggesting that 
the ions of higher molecular weight oligomers might be fragmented into smaller ions 
during the experiment (Figure 6.12).   
 
Figure 6.12 ESI-MS spectrum of complex 6.10 showing the ion mass peaks correspond to the 
oligomers in the acetonitrile solution. 
 
From the data of complex 6.9 and 6.10, it is suggested that the aggregation of the 
complexes could be due to the synergistic effect of Pt-Pt stacking, π-π stacking and van 
der Waals interactions.29 To examine the effect of Pt-Pt stacking, a palladium analogue, 
complex 6.11 was synthesised. Complex 6.11 was synthesised from [Pd(en)Cl2] and the 
tert-butyl analogue, ligand 2.8 to give a bulkier terminal group. Pd(II) metal was chosen 
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because it is also a d8 metal which can give complexes of the same geometry as Pt(II). 
We hypothesised that replacing Pt(II) with Pd(II) could prevent or at least minimise the 
aggregation of the complex as the metallophilic (M-M) interaction in Pd(II) is weaker 
than Pt(II).30 Introducing the tert-butyl chain to the complex also could prevent van der 
Waals forces at the alkyl chain and inhibit the formation of the aggregates. Complex 
6.11 was prepared using a similar procedure as complex 6.9 and 6.10, but the reaction 
time was shortened to 24 hours as Pd(II) metal is more labile compared to Pt(II). The 
synthesis pathway of complex 6.11 is illustrated in Scheme 6.2. 
 
Scheme 6.2 Synthetic pathway of complex 6.11 from [Pd(en)Cl2] precursor. 
 
After 24 hours reaction, complex 6.11 was isolated as brown sticky solid, dried under 
vacuum and purified from multiple recrystallisations in nitromethane and acetonitrile. 
ESI-mass spectrometry data shows a mass peak, m/zexptl 421.28 which is difficult to 
assign but could be the doubly charged ion, [M/2 + 2 ACN + H+]+ of complex 6.11, (ACN 
is acetonitrile). To further confirm the mass of complex 6.11, an HR-MS experiment 
was performed and the data shows that there is no mass peak at 421.28 or 294.14 
(theoretical mass of triply charged ion of complex 6.11) suggest the targetted 
compound might not have formed (Figure 6.13). 
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Figure 6.13 HR-MS spectrum of complex 6.11. 
 
Complex 6.11 was also characterised by 1H and 13C NMR spectroscopy. The appearance 
of urea NH signals at the region of 5.88 to 5.60 ppm confirms the presence of ligand 
2.8. However, in the 1H NMR spectrum of complex 6.11 three sets of resonances are 
observed for the imidazole CH1 and CH2 protons as well as three sets of urea NH3 and 
NH4 peaks (Figure 6.14). This suggests that the complex might also aggregate to form 
oligomers, similar to complex 6.9 and 6.10. In contrast with complex 6.9 and 6.10, 
complex 6.11 is only partially soluble in acetonitrile and hence the 1H DOSY NMR 
experiment cannot be performed.  
 
Figure 6.14 1H NMR spectrum of complex 6.11. 
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From the data of complex 6.9, 6.10 and 6.11, it is suggested that the cis-blocking 
ligands, ethylenediamine and cyclohexanediamine could play some role in the 
aggregation of the complexes. To test this hypothesis, we attempted to synthesise 
another Pd(II) complex using cis-block ligand without an amine group, 1,2-
bis(diphenylphosphino)ethane (dppe). The precursor, [Pd(dppe)Cl2] (6.8) was 
synthesised by reacting K2PdCl4 in concentrated HCl with dppe for 6 hours at 90 °C.31 
Metathesis on precursor 6.8 was performed using silver(I) tosylate to replace the 
chloride ion. Silver chloride formed was then filtered over celite and the remaining 
filtrate was degassed under nitrogen for 2 hours. Ligand 2.8 was added to the solution 
and the mixture was heated to reflux for 24 hours in methanol. After 24 hours 
reaction, complex 6.12 was isolated as brown solid, dried under vacuum and purified 
from multiple recrystallisation in nitromethane and acetonitrile. From the ESI-MS 
spectrum of complex 6.12, no mass peak associated to the complex was observed. 
Meanwhile, from the 1H NMR spectrum (Figure 6.15), appearance of NH urea signals in 
the range of 5.66 to 5.80 ppm might suggest that complex 6.12 have been successfully 
synthesised.  
 
Figure 6.15 1H NMR spectrum of complex 6.12. 
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From the 1H NMR spectrum, at least three sets of each signal, H1 and H2 protons of 
imidazole and also urea NH can be seen. But unfortunately, complex 6.12 is only 
partially soluble in acetonitrile, thus 1H DOSY NMR cannot be performed to confirm the 
presence of oligomers as observed in complex 6.9 and 6.10. Therefore, there is no 
solid evidence that can confirm the role of amine (in ethylenediamine and 
cyclohexanediamine) in the aggregation of the synthesised complexes. 
  
6.2.2 Solution state anion binding studies of Pt(II) and Pd(II) complexes with chloride, 
fluoride and acetate ions. 
 
The solution state binding properties of complex 6.9 were investigated using 1H NMR 
spectroscopic titrations in CD3CN solvent with chloride, fluoride and acetate ion as 
tetrabutylammonium salts. This study was performed to show whether this complex 
can be used for anion sensing. During the titration, important signals namely the CH1 
and CH2 protons of imidazole as well as NH3 and NH4 protons of urea were followed 
to investigate the anion binding behaviour of the respective compounds. The first 
titration experiment was performed using chloride as the tetrabutylammonium salt. 
The addition of up to 4 equivalents of chloride does not impart any significant changes 
to the chemical shifts of the CH1, CH2, NH3 and NH4 protons (Figure 6.16). A plausible 
reason could be associated to the size of chloride ion that does not allow it to 
penetrate into the supramolecular network of complex 6.9. In many cases, the binding 
strength decreases with the increase of ion size.32 Since complex 6.9 is not responsive 
to chloride ion, titration with larger, less strongly hydrogen bond accepting halide ions 
such as bromide and iodide was not carried out.  
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Figure 6.16 Stack plot showing the 1H NMR spectrum of compound 6.9 in CD3CN in the 
presence of chloride ion as tetrabutylammonium salt. 
 
Another titration experiment with fluoride (as the tetrabutylammonium salt) was also 
carried out. From the previous chapters, all of the synthesised hosts including the free 
ligands interact with fluoride ion though acid-base interaction, in which the 
synthesised host play their role as acid versus the highly basic fluoride ion. Since 
complex 6.9 comprises different oligomers, the H1 and H2 protons of the imidazole 
group are labelled accordingly and followed throughout titration experiments. H1a and 
H2a represent chemical shifts of the monomer, H1b and H2b is attributed to the 
chemical shifts of the dimer, H1c1, H1c2, CH2c1 and CH2c2 chemical shifts belongs to 
the trimer and finally CH1d and CH2d represent chemical shifts of the tetramer. Upon 
the addition of one equivalent of fluoride ion, peaks of H1d (tetramer) and H1c2 
(trimers) start to broaden, meanwhile peak of H1b (dimer) becomes broad and shifts 
upfield. On the other hand, the addition of one equivalent of fluoride ion does not 
cause any significant changes on the chemical shifts of the urea NH protons (Figure 
6.17). Addition of two equivalents of fluoride ion cause the peaks of H1d and H1c2 to 
move further upfield. At this point too, the urea protons peaks start to broaden and 
overlap with each other. Subsequently, three equivalents of fluoride ion added results 
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in the broadening of the H1c1, H1b and H1d peaks into the baseline. After four 
equivalents, all imidazole protons have completely deprotonated leaving only H1c2 
and H2b, although both of these peaks broadens after the addition of five equivalents 
of fluoride. The urea proton signals also reduced in the intensity and start to disappear 
as well upon addition of more equivalents of fluoride. These data have shown that 
when fluoride ion was introduced to the complex, it deprotonates the imidazole 
protons of the larger oligomers first, namely the tetramer and trimer. Fluoride only 
deprotonates the imidazole protons of the dimer and monomer after three 
equivalents of fluoride has been added. This could suggest that higher molecular 
weight oligomers are more acidic and prone to deprotonation reaction with fluoride 
ion over lower molecular weight oligomers.  
 
Figure 6.17 Stack plot showing the 1H NMR spectrum of compound 6.9 in CD3CN in the 
presence of fluoride ion as the tetrabutylammonium salt.   
 
Complex 6.9 was also titrated with acetate as tetrabutylammonium salt in CD3CN. 
Similar to the titration with fluoride ion, the H1 and H2 protons of the imidazole were 
followed throughout the titration experiments. Addition of one equivalent of acetate 
ion results in the broadening of H1c1 and H1b signals, while H1d signal split into two 
separate peaks. On the other hand, upfield shifts were observed for H1c2, H2b, H2d 
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and H2c2. Subsequent addition of two equivalents of acetate led to the disappearance 
of one of the split peaks while the rest of the imidazole protons decrease in their 
intensity possibly indicative of their involvement in hydrogen bonding with the acetate 
ion. The complete disappearances of all imidazole proton signals except H1c2 and H2b 
indicate deprotonation. Meanwhile, incremental addition of acetate ion led to the 
broadening of urea NH peaks (Figure 6.18). 
 
Figure 6.18 Stack plot showing the 1H NMR spectrum of compound 6.9 in CD3CN in the 
presence of acetate ion as tetrabutylammonium salt.  
 
Similar to complex 6.9, a titration experiment of complex 6.10 was carried out in 
CD3CN. Complex 6.10 was titrated only with fluoride and acetate as 
tetrabutylammonium salts. Similar to complex 6.9, the H1 and H2 protons of imidazole 
in complex 6.10 were followed throughout the titration experiments. H1a and H2a 
represent theresonances of the trimer, H1b1, H1b2, H2b1 and H2b2 is attributed to 
the the pentamer, while H1c and H2c belongs to the heptamer. Addition of one 
equivalent of fluoride ion cause the broadening of H1c peak as well as slight upfield 
shift of H2a peak (Figure 6.19). The H1c peak shifts upfield and H2c signal has 
diminished after the addition of two equivalent of fluoride ion. All signals except H1b2 
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and H2a disappeared after four equivalent of fluoride ion added indicating 
deprotonation. Gradual addition of fluoride ion also cause deprotonation on urea NH.  
 
Figure 6.19 Stack plot showing the 1H NMR spectrum of compound 6.10 in CD3CN in the 
presence of fluoride ion as tetrabutylammonium salt.  
 
The same pattern has been obtained from the titration experiment of complex 6.10 
with acetate (Figure 6.20). This is possibly due to the basic nature of fluoride and 
acetate ion that allow acid-base reaction to occur. 
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Figure 6.20 Stack plot showing the 1H NMR spectrum of compound 6.10 in CD3CN in the 
presence of acetate ion as tetrabutylammonium salt.  
 
Anion binding studies were also performed on complex 6.11 in DMSO-d6 since complex 
6.11 is partially soluble in CD3CN. Complex 6.11 was titrated with three anions; 
fluoride, chloride and acetate as tetrabutylammonium salts. The titration experiment 
was performed only until 1.5 equivalent as complex 6.11 does not show any response 
to the addition of these anions (Figure 6.21 – 6.23). This could be the result of using a 
more competitive solvent, DMSO-d6 that hinders the interaction between the complex 
and the anions. 
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Figure 6.21 Stack plot showing the 1H NMR spectrum of complex 6.11 in DMSO-d6 in the 
presence of chloride ion as tetrabutylammonium salt  
 
 
Figure 6.22 Stack plot showing the 1H NMR spectrum of complex 6.11 in DMSO-d6 in the 
presence of fluoride ion as tetrabutylammonium salt  
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Figure 6.23 Stack plot showing the 1H NMR spectrum of complex 6.11 in DMSO-d6 in the 
presence of acetate ion as tetrabutylammonium salt. 
  
6.3 Summary 
 
A series of Pt(II) and Pd(II) complexes, 6.9 – 6.12 have been synthesised from the 
reaction of [Pt(en)Cl2] with ligand 2.1, Pt(cyclohexanediamine)Cl2 with ligand 2.1, 
[Pd(en)Cl2] with ligand 2.8 and [Pd(dppe)Cl2] with ligand 2.8, respectively. 1H DOSY 
NMR experiments have confirmed the presence of oligomers in complex 6.9 and 6.10. 
In acetonitrile solution complex 6.9 exists as a mixture of monomer, dimer, trimer and 
tetramer. Meanwhile, DOSY NMR data suggests that complex 6.10 comprises of larger 
size oligomers; trimer, pentamer and heptamer although these are not observed by 
mass spectrometry. On the other hand, the presence of oligomers in complex 6.11 and 
6.12 cannot be proved since both of the complexes are only partially soluble in 
acetonitrile and hence cannot be studied by DOSY NMR spectroscopy. It is suggested 
that the aggregation observed in these complexes is driven by metallophilic 
interactions, hydrogen bonding interaction and π-π stacking. 
 
Anion binding studies have been performed on complex 6.9, 6.10 and 6.11 towards 
three anions; chloride, fluoride and acetate as tetrabutylammonium in CD3CN and 
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DMSO-d6 (only for complex 6.11), respectively. Complex 6.9 has been found to interact 
with fluoride and acetate ion through deprotonation mechanism but was not 
responsive towards chloride ion. Complex 6.10 also interacts with fluoride and acetate 
ion in the same manner as complex 6.9. In contrast, complex 6.11 does not respond to 
all three anions. In a nutshell, these complexes might not be suitable for anion sensing, 
at least in competitive solvents but the aggregation behaviour of these complexes 
might be interesting for other application such as in the development of 
supramolecular gelators or photoluminescence materials. 
  
6.4 Experimental 
 
All solvents used in the synthesis and purification were of analytical reagent grade. 
Anhydrous solvents were prepared on an SPS solvent purification system. Commercial 
reagents were used as supplied, without further purification. 
 
6.4.1 Instrumentation and Analytical Measurements 
 
All NMR spectra were obtained from a Bruker Avance 400 at a frequency of 400 MHz 
for 1H and 100 MHz for 13C, while 1H, 13C, 1 H-1 H COSY, 1H-1 C HSQC and 1H-13C 
HMBC spectra were obtained from a Varian INOVA 500 spectrometer at a frequency of 
500 MHz for 1H and 125 MHz for 13C. All chemical shifts are reported in parts per 
million (δ) relative to tetramethylsilane as an internal reference. Electrospray 
ionisation (ESI) mass spectrometry was recorded on a TQD mass spectrometer 
instrument. Fourier transforms infrared spectra were recorded with a Perkin-Elmer 
Spectrum 100 FT-IR spectrometer in which for each spectrum, 64 scans were 
conducted over a spectral range of 4000 to 600 cm-1 with a resolution of 4 cm-1. 
Elemental analysis was performed using an Exeter Analytical CE-400 Elemental 
Analyser.  
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6.4.2 General Procedure for 1H NMR Spectroscopic Titrations 
 
All chemical shifts are reported in ppm relative to residual solvent, DMSO-d6.  A 
solution of the host species of known concentration typically 0.5-1.5mM, was made up 
in an NMR tube using the appropriate deuterated DMSO (0.5 ml).  Solutions of the 
anions, as TBA salts (1 ml) were made ten times the concentration of the host solution.  
The guest solution was typically added in 10 μl aliquots, representing 1 equivalents of 
the guest with respect to the host.  Larger aliquots were used in some cases where no 
inflection of the trace was evident.  Spectra were recorded after each addition and the 
trace was followed simultaneously.   
6.4.3 Synthesis of the Platinum(II) and Palladium(II) complexes 
 
Synthesis of [Pt(ethylenediamine)Cl2] (6.5) 
 
To a solution of K2PtCl4 (3.688 g, 8.85 mmol) in 0.01 M HCl solution (60 mL), a solution 
of ethylene diamine (0.6 mL, 8.85 mmol) in 0.01 M HCl (60 mL) was added. The mixture 
was then stirred for 12 h at 55-60 °C under reflux. After 2 h, a yellow-green solid started 
to precipitate. The solution was allowed to cool, and the compound formed, [Pt(en)Cl2], 
was filtered off, washed carefully with small amounts of water, ethanol, and diethyl 
ether, and dried under vacuum to give analytically pure material. Yield: 275 mg (0.894 
mmol, 73%). Anal. Calcd for C2H8Cl2N2Pt: C, 7.36; H, 2.47; N, 8.59. Found: C, 7.35; H, 
2.47; N, 8.62. 
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Synthesis of [Pt(cyclohexanediamine)Cl2] (6.6) 
 
To a solution of K2PtCl4 (3.688 g, 8.85 mmol) in 0.01 M HCl solution (60 mL), a solution 
of cyclohexane diamine (0.6 mL, 8.85 mmol) in 0.01 M HCl (60 mL) was added. The 
mixture was then stirred for 12 h at 55-60 °C under reflux. After 2 h, a yellow-green 
solid started to precipitate. The solution was allowed to cool, and the compound 
formed, [Pt(cyclohexanediamine)Cl2], was filtered off, washed carefully with small 
amounts of water, ethanol, and diethyl ether, and dried under vacuum to give 
analytically pure material. Yield: 2.74 g (8.4 mmol, 95%). Anal. Calcd for C6H14Cl2N2Pt: C, 
18.96; H, 7.31; N, 7.37. Found: H, 18.93; C, 3.67; N, 7.32. 
 
Synthesis of [Pd(ethylenediamine)Cl2] (6.7) 
 
To a solution of K2PdCl4 (2.614 g, 8 mmol) in 0.1 M HCl solution (25 mL), a solution of 
ethylenediamine (0.58 mL, 8 mmol) in 0.05 M HCl (150 mL) was added. The mixture was 
then stirred for 1 h at 62 °C under reflux. After 1 h, a yellow-orange precipitate was 
obtained. The solution was allowed to cool, and the compound formed, 
[Pd(ethylenediamine)Cl2], was filtered off, washed carefully with small amounts of 
water, ethanol, and diethyl ether, and dried under vacuum to give analytically pure 
material. Yield: 0.83 g (7 mmol, 87%). Anal. Calcd for C2H8Cl2N2Pd: C, 10.12; H, 3.40; N, 
11.80. Found: H, 10.12; C, 3.36; N, 11.71. 
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Synthesis of [Pd(1,2-Bis(diphenylphosphino)ethane)Cl2] (6.8) 
 
To a solution of K2PdCl4 (1.62 g, 4.96 mmol) in concentrated HCl solution (60 mL), a 
solution of 1,2-Bis(diphenylphosphino)ethane (2 g, 4.96 mmol) in ethanol (40 mL) was 
added. The mixture was then stirred for 6 h at 90 °C under reflux. After 6 h, a light 
yellow precipitate was obtained. The solution was allowed to cool, and the compound 
formed, [Pd(1,2-Bis(diphenylphosphino)ethane)Cl2], was filtered off, washed carefully 
with small amounts of water, ethanol, and diethyl ether, and dried under vacuum to 
give analytically pure material. Yield: 2.43 g (4.22 mmol, 85%). Anal. Calcd for 
C26H24Cl2P2Pd: C, 54.24; H, 4.20. Found: C, 54.24; H, 4.17. 
 
Synthesis of of  [(ethylenediamine)Pt(1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐
butyl)urea)2].2CF3SO3¯ (6.9)  
 
Formation of the [(ethylenediamine)Pt(CF3SO3)2] intermediate was achieved via by 
stirring compound 6.1 (0.81 g, 2.5 mmol) with silver trifluoromethanesulfonate (0.64 g, 
2.5 mmol) for 2 hours in methanol (100 mL) in the dark at room temperature. AgCl 
precipitate formed was removed by filtration over celite. The yellow filtrate was then 
degassed for 2 hours before subsequent addition of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐
butyl)urea (0.53 g, 2.5 mmol). The mixture was then stirred and heated to 70 ⁰C for 3 
days. Cooling and removal of the solvent led to the formation of the product as a 
brown viscous liquid.  (1.27 g, 1.88 mmol, 75%). 1H NMR: δH (400 MHz; DMSO-d6; 
237 
 
Me4Si) 12.64 (1 H, br s, H2), 8.47 (1 H, d, J 1.1, H1), 6.40 (1 H, s, H3), 5.84 (1 H, t, J 5.6, 
H6), 5.74 (1 H, t, J 5.6, H7), 3.17 (2 H, m, H5), 3.02 ( 2 H, m, H8), 2.52 (2 H, t, J 7.1 H4), 
1.12 (2 H, m, H9), 1.06 (2 H, m, H10) , 0.65 (3 H, t, J 8.0, H11). 13C {1H} NMR: δC {1H} 
(101 MHz; DMSO) 158.50 (Cf), 138.37 (Ca), 38.76 (Cc), 39.36 (Cb), 32.59 (Ce and Cg), 
32.53 (Cd), 19.95 (Ch and Ci), 14.18 (Cj). FTIR: νmax/cm-1 3371 (NH), 1654 (CO), 1599 and 
1432 (imid. ring), m/z (ESI-MS) 337.88 [(M-2(CF3SO3)¯)/2 + H+]+, m/z (HRMS) 337.88 
[(M-2(CF3SO3)¯)]2+. Anal. Calcd for C24H44F6N10O8PtS2: C, 29.60; H, 4.55; N, 14.38. 
Found: H, 29.99; C, 4.59; N, 14.24. 
 
Synthesis of [(cyclohexanediamine)Pt(1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐butyl) 
urea)2].2CF3SO3¯ (6.10)  
 
Formation of the [(cyclohexanediamine)Pt(CF3SO3)2] intermediate was achieved via by 
stirring compound 6.2 (0.95 g, 2.5 mmol) with silver trifluoromethanesulfonate (0.81 g, 
2.5 mmol) for 2 hours in methanol (100 mL) in the dark at room temperature. AgCl 
precipitate formed was removed by filtration over celite. The yellow filtrate was then 
degassed for 2 hours before subsequent addition of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐
butyl)urea (0.53 g, 2.5 mmol). The mixture was then stirred and heated to 70 ⁰C for 3 
days. Cooling and removal of the solvent led to the formation of the crude product as 
an brown solid (1.25 g, 1.7 mmol, 68%). 1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 12.64 
(1 H, br s, H2), 8.47 (1 H, d, J 1.1, H1), 6.40 (1 H, s, H3), 5.84 (1 H, t, J 5.6, H6), 5.74 (1 H, 
t, J 5.6, H7), 3.17 (2 H, m, H5), 3.02 ( 2 H, m, H8), 2.52 (2 H, t, J 7.1 H4), 1.12 (2 H, m, 
H9), 1.06 (2 H, m, H10) , 0.65 (3 H, t, J 8.0, H11). 13C {1H} NMR: δC {1H} (101 MHz; 
DMSO) 158.50 (Cf), 138.37 (Ca), 38.76 (Cc), 39.36 (Cb), 32.59 (Ce and Cg), 32.53 (Cd), 
19.95 (Ch and Ci), 14.18 (Cj). FTIR: νmax/cm-1 3372 (NH), 1655 (CO), 1599 and 1496 
(imid. ring), m/z (ESI-MS) 364.68 [(M-2(CF3SO3¯)]2+m/z (HRMS) 364.68 [(M-
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2(CF3SO3)¯)/2 + H+]+. Anal. Calcd for C28H50F6N10O8PtS2·2CH3CN: C, 34.62; H, 5.08; N, 
15.14. Found: H, 34.45; C, 5.13; N, 14.17. 
 
Synthesis of [(cyclohexanediamine)Pd(1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐tert-
butyl)urea)2]. 2CH3C6H4SO3¯ (6.11)  
 
Formation of the [(ethylenediamine)Pt(CF3SO3)2] intermediate was achieved via by 
stirring compound 6.3 (0.81 g, 2.5 mmol) with silver tosylate (0.70 g, 2.5 mmol) for 2 
hours in methanol (100 mL) in the dark at room temperature. AgCl precipitate formed 
was removed by filtration over celite. The yellow filtrate was then degassed for 2 hours 
before subsequent addition of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐tert-butyl)urea (0.53 
g, 2.5 mmol). The mixture was then stirred and heated to 70 ⁰C for 24 h. Cooling and 
removal of the solvent led to the formation of the product as a beige solid (1.85 g, 1.8 
mmol, 72%). 1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 12.64 (1 H, br s, H2), 8.47 (1 H, d, 
J 1.1, H1), 6.40 (1 H, s, H3), 5.84 (1 H, t, J 5.6, H6), 5.74 (1 H, t, J 5.6, H7), 3.17 (2 H, m, 
H5), 3.02 ( 2 H, m, H8), 2.52 (2 H, t, J 7.1 H4), 1.12 (2 H, m, H9), 1.06 (2 H, m, H10) , 0.65 
(3 H, t, J 8.0, H11). 13C {1H} NMR: δC {1H} (101 MHz; DMSO) 158.50 (Cf), 138.37 (Ca), 
38.76 (Cc), 39.36 (Cb), 32.59 (Ce and Cg), 32.53 (Cd), 19.95 (Ch and Ci), 14.18 (Cj). FTIR: 
νmax/cm-1 3383 (NH), 1655 (CO), 1599 and 1496 (imid. ring), Anal. Calcd for 
C36H58O8N10PdS2·2H2O: C, 44.78; H, 6.47; N, 14.51. Found: H, 44.58; C, 6.11; N, 14.09. 
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Synthesis of of  [(1,2-Bis(diphenylphosphino)ethane)Pd(1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐
(4‐tert-butyl)urea)2]. 2CH3C6H4SO3¯ (6.12)  
 
Formation of the [(1,2-bis(diphenylphosphino)ethane)Pt] (CF3SO3)2 intermediate was 
achieved via by stirring compound 6.4 (1.4 g, 2.5 mmol) with silver tosylate (0.69 g, 2.5 
mmol) for 2 hours in methanol (100 mL) in the dark at room temperature. AgCl 
precipitate formed was removed by filtration over celite. The yellow filtrate was then 
degassed for 2 hours before subsequent addition of 1‐[2‐(1H‐imidazol‐4‐yl)ethyl]‐3‐(4‐
tert-butyl)urea (g, 2.5 mmol). The mixture was then stirred and heated to 70 ⁰C for 24 
h. Cooling and removal of the solvent led to the formation of the product as a beige 
solid.  (1.95 g, 1.55 mmol, 62%). 1H NMR: δH (400 MHz; DMSO-d6; Me4Si) 12.64 (1 H, br 
s, H2), 8.47 (1 H, d, J 1.1, H1), 6.40 (1 H, s, H3), 5.84 (1 H, t, J 5.6, H6), 5.74 (1 H, t, J 5.6, 
H7), 3.17 (2 H, m, H5), 3.02 ( 2 H, m, H8), 2.52 (2 H, t, J 7.1 H4), 1.12 (2 H, m, H9), 1.06 
(2 H, m, H10) , 0.65 (3 H, t, J 8.0, H11). 13C {1H} NMR: δC {1H} (101 MHz; DMSO) 158.50 
(Cf), 138.37 (Ca), 38.76 (Cc), 39.36 (Cb), 32.59 (Ce and Cg), 32.53 (Cd), 19.95 (Ch and 
Ci), 14.18 (Cj). FTIR: νmax/cm-1 3371 (NH), 1652 (CO), 1597 and 1436 (imid. ring), Anal. 
Calcd for C60H74O8N8P2PdS2·2H2O: C, 55.27; H, 6.03; N, 8.59. Found: H, 55.18; C, 5.87; 
N, 8.49. 
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Chapter 7 
Conclusion 
 
The main aims of this work were to synthesise novel imidazole urea-based anion 
receptor compounds using both organic and transition metal cores. A series of imidazole 
urea ligands, comprising of different terminal groups ranging from aliphatic, branched 
and aromatic groups have been synthesised and characterised. Imidazole urea was 
chosen due to the availability of its cation binding site (imidazole nitrogen) and anion 
binding site (urea NH) that allows the interaction of these compounds with transition 
metal ions such as Cu(II), Co(II), Ni(II), Ag(I), Ru(II), Pt(II) and Pd(II) and anions such as 
halides, nitrate, acetate and benzoate. In Chapter 2, free imidazole urea ligands have 
been shown to form complexes in unidentate fashion with Cu(II), Co(II) and Ni(II). Crystal 
structures of these complexes also suggested that the anions such as chloride from the 
metal salts used form hydrogen bonds with the urea NH groups which influence how 
the molecules are packed. Halide binding experiments on the imidazole urea ligands 
show that the anion binding behaviour of these ligands was influenced by urea 
conformation along with imidazole tautomerism. Titration of ligands 2.6 and 2.7 
(imidazole urea bearing aromatic terminal group) with halide ions suggests the presence 
of isomers in which one of the isomers responds to the halide ion while the other one 
does not. This behaviour, however was only seen in imidazole urea bearing aromatic 
group but not in imidazole urea with aliphatic terminal groups. The ability of these 
compounds to interact with cations and anions has led us to use these compounds as 
metal and anion binding sites in synthesising preorganised anion receptor compounds 
based on organic and metal-organic scaffolds.   
 
In Chapter 3, these imidazole ureas have been reacted with silver salts of different 
counter ions such as silver(I) nitrate, silver(I) hexafluorophosphate, silver(I) 
tetrafluoroborate and silver(I) perchlorate. When silver(I) salts (except silver(I) nitrate) 
were added to the solution of 10 mg of ligand 2.3 (imidazole urea with dodecyl group) 
in 0.5 mL THF, THF: H2O (8:2), THF: H2O (7:3) and DMSO, after brief heating and sonicate, 
the solution turned into a gel instantaneously. The formation of a gel could be facilitated 
by the symmetrical hydrogen bonding between complexes as well as van der Waals 
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interactions of the hydrophobic alkyl chains. The obtained gel is not thermoreversible 
but it is stable for a period of weeks as long as it is stored in the dark. However, upon 
exposure to light, silver nanoparticles form as evidenced by a UV-Vis absorption band 
that develops at around 430 nm corresponded to typical surface plasmon absorption of 
silver nanoparticles. Addition of anions such as Cl¯, Br¯, NO3¯, acetate, HSO4¯, H2PO4¯ 
and oxalate interrupts the hydrogen bonding between the urea thus induced the 
transition from gel to solution. 
 
In Chapter 4, a series of preorganised hosts have been prepared using triethylbenzene 
and mesitylcalixarene cores. Titration of one of the tripodal hosts, 4.2 prepared using 
ligand 2.3 with chloride ion (as the tetrabutylammonium salt) in DMSO-d6 did not cause 
any significant changes to the chemical shift of the urea protons NH3 and NH4 although 
the free ligand itself, 2.3 shows moderate binding to the urea NH in CD3CN. In contrast, 
when titrated with fluoride and acetate ions in DMSO-d6, tripodal host, 4.2 showed 
colour changes of the solution from yellow to pink suggesting the deprotonation of 
imidazole protons, H1 and H2 by these strongly basic anions. A similar observation was 
also recorded for tripodal host 4.3 suggesting that this system might not be a suitable 
system for anion sensing, at least not in a competitive solvent. Another organic-based 
host, 4.6 based on a mesitylcalixarene core does not show any interaction with chloride, 
acetate and nitrate ions (as tetrabutylammonium salts). However, when the 
tetrabutylammonium salts were replaced with zinc salts, such as zinc(II) chloride, zinc(II) 
acetate and zinc(II) nitrate, there are some changes in the chemical shift of imidazole 
and urea protons observed in the 1H NMR spectra. A plausible explanation for this result 
could be that when the zinc metal coordinates to the imidazole nitrogen atom, while 
the anions of the salt disrupt the hydrogen-bonding network formed by the imidazole 
moiety.  
 
 
Apart from organic-based hosts, transition metal-based hosts have also been prepared 
using Ru(II), Pt(II) and Pd(II) precursors (Chapters 5 and 6). Three [9]ane-S3-capped Ru(II) 
complexes of imidazole ureas, 5.1-5.3 have been synthesised and characterised. The 
interaction of these complexes with anions such as chloride, fluoride, acetate, benzoate 
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and hydrogen sulphate ions have been studied using 1H NMR spectroscopy in DMSO-d6. 
Complex 5.2 containing a dodecyl terminal group only responds to basic anions such as 
fluoride, acetate and benzoate. Addition of fluoride induces deprotonation of complex 
5.2, while the addition of acetate and benzoate separates the proton NMR signals into 
two different sets, in which one set shows a response to the ions while the other does 
not. In contrast, complex 5.3 with a methylphenyl terminal group, only interacts with 
chloride and fluoride ion. Chloride ions form hydrogen bonding with the urea NH while 
fluoride ion deprotonates the urea NH. The results suggest that these complexes too 
might not be suitable for anion sensing purposes at least in a competitive solvent such 
as DMSO-d6.  
 
On the other hand, a series of Pt(II) and Pd(II) complexes, 6.9 – 6.12 have been 
synthesised from the reaction of [Pt(en)Cl2] with ligand 2.1, Pt(cyclohexanediamine)Cl2 
with ligand 2.1, [Pd(en)Cl2] with ligand 2.8 and [Pd(dppe)Cl2] with ligand 2.8, 
respectively. Complexes 6.9 and 6.10 have been shown to form a mixture of oligomers, 
evidence from the 1H DOSY NMR spectra. Complex 6.9 self-assembles in acetonitrile 
solution forming monomer, dimer, trimer and tetramer while complex 6.10 self-
assembled and formed larger oligomers; trimer, pentamer and heptamer. Complex 6.11 
also shows different sets of proton NMR signals which might result from oligomerisation 
although this behaviour was not confirmed by 1H DOSY NMR. The aggregation observed 
in these complexes could possibly be driven by metallophilic interactions, hydrogen 
bonding interaction and π-π stacking. The interaction of complex 6.9 - 6.11 with 
chloride, fluoride and acetate ions was studied using 1H NMR spectroscopy in CD3CN (for 
complex 6.9 and 6.10) and DMSO-d6 (for complex 6.11). The result shows that 
complexes 6.9 and 6.10 only interact with fluoride and acetate ion through 
deprotonation mechanism but were not responsive towards chloride ion, while complex 
6.11 does not interact with any of the three ions studied.  
 
